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This thesis is about the effectiveness of psychological treatments for adult patients 
with eating disorders, a range of psychiatric disorders for which treatment outcome 
is still rather poor. Since 1996, when I first started working with eating disorder 
patients, I was struck by the profound impact eating disorder psychopathology has 
on daily life of the women and men seeking treatment. For patients with anorexia 
nervosa, in particular, there is considerable  room for improvement when it comes 
to remission rates. This motivated us to seriously reconsider the treatment we were 
offering to patients with anorexia nervosa at Novarum, the center for eating disor-
ders & obesity in Amsterdam, were I started working in 2003. For anorexia nervosa, 
only a limited number of specialized psychological treatments is available and, as 
research on their clinical outcome is still at an early stage, findings about their effica-
cy are inconclusive as solid research on clinical outcome is still early. Exploring liter-
ature on the efficacy of psychological treatments of anorexia nervosa was a rather 
humbling experience, which will be discussed in the first part of this thesis. 
 
The second part of this thesis focuses on the effectiveness of cognitive behavior 
therapy-enhanced (CBT-E), a psychological treatment developed by Professor Fair-
burn et al. at Oxford University, which, due to its richness, impressed us at Novarum. 
The reported outcome of two CBT-E, academic efficacy studies run by Fairburn et 
al. in 2009 (including normal weight eating disorder patients) and in 2013 (including 
underweight patients from BMI 17.5 onwards) were promising. With regard to feasi-
bility of CBT-E, in 2011, an Australian CBT-E effectiveness study including low weight 
patients, set in a routine setting, showed findings in line with the 2009 CBT-E original 
efficacy study (Byrne et al., 2011). In 2013, an Italian inpatient efficacy study including 
severely underweight patients was published, in which the inpatient unit of an eating 
disorder treatment center was redesigned according to CBT-E key principles (Dalle 
Grave, 2012; Dalle Grave et al., 2013).
After being trained by Professor Fairburn, we started planning implementation 
of CBT-E throughout Novarum, hoping that, in line with earlier findings, changing 
to offering empirically supported treatment interventions might improve clinical 
outcome (Kazdin, Fitzsimmons-Craft, & Wifley, 2017; Waller & Turner, 2016). In 2015, 
we redesigned our treatment center according to CBT-E principles and started offer-
ing CBT-E to all our inpatients and outpatients with anorexia nervosa, bulimia nervo-
sa, binge eating disorder or with other specified feeding or eating disorders. After 
the implementation, we examined whether outcomes of academic trials can be repli-
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patients (Royal Australian and New Zealand College of Psychiatrists, 2014). The physical 
consequences of eating disorder behaviors can be very serious and may lead, besides 
risks to physical health, to cognitive and psychological dysfunctions which in turn 
contribute to maintaining eating disorder pathology. Consequently, when treating 
eating disorder patients, being fully aware of all possible associated physical risks 
and their subsequent effects on cognitive and psychological functioning is crucial. 
This is of particular relevance in underweight eating disorder patients and / or in 
eating disorder patients who under-eat while having a normal weight. 
At the other end of the spectrum, when treating eating disorder patients who 
are (morbidly) obese, it is as essential to understand physical risks associated with 
obesity. 
Therapists also need to be aware that people with eating disorders may be vulner-
able to stigma and shame (National Institute for Health and Care Excellence, 2017).
Prevalence eating disorders
Among young European females, anorexia nervosa is reported by <1–4%, 
bulimia nervosa by <1–2%, binge eating disorder by <1–4%, and subthreshold eating 
disorders by 2–3%. Among European men, 0.3–0.7% report an eating disorder 
(Keski-Rahkonen & Mustelin, 2016). Although anorexia nervosa is a relatively rare 
disorder in many non-western countries, bulimia nervosa and binge eating disorder 
are common disorders around the world (Hoek, 2016). Literature suggests that the 
incidence of anorexia nervosa appears stable and that of bulimia appears be declin-
ing (Keski-Rahkonen & Mustelin, 2016), although a recent study suggests that the 
weighted means of point prevalence for eating disorders increased from 3.5% in the 
2000–2006 period to 7.8% in the 2013–2018 period (Galmiche, Déchelotte, Lambert, 
& Tavolacci, 2019). The findings may be conflicting, partly because DSM-5 includes a 
considerably revised eating disorder section compared with earlier editions (Smink, 
van Hoeken, Oldehinkel, & Hoek, 2014). 
Although the numbers of individuals receiving treatment have increased, only 
about one-third is detected by healthcare (Keski-Rahkonen & Mustelin, 2016).
Treating anorexia nervosa
There is a growing body of evidence supporting the efficacy of family treatment for 
adolescents and children with anorexia nervosa (Royal Australian and New Zealand 
College of Psychiatrists, 2014; National Institute for Health and Care Excellence, 
cated in a real world setting for all referred inpatients and outpatients, with all staff 
members delivering CBT-E interventions. Besides clinical outcome, direct treatment 
costs of CBT-E and treatment-as-usual were compared.  
In Part II of this thesis, findings of two consecutive cohort studies are presented; 
Chapter 3 presents findings on differential (cost-)effectiveness of treatment-as-usual 
and CBT-E for inpatients and outpatients with a body mass index (kg/m2) over 17.5. 
Chapter 4 then presents  findings on differential (cost-)effectiveness of CBT-E Under-
weight and treatment-as-usual on inpatients and outpatients with anorexia nervosa. 
Around the time when I started working at Novarum, in 2003, bariatric surgery 
(mainly gastric banding) started becoming treatment of first choice for morbidly 
obese patients, and we saw the first bariatric patients seeking specialized psycho-
logical help. Despite the fact that they did lose excess weight, they had developed 
post-operative binge eating and started to regain weight, or their daily functioning 
was still affected by a poor body image. Although bariatric surgery is beneficial 
for a significant number of severe obese individuals, and ameliorates the physical 
risks associated with obesity, in those days, we as eating disorder therapists struggled 
to come to terms with the surgery. We wondered to what extent the behavioral 
and psychological factors associated with loss of control over eating, reported by a 
considerable number of morbidly obese individuals, might benefit from a surgical 
procedure targeted at the somatic aspects of obesity and were somewhat doubtful 
about the long-term success of bariatric surgery for at least a subgroup of severe 
obese patients. 
Part III of this thesis gives an account of our search to optimize clinical benefits and 
post-operative mental well-being by increasing understanding of the psychological 
and behavioral factors related to both suboptimal weight loss and to post-operative 
(re)development of eating disorder pathology.
Before the different chapters and the accompanying hypotheses are described in 
more detail, a brief overview of both the prevalence of eating disorders and (morbid) 
obesity will be given. This is followed by a description of efficacy and effectiveness of 
recommended psychological therapies for eating disorders and obesity.
Prevalence	and	treatment	of	eating	disorders
The eating disorder section in the American Psychiatric Association DSM-5 edition 
includes the following classifications: anorexia nervosa, bulimia nervosa, binge 
eating disorder and other specified feeding or eating disorders (American Psychiatric 
Association, 2013). Eating disorders affect both mental and physical well-being of 
Chapter	1Chapter	1
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materials (National Institute for Health and Care Excellence, 2017).
In the systematic review by De Jong et al., posttreatment remission rates ranged 
from 22% to 68% for bulimia nervosa, binge eating disorder and atypical, non-under-
weight eating disorders (De Jong, Schoorl, & Hoek, 2018).
 
Status	Cognitive	behavior	therapy-Enhanced	
Individually based Cognitive behavior therapy for eating disorders, like CBT-E, 
is the leading empirically supported treatment for bulimia nervosa and for binge 
eating disorder (National Institute for Health and Care Excellence, 2004; National 
Institute for Health and Care Excellence, 2017). Starting in 2003, the cognitive 
behavioral treatment for bulimia nervosa as developed by Fairburn et al. at Oxford 
University was adapted to make it suitable for the whole range of eating disorders, 
including anorexia nervosa, by focusing on modifying the mechanisms supposed to 
perpetuate all forms of eating disorder psychopathology. In 2008, the new enhanced 
form of the treatment (CBT-E) was officially published (Fairburn, 2008; Fairburn, 
Cooper, & Shafran, 2003). 
CBT-E, an individually based treatment, takes different forms, the regular CBT-E 
has been developed for eating disorder patients with normal weight. For underweight 
eating disorder patients with a minimum BMI of 15 who can safely be treated in an 
outpatient setting, CBT-E Underweight has been developed (Fairburn, 2008). Both the 
normal weight and the underweight version can be delivered in the so-called focused 
version, which is the core treatment, or in the so-called broad version. The CBT-E 
broad version is designed for eating disorder patients who are additionally diagnosed 
with comorbid psychopathology of interpersonal difficulties, core low self-esteem 
and /or clinical perfectionism.
The default version of CBT-E for normal weight eating disorder patients takes 
20 sessions; CBT-E Underweight takes up to 40 sessions, depending on the degree of 
underweight (Fairburn, 2008). 
With regard to effectiveness, Fairburn et al. reported the following findings on 
CBT-E focused version for normal weight patients in 2009: at end of treatment, 51.3% of 
patients were in remission, defined as having a global EDE-score below one standard 
deviation above the community mean (i.e. below 1.74). Of the 77.9% of patients 
completing treatment, 66.1% were in remission (Fairburn et al., 2009). In the 2015 
study for normal weight patients, 65.5% of patients were in remission at end of treat-
ment. Of the 73.8% of patients completing treatment, 75% were in remission at end 
of treatment (Fairburn et al., 2015).
2017). For adults with anorexia nervosa, eating-disorder-focused CBT, Maudsley 
Anorexia Nervosa treatment for Adults (MANTRA; Schmidt, Wade, & Treasure, 
2014) and Specialist Supportive Clinical Management (SSCM; McIntosh et al., 2006) 
are the recommended psychological treatments (National Institute for Health and 
Care Excellence, 2017). There is a lack of evidence for  prioritizing one specialized 
psychological treatment over the other (Hay, Claudino, Touyz, & Abd Elbaky, 2015). 
Furthermore, evidence is lacking for prioritizing specialized over non-specialized, 
control treatments regularly offered in routine practice (Zeeck et al., 2018; Murray, 
Quintana, Loeb, Griffiths, & Le Grange, 2019). 
Treatment is being offered in outpatient, day patient (partial hospitalization), and 
inpatient settings, and no conclusive recommendations can be made with regard to 
optimum treatment setting (Madden, Hay & Touyz, 2015; Hay et al., 2019). Guidelines 
do however agree on hospital admission in case of high medical or psychiatric risk 
(Hay et al., 2019).
Anorexia nervosa is the most difficult to treat eating disorder, with outcomes 
for adult patients being weaker compared with non-underweight eating disorder 
patients (Waller, 2016). Around 30% of patients recover in the first decade of the 
disorder (Wonderlich, Bulik, Schmidt, Steiger, & Hoek, 2020) and recent data suggest 
that approximately another third of patients followed through a second decade will 
also recover (Eddy et al., 2017; Wonderlich, Bulik, Schmidt, Steiger, & Hoek, 2020). At 
the same time, reluctance to engage in treatment is common (Fairburn et al., 2013).
In clinical practice, making actual use of the recommended specialized treat-
ments is slow, especially for (inpatient) underweight eating disorders patients, despite 
findings indicating that the use of evidence-based interventions can enhance clini-
cal outcomes (Thompson-Brenner et al., 2018; Kazdin, Fitzsimmons-Craft, & Wifley, 
2017; Waller & Turner, 2016).
Treating bulimia nervosa and binge eating disorder 
For adult patients with bulimia nervosa, international guidelines recommend 
bulimia-nervosa-focused guided self-help, using cognitive behavioral self-help mate-
rials for eating disorders. If guided self-help is unacceptable, contraindicated, or 
ineffective after 4 weeks of treatment, individual eating-disorder-focused cognitive 
behavioral therapy is recommended as preferred, empirically-supported treatment 
(Royal Australian and New Zealand College of Psychiatrists, 2014; National Institute 
for Health and Care Excellence, 2017). For adults with binge eating disorder, the 
National Institute for Health and Care Excellence recommends a binge-eating-dis-
order-focused guided self-help program, based on cognitive behavioral self-help 
Chapter	1Chapter	1
1514
affects mental well-being. Obesity is clearly associated with an increased risk of 
depression, with gender acting as a moderating factor, obese women are more likely 
to experience a mood disorder (Luppino et al., 2010). Literature suggests that 30% of 
obese individuals seeking weight control treatment might be diagnosed with a binge 
eating disorder (de Zwaan, 2001; Meany, Conceição, & Mitchell, 2014). Compared to 
non-binging obese individuals, obese binge eating disorders patients were found 
to have a higher prevalence of psychiatric disorders (Hudson, Hiripi, Pope, Jr., & 
Kessler, 2007). In obese individuals opting for bariatric surgery, findings indicate a 
pre-operative prevalence of axis I disorders between 27% and 42%, mainly consisting 
of affective disorders, anxiety disorders and eating disorders (Herpertz et al., 2004). 
Pre-operative prevalence of axis II disorders, is estimated between 22% and 24% of 
individuals (Herpertz et al., 2004).
Treating obesity
In 2014, international guidelines recommended multicomponent interventions 
for the treatment of obesity, weight management programs should include behavior 
change strategies to increase people’s physical activity levels or decrease inactivity, 
improve eating behavior, improve the quality of the person’s diet, and reduce energy 
intake (National Institute for Health and Care Excellence, 2014). 
As non-surgical interventions aimed at morbid obesity are usually ineffective in 
the long run, weight loss surgery has been suggested as the most effective method to 
lose weight (Wimmelmann, Dela, & Mortensen, 2014). Weight loss surgery is recom-
mended for adults with acceptable surgical risk and a BMI over 40, or over 35 when 
major obesity-related morbidities are involved (National Institute for Health and Care 
Excellence, 2014). In addition, in the Netherlands, earlier non-surgical weight loss 
interventions must have proven ineffective in order to apply for bariatric surgery.
Although the majority of patients achieve a successful degree of excess weight 
loss after surgery, 20-30% of patients experience suboptimal weight loss (Livhits et 
al., 2011). Factors associated with this poorer weight loss are being male, having a 
lower socioeconomic status, having super obesity (BMI ≥ 50) at time of surgery, and 
a relatively older age (Livhits et al., 2011; Wimmelmann et al., 2014). Post operatively, 
the following areas of functioning are associated with poorer weight loss: (a) reported 
disturbed eating behaviors, (b) poor adherence to post-operative treatment plan and 
(c) poor psychological functioning (Hindle, De la Piedad Garcia & Brennan, 2017).
Whether the presence of psychopathology should be considered an impediment 
to bariatric surgery is controversial (Wimmelmann et al., 2014). In their systemat-
ic review, Herpertz et al. (2004) state that, apart from serious psychiatric disorders 
In a 2011 Australian CBT-E effectiveness study, the proportion of patients in 
remission resembled the percentage found in the Fairburn 2009 study (Fairburn et 
al., 2009; Byrne et al. 2011). The main difference with the Fairburn efficacy study was 
the drop-out rate, which was substantially higher in the Australian trial (40% versus 
22.1%) (Byrne et al., 2011).
In 2013, Fairburn et al. presented findings of their CBT-E Underweight study for 
anorexia nervosa patients with a BMI between 15 and 17.5. For the 64% of patients 
completing treatment, there was a substantial increase in BMI (mean 2.77 kg/m2, 
SD 1.81). Healthy weight was reached by 62% of patients who completed treatment. 
A 2013 CBT-E inpatient study by Dalle Grave et al., including severely underweight 
patients, found 86.1% of completers achieved body mass index ≥ 18.5. Six months 
after discharge, during which the majority of patients received outpatient treatment, 
38.8% of adult patients still had a healthy weight (Dalle Grave et al., 2013).
Over the last five years, particularly for normal weight adult patients with bulimia 
nervosa, binge eating disorder and atypical eating disorders, the evidence base of 
cognitive behavioral therapy-enhanced as leading approach has broadened (Waller, 
2016; Hilbert, Hoek, & Schmidt, 2017; De Jong, Schoorl, & Hoek, 2018). In the 
systematic review of De Jong et al. posttreatment remission rates for normal weight 
eating disorders were found ranging from 22 % to 68%; the found wide range was 
partly explained by differences in samples and in used outcome measures (De Jong, 
Schoorl, & Hoek, 2018). 
A review published in 2016, including three studies apart from the Oxford group, 
suggests that CBT-E Underweight does moderately well, with approximately 30% 
of patients with anorexia nervosa entering treatment recover by end of outpatient 
therapy (Waller, 2016). 
Eating	disorders	and	obesity
Obesity is defined as abnormal or excessive fat accumulation that may impair 
health. Its fundamental cause is an energy imbalance between the consumption 
and expenditure of calories (World Health Organization, 2020). Worldwide, the prev-
alence of obesity has nearly tripled since 1975, with 13% of adults (11% men,15% 
women) being obese, i.e. having a body mass index (BMI: kg/m2) of 30 or higher 
(World Health Organization, 2020). The prevalence of morbid obesity (BMI ≥ 40) 
worldwide, is estimated at 0.64% in men and 1.6% in women (NCD Risk Factor 
Collaboration, 2016).
Besides the associated serious physical health risks, being (morbidly) obese also 
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At the same time, a psychological, specialized treatment method offers a frame-
work, a language in which the multifarious interventions are offered, rather than the 
eclectic framework usually offered in control conditions. As an eclectic approach 
may dilute the efficacy of the interventions offered, we hypothesized that a special-
ized treatment would enhance clinical outcome. 
Part	II includes Chapter	3 and Chapter	4 which examine the effects of the CBT-E 
implementation in 2015 within the outpatient and inpatient settings of our treat-
ment center. In these chapters, two consecutive cohort studies are presented, using 
a nonequivalent control group pretest-posttest design in consecutive cohorts, in which 
we examined differential effectiveness and cost-effectiveness between two cohorts, 
one was offered treatment-as-usual, thereafter, the next cohort was offered CBT-E. 
The first cohort of outpatients and inpatients received optimized treatment-as-usu-
al between 2012-2014, the next cohort of all referred outpatients and inpatients was 
offered CBT-E between 2015-2017. The aims of the studies presented in Chapter 3 and 
4 were twofold; first, to examine whether similar treatment outcomes as in CBT-E 
efficacy studies can be found in a real-world setting. Second, we examined differ-
ential cost-effectiveness of CBT-E compared to treatment-as-usual. Examining cost- 
effectiveness of recommended, specialized treatments beside effectiveness is valu-
able (Crow et al., 2013), and may contribute to decision making on what treatment 
best to offer in clinical practice. Cost-effectiveness studies in the field of eating disor-
ders are rare. 
Chapter 3 examines differential (cost-) effectiveness for eating disorder patients 
with a body mass index (kg/m2) over 17.5, and Chapter 4 examines differen-
tial outcome for patients with anorexia nervosa who regularly get to be admitted 
in an inpatient unit in the course of their treatment. We hypothesized that for both 
normal weight eating disorder patients and underweight eating disorder patients, 
CBT-E would be superior to treatment-as-usual, both on effectiveness and on cost- 
effectiveness, as we assumed that offering a specialized psychological treatment 
would enhance clinical outcome compared to a more eclectic approach. As out- 
patient CBT-E treatment has a fixed duration, and as the duration of the CBT-E based 
inpatient stay is limited by nature, we assumed a reduction in direct treatment costs 
in both the CBT-E normal weight and the underweight cohorts. 
In Part	 III, including the Chapters	5 and 6, the focus shifts from underweight 
eating disorders and normal weight eating disorders to obesity. Both chapters focus 
on the psychological and behavioral factors associated with effects of bariatric 
surgery. A brief report is presented in Chapter 5 describing how, from 2004 onwards, 
when the knowledge of the association between psychological and behavioral factors 
and clinical outcome after bariatric surgery was still limited, Novarum developed a 
including personality disorders, psychiatric comorbidity appears to be of more 
predictive value for mental and physical well-being after surgery, than that it is 
predictive for weight loss.
In the Netherlands, some hospitals exclude patients who are diagnosed with a 
binge eating disorder or other specified feeding or eating disorder similar to binge 
eating disorder. Those patients are referred for treatment of their disturbed eating 
behavior to a specialized eating disorder facility, prior to surgery. 
Literature suggests that, in some cases, pre-operative binge eating pathology 
disappears after surgery, while, at the same time, it is reported that post-operative 
disturbed eating behavior may develop though not being present pre-operatively 
(Meany, Conceição, & Mitchell, 2014). Post-operative, early identification of psycho-
social factors negatively associated with suboptimal weight loss, such as loss of 
control over eating and low motivation for behavior change, may help improve the 
overall efficacy of bariatric surgery (Sheets et al., 2015).
Outline	of	this	thesis
Part	I consists of Chapter	2	and concerns the efficacy of specialized psychological 
treatments for anorexia nervosa. As there has been a recent increase of high-quality 
randomized controlled trials, run with newly developed psychological treatments, 
it made sense to conduct a meta-analysis examining whether the evidence base for 
specialized psychological treatments can be broadened. Previously, no significant 
benefits of specialized treatments over control conditions on either weight regain 
or decrease of eating disorder psychopathology, could be established. In Chapter 2, 
we systematically assess whether specialized treatments for anorexia nervosa are 
superior to non-specialized, control treatments, by conducting a meta-analysis. We 
hypothesized that a difference in treatment effect would be found on either weight 
regain or on the improvement of eating disorder pathology, in favor of specialized 
psychological treatments.
 
Since for anorexia nervosa a multimodal treatment, aimed at nutritional & phys-
ical rehabilitation, besides targeting the eating disorder psychopathology, is recom-
mended for patients with anorexia nervosa, examining the benefits of psychological 
interventions when treating severe anorexia nervosa patients is complicated. Conse-
quently, various types of multifarious interventions (i.e. somatic- nutritional-, phar-
macological- and psychological interventions) are offered, particularly when under-
weight patients are treated within an inpatient setting. The effect of psychological 




psychological, multimodal group-based treatment, in collaboration with a general 
hospital, for morbidly obese patients awaiting surgery. This report includes a brief 
description of two pilot cohort studies in which treatment outcome of this group-
based treatment was examined, both for participants opting for surgery and for obese 
participants who did not. Chapter 6 presents a cross-sectional cohort study, aimed at 
identifying post-operative demographic, behavioral and psychological factors asso-
ciated with suboptimal weight loss in participants who have had bariatric surgery. 
We hypothesized that as the presence of eating disorder pathology may interfere 
with the ability to adhere to the recommended postsurgical eating pattern, reported 
post-operative eating disorder pathology was associated with suboptimal weight loss, 
Part	IV consists of the Chapters	7,	8 and 9. In Chapter 7 we provide a general 
discussion of our main findings, limitations and clinical implications. We conclude 
this thesis with two summaries, a general summary in Chapter 8, followed by a Dutch 
summary in Chapter 9.
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Objective: This meta-analysis examines the efficacy of recently developed psycho-
logical treatments for anorexia nervosa, compared with control condition. Outcome 
criteria are weight gain, eating disorder pathology and quality of life. 
Method: Twelve thousand nine hundred ninety-seven abstracts, published 
between 1980 and 2017, were retrieved. End-of-treatment data from 1,279 partici-
pants, from 15 of 17 eligible studies, were used to calculate pooled effect sizes (Hedg-
es’ g) for outcome using random-effects model. Subgroup analyses were used to 
explore the influence of various patient- and study characteristics. 
Results: No significant differences between psychological treatment and controls 
were found on weight gain, g = 0.07, 95% CI [-0.09, 0.23], eating disorder pathology, 
g = 0.06, 95% CI [-0.10, 0.21] and quality of life, g = -0.11, 95% CI [-0.36, 0.15]. Studies 
including only patients over 18 years of age were more effective on weight gain than 
studies including adolescents as well. High-quality studies and studies with reported 
therapist training, had larger effects on weight gain and quality of life compared with 
low-quality studies and studies without reported training. 
Conclusions: Despite progress in the development of specialized treatments, 
the efficacy of psychological treatment over an active control condition could not 
be established. Outcomes, however, are obscured by low-quality and heterogenous 
studies. 
Introduction
Anorexia nervosa is a mental disorder with a poor prognosis (Galsworthy-Francis 
& Allan, 2014) and significant impact on the psychological and physical well-being 
of affected individuals (Hay et al., 2014). Anorexia nervosa has one of the highest 
mortality rates of all mental disorders (American Psychiatric Association, 2006). The 
American Psychiatric Association DSM-5 diagnostic criteria for anorexia (American 
Psychiatric Association, 2013) include self-imposed or maintained weight loss such 
that the person is underweight (for age and height) and associated over-evaluation of 
(the control of) shape and weight. 
Although there is a growing body of evidence that supports the efficacy of family 
treatment for adolescents and children, (Hay et al., 2014; NICE, 2017), there is a lack 
of high-quality evidence to guide the clinician in the treatment of adults who have 
anorexia nervosa. Specialized psychological treatments have not proven to be more 




• No significant differences between psychological treatment and control 
 condition were found on weight gain, on eating disorder pathology and 
 on quality of life.
•  Studies including only patients over 18 years of age were more effective 
 on weight gain than studies including adolescents as well.
•  High-quality studies and studies with reported therapist training, 
 had larger effects on weight gain and quality of life compared with lower 
 quality studies and studies without reported training.
Method
Appendix A provides an overview of the extent to which this study was conducted in 
accordance to the Preferred Reporting Items for Systematic Review and Meta-Analysis 
Protocols (PRISMA-P) guidelines (Moher et al., 2015).
Selection procedure
For this meta-analysis, a systematic extensive electronic database literature 
search (from 1980 to 2017) for RCTs was conducted in the following databases: 
PubMed, PsycINFO, Embase, and Cochrane Library combining index and free terms 
of anorexia nervosa and psychological treatments (see Appendix B for an example of 
PubMed search string). Articles were also found via hand searches of reference lists 
by the first authors. The World Health Organization’s International Clinical Trials 
Registry was searched for unpublished studies.
Study selection 
RCTs written in English or Dutch, published in peer-reviewed journals, were 
included in this meta-analysis if (a) a psychological treatment was compared with 
a control condition (b) the psychological treatment consisted of at least some face 
to face verbal contacts, and (c) the study reported on patient groups diagnosed with 
anorexia nervosa and included patients 12 years of age or above. Studies or arms 
were excluded if insufficient statistics were available to calculate effect sizes. 
Psychological treatments could include psychodynamic or psychoanalytic ther-
apy, cognitive (behavioural) therapy, interpersonal therapy, family therapy, social 
skills training, motivational interviewing and combinations of the above. Control 
conditions to be included could be treatment as usual (TAU) among which are dietary 
ing individual psychological therapies with each other, no specific treatment is 
consistently superior to any other specific approach (Hay, Claudino, Touyz, & Elbaky, 
2015). 
Recent guidelines recommend that anorexia nervosa programs should focus 
on engaging the patient, on nutritional & physical rehabilitation in order to regain 
weight, and on provision of structured psychological treatment. In addition, treat-
ment outcome should aim at supporting quality of life (QoL) changes, needed for 
improvement or recovery (NICE, 2017).
Although evidence is yet insufficient to support outpatient- versus inpatient 
programs, the treatment of anorexia nervosa has moved clinically from long-term 
inpatient programs with outpatient follow-up, to a more common model of individual 
outpatient treatment with hospital backup (Hay, Claudino, Smith et al., 2015). 
Methodologically robust studies are small in number and inconclusive, meaning 
that conflicting results are common in anorexia nervosa literature (Hay et al., 2014). 
In less recent randomized controlled trials (RCTs), sample sizes were inappropriate 
small, treatment outcomes were addressed in varied ways and different treatments 
were employed within the same setting (Fairburn, 2005). 
With the increase of recent RCTs run with newly developed psychological treat-
ments and significantly larger sample sizes (Byrne et al., 2017), examining the effects 
by conducting an up-to-date meta-analysis including the most recent studies, is sensi-
ble. This meta-analysis, in contrast to other recent meta-analyses (Murray, Quintana, 
Loeb, Griffiths, & Le Grange, 2018; Zeeck et al., 2018) includes end-of -treatment 
outcome measures on weight gain, eating disorder pathology and on QoL. In addi-
tion, this study includes a 2017 large RCT (Byrne, 2017). Whereas other meta-analyses 
 included RCTs on various non-psychological treatment modalities (Murray et al., 
2018), or studies comparing two psychological treatment conditions (Zeeck et al., 
2018), this study examines the effects of psychological treatments versus a control 
condition for patients with anorexia nervosa from 12 years and older. This present 
study provides an up-to-date overview and is an addition to the available body of 





For each comparison between psychological treatment and control condition, 
we calculated the pooled effect sizes (Hedges’ g; weighted by inverse variance) for 
the primary and secondary outcomes. Effect sizes were calculated by subtracting the 
mean score at posttest of the psychological treatment group from the mean score of 
the control group and dividing the result by the pooled weighted standard deviations 
of the two groups. Effect sizes of 0–0.32 are considered to be small, while effect 
sizes of 0.33 – 0.55 are moderate and effect sizes of 0.56 – 1.2 are large (Lipsey & 
Wilson, 1993). When means and standard deviations were not reported, we used 
other statistics (p value) to compute the effect size (Dare, Eisler, Russell, Treasure, 
& Dodge, 2001). As weight is assessed in various ways (see Appendix C), we reported 
a combined effect size. To explore whether this influenced the results, we also 
performed the meta-analyses including only BMI or kg.
 With regard to our secondary outcome measures, we calculated pooled mean 
effect sizes, using the random effects model in the Comprehensive Meta-Analysis 
(CMA) software package (version 3; Borenstein & Rothstein, 2009). We also calculated 
the I2 statistic, where a value of 0% indicates that there is no observed heterogeneity, 
50% determines a moderate heterogeneity and 75% a high heterogeneity (Higgins, 
Thompson, Deeks, & Altman, 2003). The 95% confidence intervals around the I2 was 
calculated using the non-central χ²-based approach within the heterogi module for 
Stata (release 15; StataCorp., 2017). Potential publication bias was examined accord-
ing to Duval and Tweedie’s trim and fill procedure (Duval & Tweedie, 2000) using 
Comprehensive Meta-Analysis, which calculates an adjusted effect size taking into 
account missing studies. The symmetry of the funnel plots were tested using the 
Begg & Mazumdar rank correlation test (Begg & Mazumdar, 1994) and Egger’s test 
(Egger, Davey Smith, Schneider, & Minder, 1997). 
In this meta-analysis, five studies were included in which two psychological treat-
ments were compared with the same control group (Byrne et al., 2017; Dare et al., 
2001; Gowers et al., 2007; McIntosh et al., 2005; Zipfel et al., 2014), thus resulting in 
multiple comparisons in the same analysis. Because those comparisons are not inde-
pendent from each other, this may have resulted in an artificial reduction of heter-
ogeneity and may have influenced the pooled effect size. We therefore performed 
a sensitivity analysis by including the largest effect size and smallest effect size for 
each of these studies separately. Sensitivity analyses were conducted on low risk of 
bias studies and on outpatient studies.
Subgroup analyses were used to explore the influence of various patient- and 
study characteristics. We performed subgroup analyses when at least three studies 
were available per subgroup condition. Subgroup analyses were performed using the 
advice and psychoeducational interventions, and placebo conditions. The non-spe-
cific treatment modality Specialist Supportive Clinical Management (SSCM) is regard-
ed as a control condition, although recent guidelines consider SSCM as a psycholog-
ical treatment (NICE, 2017). Treatment and control conditions could be individually 
or group based, inpatient as well as outpatient settings were included. During the 
screening phases, the references were independently rated by three researchers 
(LH, EB, and GK). Discrepancies were resolved by consensus and if needed, a senior 
reviewer was consulted (JD). 
Risk of bias
The quality of the studies was assessed using The Cochrane Collaboration’s tool 
for assessing risk of bias in randomized trials (Higgins et al., 2011). The following 
domains on study and/or outcome level were independently assessed for each study 
by two researchers (EB and ID): sequence generation, allocation concealment, 
incomplete data and selective outcome reporting. Assessing incomplete data includ-
ed screening using intention-to-treat (ITT) data. For each domain of potential bias, a 
value was given; ‘0’ indicating low risk of bias, ‘2’ indicating high risk and ‘1’ indicat-
ing lack of sufficient information for a value to be given. For each study, a global risk 
of bias score was computed by adding up the values of all domains. Studies with a 
very low risk of bias (i.e. no potential bias at all domains) were considered high-qual-
ity studies. Discrepancies were resolved by consensus within the review team and if 
needed, a senior reviewer was consulted (EK).
Outcomes
Meta-analyses were performed at post-treatment on intention-to-treat data. 
Primary outcome in this meta-analysis was weight gain. Weight gain could be meas-
ured in terms of kilogrammes (kg), body mass index (BMI: body weight in kg divid-
ed by height in m squared; kg/m2), ideal body weight, adjusted body weight, mean 
matched population weight (expressed as the percentage of the average weight for 
age, height and sex) or as a percentage of body fat. Eating disorder pathology was 
measured by a structured interview or a patient-reported measure, providing either 
a global score or separate scores for different domains. A measure of QoL was defined 
as any patient-reported measure assessing perceived quality of life or social impair-
ment due to eating disorder pathology. With regard to variables related to patient 
characteristics at baseline (BMI, onset age, duration of illness), an average of the 




The search yielded 12,997 results out of which a total of potential 169 RCTs 
remained for a subsequent full-text screening. At the latest update, it was decided 
to exclude RCTs published before 1980. No unpublished eligible RCTs were found. 
Finally, 17 studies were included in this meta-analysis (see PRISMA flow chart, Figure 1).
mixed effects model, which pools studies within subgroups with the random effects 
model and tests for significant differences between subgroups with the fixed effects 
model. Given the modest evidence for family therapy for younger anorexia nervosa 
patients, living with their family and an illness duration of less than three years (Hay 
et al., 2014) subgroup analyses were performed on studies including patients under 
18 and on studies including family therapy. Given the efficiency of the control condi-
tion SSCM (NICE, 2017), subgroup analyses were performed on studies including 
SSCM. Additional subgroup analyses for the study characteristics baseline BMI, age 
of illness onset, duration of illness, therapy setting, number of treatment sessions, 
availability of treatment manual, and training of the therapists were exploratory.
Finally, we conducted meta-regression analyses using the mixed effects model, to 
assess whether the continuous variable year of publication predicted the effect sizes, 
indicated by a z value and an associated p value. 
Power calculation
We conducted a power calculation according to the procedures described by 
Borenstein, Hedges and Rothstein (2009), to examine how many studies would have 
to be included in order to have sufficient statistical power to identify significant 
effects. We estimated the number of studies needed to identify an effect size of 0.3. 
The power calculation indicated at least 20 studies with a mean sample size of 30 (15 
participants per condition) had to be included, for being able to detect an effect size 
of d = .30 (conservatively assuming a medium level of between-study variance, τ2, a 
statistical power of .80, and a significance level of α = .05). Alternatively, we would 
need 15 studies with 40 participants each or 14 studies with 50 participants to detect 
an effect size of d = .30.
FIGURE 1  
Preferred reporting items for systematic review and meta-analysis flow chart of the study selection process
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Removing three outlier arms lowered heterogeneity to I2 = 30, 95% CI [0, 59]. No indi-
cation for publication bias was found. Sensitivity analysis including only the largest 
effect size of each study resulted in an overall effect size of g = 0.10, 95% CI [-0.09, 
0.28]. When only the smallest effect size was included, the pooled effect size was 
g = 0.06, 95% CI [-0.10, 0.21]. Including only high-quality studies in a sensitivity anal-
ysis did not result in a significant difference between treatment and control condi-
tions. Subgroup analyses showed that studies including patients of 18 years of age had 
a significantly higher effect size, g = 0.23, 95% CI [0.06, 0.40], than studies including 
patients under 18, g = -0.18, 95% CI [-0.41, 0.6], p = .006. High-quality studies differed 
significantly, g = 0.27, 95% CI [0.02, 0.52], from lower quality studies, g = -0.08, 95% CI 
[-0.24, 0.09], p = .025, with regard to the effect on weight gain. 
Meta-regression analysis showed that publication year was not significantly 
associated with effect on weight gain, b = 0.002, 95% CI [-0.01, 0.02], p = .813.
Study characteristics
The 17 randomized controlled trials included a total of 1,279 participants: 761 
in the psychological treatment conditions and 518 in the control treatment condi-
tions (see Appendix C). Some studies reported on multiple psychological treatment 
conditions versus one control condition, resulting in a total of 24 arms. Most studies 
included adult patients (n = 9), three reported on adolescents and five reported on 
both adolescents and adults. The number of patients in the experimental conditions 
ranged from 10 to 80 per study. Mean pre-treatment BMI ranged from 15.0 to 18.1. 
The majority of the treatment conditions for adults reported on cognitive (behaviour) 
therapy (n = 5), Maudsley Model of Anorexia Nervosa Treatment for Adults (n = 3) or 
cognitive analytical psychotherapy or focal psychodynamic therapy (n = 4). In studies 
in which only adolescents were treated, all treatment conditions included family 
interventions (n = 3). The majority of the control conditions was defined as treatment 
as usual (TAU) (n = 6) or SSCM (n = 5). Three of the 17 studies were inpatient studies, 
although hospitalization was offered to a minority of patients in several outpatient 
studies. In one study, both an inpatient and an outpatient treatment were compared 
with TAU (Gowers et al., 2007). Besides the family therapy conditions, all conditions 
but one (Pillay & Crisp, 1981) were individually based treatments. The offered outpa-
tient treatment doses ranged from four sessions (Motivational Interviewing; Wade, 
Frayne, Edwards, Robertson, & Gilchrist, 2009) to a little over 40 sessions (Cognitive 
Behavioral Therapy-Enhanced; Byrne et al. (2017) and Focal Psychodynamic Therapy; 
Zipfel et al. (2014). The mean number of outpatient sessions was 23.2 (range 0-58.3) 
and dropout rates per arm ranged from 7% (Hall & Crisp, 1987) to 100% (Serfaty, 
Heap, Ledsham, & Jolley, 1999).
Six studies were assessed as having a low risk of bias based on the Cochrane 
domains (Higgins et al., 2011), meaning that 35% of the included studies are regard-
ed high-quality studies. A high risk of bias with regard to the domain incomplete data 
was the most commonly found risk of bias (n = 4). With regard to allocation conceal-
ment, this domain was unclear in seven studies and was in one study found to be a 
high risk of bias. All relevant study characteristics can be found in Appendix C. 
Weight gain
Twenty comparisons were included in the meta-analysis of weight gain (Figure 2). 
The pooled effect size indicating the difference between psychological treatment and 
control condition on weight gain at post-treatment was not significant, g = 0.07, 95% 
CI [-0.09, 0.23]. Similarly, no significant differences were found when the effects were 
examined for BMI and kg separately (Table 1). Including all 23 comparisons from 16 
studies resulted in a very high between-study heterogeneity, I2 = 85, 95% CI [78, 89]. 
FIGURE 2  
Standardized mean differences of psychological treatments for anorexia nervosa compared with control conditions 
on weight gain
ABW = average body weight; FPT = Focal psychodynamic therapy; FT= family therapy; IBW = Ideal body weight; IP= inpatient; IPT = Interpersonal 








Thirteen comparisons were included in the meta-analysis of eating disorder 
pathology. No significant difference between psychological treatment and control 
treatment on eating disorder pathology was found, g = 0.06, 95% CI [-0.10, 0.21]. 
Examining the effects for BMI and kg separately does not lead to a different finding. 
A very high between-study heterogeneity was detected including all 16 comparisons, 
I2 = 87, 95% CI [80, 91]. After removing three outliers, heterogeneity lowered, 
I2 =17, 95% CI [0, 56] (Table 2). Examining potential publication bias using Duvall and 
Tweedie’s trim and fill procedure resulted in g = 0.10, 95% CI [-0.07, 0.26], with one 
study imputed. Testing the symmetry of the funnel plot using the Begg & Mazumbar’s 
test (Kendall’s T = 0.064, p = .760) and Egger’s test (T = 0.358, df = 11, p = .727), did not 
reveal significant publication bias.
 Sensitivity analyses including only the largest or smallest effect size of each 
study, including only high-quality studies, or including only outpatient studies, 
did not result in significant differences between treatment and control conditions. 
Neither when the effects were examined for Eating Disorder Examination-Interview 
and Eating Disorder Inventory separately. Finally, a series of subgroup analyses were 
conducted, but none of the included moderators was significantly associated with 
eating disorder pathology. The meta-regression analysis showed that publication 
year was not significantly associated with the effect on eating disorder pathology, b = 








Quality of life 
Nine comparisons were included in the meta-analysis of the effect of psychologi-
cal treatment on QoL and no significant differences were found on QoL, g = 0.11, 95% 
CI [-0.36, 0.15]. Including all ten comparisons led to a high heterogeneity, I2 = 71, 95% 
CI [46, 85], so one outlier was removed, lowering heterogeneity to I2 = 48, 95% CI [0, 
76] (Table 3). No indication for publication bias was found. 
Sensitivity analyses including only the largest or smallest effect size of each study, 
including only high-quality studies, or including only outpatient studies did not 
result in significant differences between treatment and control condition. Neither 
when the effects were examined for the Clinical Impairment Assessment separately.
Subgroup analysis showed that the effect of high-quality studies on Qol was signif-
icantly different, g = 0.10, 95% CI [-0.17, 0.38], compared with lower quality studies, 
g = -0.35, 95% CI [-0.70, 0.01], p = .041. Furthermore, a significant difference on QoL 
was found between studies in which therapist training was reported, g = 0.10, 95% CI 
[-0.17, 0.38], compared with studies in which training was not reported, g = -0.35, 95% 
CI [-0.70, 0.01], p = .042.
 Meta-regression showed that publication year was not significantly associated 
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In recent guidelines SSCM is one of the psychological treatments to be considered 
(NICE, 2017). In this meta-analysis, SSCM is regarded a control treatment, in line with 
the original design in all RCTs but one (Touyz et al., 2013) including SSCM. Subgroups 
analyses did not show a difference in effect size on weight gain, eating disorder 
pathology or Qol between SSCM and other TAU conditions. 
To our knowledge, there are no previous studies in line with our finding that for 
patients over 18 a larger effect on weight gain is found; former theorizing did postu-
late that treatment targeted at adolescents was more efficacious (Murray et al., 2018). 
In the recent meta-analysis of Murray et al. (2018), age did not moderate treatment 
outcome. Zeeck et al. (2018) stated that psychotherapeutic interventions seemed to 
be more effective in terms of weight gain for adolescents. In both studies, however, 
it is unclear whether “adolescent” was strictly defined as being under 18. With the 
small number of included high-quality studies, it’s of interest, when more high-quali-
ty studies are becoming available for conducting meta-analyses, whether our finding 
can be replicated. 
The finding that training therapists leads to better outcome, at least on QoL, 
matches earlier studies that proper training is related to improved outcome (Gyani, 
Shafran, Layard, & Clark, 2013). Literature suggests that manualized based approach-
es led by a specialist (i.e. trained) therapist show the most promising evidence base 
(Hay et al., 2014). 
Limitations
Our meta-analysis has several limitations and therefore, the results should be 
interpreted with caution. Due to the high statistical heterogeneity, we had to exclude 
two outlier studies (Schmidt et al., 2015; Zipfel et al., 2014) from all further analyses. 
Schmidt et al. (2015) compared the Maudsley Model of Anorexia Nervosa Treatment 
for Adults with SSCM. In the study from Zipfel et al. (2014), focal psychodynamic 
therapy was compared with enhanced cognitive behavior therapy and with a broad 
optimized treatment-as-usual condition. In both studies, no significant differences 
between the conditions were found. The treatment and control arms differed greatly 
from each other and the five comparisons showed outcomes in different directions; 
with regard to weight gain, in the Zipfel study, one treatment arm was more effective 
than control and one treatment arm was less effective. On eating disorder patholo-
gy, both treatment conditions were more effective than control. In the Schmidt 2015 
study, the treatment condition did better than control with regard to both weight gain 
and eating disorder pathology. In both studies, none of the found differences were 
statistically significant. These studies are recent, large RCTs and it is possible that their 
findings may be closer to true effect size of psychological interventions. However, 
Discussion
In this meta-analysis, the efficacy of psychological treatments for anorexia nervo-
sa compared with a control condition was examined. The results suggest that with 
regard to weight gain, eating disorder pathology, and QoL, no differences between 
psychological treatment and control condition are found. Studies including only 
patients over 18 years of age were more effective on weight gain than studies includ-
ing adolescents as well. High-quality studies (i.e. studies which are methodological-
ly robust) differed significantly from low-quality studies with regard to weight gain. 
In addition, with regard to QoL, high-quality studies and studies in which therapist 
training was reported, differed significantly from low-quality studies and studies 
without reported training. However, including only high-quality studies in the 
meta-analyses did not establish a significant difference between psychological and 
control conditions.
The main finding of not being able to establish differences between psycho-
logical treatment and control conditions with regard to weight gain and/or eating 
disorder pathology is in line with previous studies (Hay, Claudino, Smith, et al., 2015; 
Zeeck et al., 2018). Adding recent, large RCTs, as we did in this meta-analysis, did not 
result in a different finding. The recent meta-analysis of Murray (Murray et al., 2018) 
found that specialist treatments (not just psychological treatments) showed a signifi-
cant treatment effect over control conditions with regard to weight-based symptoms 
improvement at end-of-treatment, although at follow up this difference did not last. 
The results suggest that the field still lacks psychological interventions of enough 
strength for added value to be detected. 
At the same time, it seems that low-quality studies obscure the effects of psycho-
logical treatment. The finding that high-quality studies differ significantly from 
low-quality studies with regard to weight gain and QoL, suggests that psychological 
interventions can have additional benefits over and above control treatment.
In addition, the lack of difference between psychological and control condition 
may also be related to the fact that included studies are heterogeneous; even the 
recent large, methodologically sound RCTs are heterogeneous and show contradic-
tory findings. Furthermore, the lack of difference can possibly be explained by the 
nature of the control conditions. The control conditions in this meta-analysis consist-
ed of multimodal interventions in line with recommended core elements for anorex-
ia nervosa treatment, such as engaging the patient, nutritional & physical rehabilita-
tion and structured psychological interventions (Hay Claudino, Smith et al., 2015). By 
using such plausible active control conditions, it is hard to distinguish the additional 




The finding that therapist training seems to be related to outcome, is a reminder 
that proper training for staff is essential in order for being able to deliver the original 
treatment to its full potential. 
Conclusion
This meta-analysis shows that, despite progress in development of new psycho-
logical treatments, the efficacy of psychological treatment over control condition 
could not be established. Although no indication for publication bias was found, the 
number of low-quality studies and the high heterogeneity reduces the strength of 
the evidence. More high-quality, homogeneous data are needed for firm conclusions 
regarding the efficacy of psychological treatment for anorexia nervosa to be drawn.
Appendix	A	
Selected characteristics of the studies comparing psychological treatment with control 
treatment in patients with anorexia nervosa
Appendix	B
Studies included in meta-analysis
it was decided to exclude them because their presence influenced subsequent 
subgroup analyses and thus, it could not be concluded whether subgroup differences 
were related to the particular subset of studies (e.g., high-quality trials) or due to the 
presence of these two outliers. 
The finding of high heterogeneity can also be indicative of a large variety in 
included patient groups. In addition, the variety in used outcome measurements, 
probably assessing slightly different constructs, may have increased heterogeneity. 
This large variety in measures led to a limited number of studies that could be 
included in the subgroup analyses. Because of these small sample sizes, we may have 
lacked adequate power to detect effect sizes.
In the included studies, both in the treatment and in control arms, a large variety 
of interventions is used. There are only few direct replications, and these replication 
studies have been done with different patient populations, leading to small subgroup 
samples. 
Finally, in addition to previous mentioned risk of biases, in some studies princi-
pal investigators were also responsible for the development of treatment interven-
tions used in the RCT, so researcher allegiance cannot be excluded.
Suggestions for further research
In general, by using meta-analysis, multiple trials showing non-significant or 
only minor benefits may result in a significant difference between products as the 
power of the individual studies is magnified. Alternatively, the significant benefit 
observed in a few trials may be outweighed by multiple trials showing no difference 
between products. Therefore, using individual patient data meta-analyses instead, 
might produce a better estimate of the pooled effect size. 
 
Standardized outcome measures are essential in the assessments of the treatment 
effects and should preferable be chosen in line with other, high-quality RCTs. In addi-
tion, replication studies in which similar psychological interventions are replicated 
for homogenous patient groups may reduce heterogeneity. 
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Background: Even though evidence-based interventions can enhance clinical 
outcomes and cost-effectiveness, in the field of eating disorders, implementation of 
empirically-supported treatments (ESTs) in routine inpatient and outpatient settings 
is slow.
Objective: This study examined differential (cost-) effectiveness, after imple-
menting evidence-based Cognitive Behavioral Therapy-Enhanced (CBT-E) through-
out a Dutch treatment center. 
Method: Two consecutive cohorts of adult patients, BMI between 17.5 and 40, 
were compared, with one cohort (N = 239) receiving treatment-as-usual (TAU) 
between 2012-2014, the other (N = 320) receiving CBT-E between 2015-2017.
Results: Eating disorder pathology, measured with self-reports, decreased signif-
icantly in both cohorts; overall, no differences in clinical outcomes between both 
cohorts were found. Treatment costs and treatment duration were considerably 
lower in 2015-2017. When limiting the cost analysis to direct costs, there is a 71% 
likelihood that CBT-E is more cost effective and a 29% likelihood that CBT-E leads to 
fewer remissions at lower costs, based on the distribution of the cost-effectiveness 
plane. The likelihood that TAU leads to lower costs is 0%.
Discussion: Findings show that implementing an empirically-supported treat-
ment throughout inpatient and outpatient settings, leads to lower costs with similar 
treatment effect, and has the advantage of shorter treatment duration and a shorter 
inpatient stay. 
Introduction
Although it has been established that empirically-supported treatments (ESTs) 
can be successfully implemented in non-academic, routine practice, in the field of 
eating disorders, the dissemination and implementation of ESTs are slow (Kazdin, 
Fitzsimmons-Craft, & Wifley, 2017; Waller, 2016; Lilienfeld et al., 2013), with poten-
tially suboptimal treatment delivery and treatment outcomes. Given the difficulty of 
implementing cohesive evidence-based practices in inpatient settings with multi-
modal, multidisciplinary teams, implementation of ESTs in these settings is even 
slower (Thompson-Brenner et al., 2018). Most residential programs have maintained 
a heterogeneous therapeutic stance offering a range of eclectic, often not theoretical-
ly cohesive, interventions (Guarda & Attia, 2018).
International guidelines propose eating-disorder-focused cognitive behavior 
therapy as preferred, EST for bulimia nervosa and binge eating disorder (RANZCP, 
2014; NICE, 2017). For adults with anorexia nervosa, eating-disorder-focused cogni-
tive behavioral therapy (CBT) is also one of the recommended treatments, besides 
Maudsley Anorexia Nervosa Treatment for Adults and Specialist Supportive Clinical 
Management. For other specified eating disorders, guidelines recommend treat-
ments for the eating disorder it most resembles (NICE, 2017). A specific transdiag-
nostic, enhanced eating-disorder-focused individual cognitive behavior therapy 
(CBT-E) has been developed by C. Fairburn (Fairburn, 2008). Originally an outpatient 
treatment, CBT-E has been further developed as a treatment framework for inpatient 
settings (Dalle Grave, Bohn, Hawker & Fairburn, 2008; Dalle Grave, Calugi, El Ghoch, 
Conti, & Fairburn, 2014; Van den Berg, Schlochtermeier, Goudriaan, & Dekker, 2017).
Previous eating disorder effectiveness studies on adult patients have showed 
that ESTs can successfully be delivered in routine settings with clinical outcome 
resembling results found in research trials (Byrne, Fursland, Allen, & Watson, 2011; 
Knott, Woodward, Hoefkens, & Limbert, 2015; Turner, Marshall, Stopa, & Waller, 
2015). These outpatient studies did not, however, include inpatients and/or day care 
patients, and the reported number of therapists involved in these studies was limited 
(N = 4, Byrne et al., 2011; N = 11, Turner et al., 2015; N = 10, Knott et al., 2015). In 
addition, from these publications it is unclear whether the ESTs were offered to all 
referred patients rather than to a selected patient sample and were delivered by all 
staff members rather than by a selected therapist group.
Almost no effectiveness studies concerning implementation of ESTs in routine 
inpatient eating disorders settings exist (Thompson-Brenner et al., 2018). Though 
examining the cost-effectiveness of ESTs next to effectiveness, is valuable (Crow 
et al., 2013), cost-effectiveness studies for eating disorders are limited. One recent 
systematic review of economic evaluations, including studies published up to March 
2017, found that no conclusive recommendations could be drawn regarding the most 
cost-effective eating disorder interventions (Le, Hay, & Mihalopoulous, 2018). In that 
review, only one study comparing face-to-face psychological treatments for adult 
patients was included. 
To our knowledge, no (cost) effectiveness studies have been done on large 
samples of referred patients receiving empirically-supported inpatient and / or 
outpatient treatment in a routine setting. The study aims, therefore, are to exam-
ine (a) effectiveness and (b) cost-effectiveness of an EST, CBT-E, compared to treat-
ment-as-usual (TAU). In it, CBT-E was offered to all referred patients (N = 320), with a 
body mass index (BMI: kg/m2) between 17.5 and 40, inpatients as well as outpatients, 
between 2015 and 2017. TAU, offered to patients (N = 239) between 2012 and 2014, 
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consisted of heterogeneous, eclectic psychological interventions, psychoeducation 
and dietary advice. This study is the first CBT-E (cost) effectiveness study including 
all referred inpatients and outpatients, treated by all staff members in a routine 
treatment center, during a two-and-a-half year period. We hypothesized that imple-
menting CBT-E would lead to an improvement in effectiveness and cost-effectiveness 
compared to TAU. 
Method
The design and reporting follows the Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) statement (Vandenbroucke et al., 2007) and 
the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) state-
ment (Husereau et al., 2013). Dutch Commission on Human Research (CCMO) has 
ruled that no ethical approval is needed for research with anonymized data obtained 
in routine practice: all patients gave consent for data to be collected as part of routine 
service evaluation.
Design and participants
Treatment costs and clinical outcome on eating disorder and general patholo-
gy were compared between two samples: the first sample consisted of all referred 
patients, BMI between 17.5 and 40, receiving TAU between July 1, 2012 and Decem-
ber 31, 2014 (N = 785). After implementing CBT-E throughout the out- and inpatient 
units in 2015, the second sample consisted of all referred patients receiving CBT-E 
between July 1, 2015 and December 31, 2017 (N = 900). In both cohorts, inpatient and 
outpatient treatment were offered.
Patients were referred by general practitioners, secondary healthcare profession-
als or general hospitals to a Dutch routine eating disorder center which treats patients 
over 18, voluntarily. All patients met DSM-IV (American Psychiatric Association, 
1994) or DSM-5 (American Psychiatric Association, 2013) eating disorder criteria, as 
assessed by a clinical psychologist or psychiatrist. Patients with under three contacts 
were excluded; as assessment takes up to three contacts, it is assumed that those 
patients have not started psychological treatment. Due to differences in, somatically 
related, treatment costs, analyses of patients with BMI < 17.5 will be presented sepa-
rately. Figure 1 shows the recruitment and retention figures for both cohorts.
FIGURE 1  
Flowcharts of cohorts 2012-2014 and 2015-2017
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Measures
Patients completed self-report measures as part of routine practice at start and 
end-of-treatment (EOT). Since, as is common in routine settings (Turner et al., 2015), 
a proportion of the data were not collected, numbers vary across some analyses (see 
tables 1,2,3). The Dutch Eating Disorders Examination-Questionnaire (EDE-Q 6.0; 
Fairburn & Beglin, 2008; Aardoom, Dingemans, Slof op ‘t Landt, & Van Furth, 2012) 
has good psychometric properties and was used to asses eating disorder pathology. 
General psychiatric symptomatology was assessed using the Dutch Depression Anxi-
ety and Stress Scale which has good psychometric properties (DASS-21; Lovibond & 
Lovibond, 1994; De Beurs, Van Dyck, Marquenie, Lange, & Blonk, 2001). 
The effect measure for the cost-effectiveness analysis was the proportion of 
patients with an EDE-Q global score under one standard deviation (SD) above 
community mean, that is, below 2.77 (UK norms).
Intervention
TAU during July 1, 2012 - December 31, 2014
TAU was based on an eclectic approach of cognitive and behavioral interventions, 
psychoeducation, dietary advice, schema therapy and psychomotor inventions. TAU 
was delivered in inpatient units, daycare units and in an outpatient unit where treat-
ment was delivered either individually or in groups. Treatment duration was not 
fixed and differed considerably between therapists and units. Underweight inpa-
tients could be hospitalized until they reached healthy weight. In the day care units, 
patients were treated either after being hospitalized or when outpatient treatment 
was assumed to be insufficient.
CBT-E during July 1, 2015- December 31, 2017
CBT-E is a time limited, individually based treatment. In the outpatient setting, 
the focused form of CBT-E, a 20-sessions treatment over a 20 week period, was 
offered. For underweight patients the number of sessions can extend up to 40, or in 
certain cases slightly more, depending on the degree of underweight, consistent with 
CBT-E guidelines (Fairburn, 2008). Following CBT-E principles, weight regain can be 
achieved during outpatient treatment. Accordingly, the primary goal of hospitaliza-
tion is making patients psychiatrically and somatically stable enough to profit from 
outpatient treatment (Dalle Grave, Bohn, Hawker & Fairburn, 2008). When patients 
are stable, outpatient CBT-E starts. By consequence, the duration of the inpatient 
stay reduced after implementing CBT-E. The inpatient program is derived from 
outpatient-based CBT-E and retains all CBT-E main strategies, provided in individual 
sessions, psychoeducational group meetings and a weekly review meeting between 
patient and her / his therapists (Dalle Grave, Bohn, Hawker & Fairburn, 2008). A 
physical exercise group is also part of the program. Within this CBT-E framework 
of outpatient care by default and inpatient care as short as possible, day care is no 
longer needed.
Implementation of CBT-E
In early 2015, after training all staff, irrespective of their discipline, the treatment 
center transformed both inpatient and outpatient units into CBT-E based programs. 
Two inpatient units were combined into one, in which TAU modules incompatible 
with CBT-E (e.g. a schema therapy group) were terminated. As CBT-E is individual-
ly based, outpatient therapy groups were phased out during a 6-month period, and 
terminated. In the outpatient unit, the only psychological treatment offered is CBT-E 
focused. The two daycare units were also terminated. A detailed description of the 
implementation plan and the CBT-E inpatient program, has been provided in a previ-
ous publication (Van den Berg et al., 2017).
Therapist Training 
During 2012-2014, 40 staff members (psychologists, psychotherapists, psychia-
trists, nurse practitioners, psychiatric nurses, dieticians and a psychomotor thera-
pist) were employed throughout the treatment center. Psychological treatment was 
delivered by 24 therapists (psychologists, psychotherapists, psychiatrists and nurse 
practitioners), other staff members delivered partial treatment interventions in the 
inpatient and daycare units. No uniform treatment manuals were used and no struc-
tured supervision was offered.
During 2015-2017, CBT-E was delivered by 44 therapists; including the 40 
colleagues from the 2012-2014 episode. In contrast to the TAU episode, during 2015-
2017, psychiatric nurses, dieticians and a psychomotor therapist delivered psycho-
logical treatments as well. All therapists successfully completed the web based CBT-E 
training provided by Centre for Research on Eating Disorders at Oxford, worked 
through the guide (Fairburn, 2008), and all but five colleagues attended a 2-day work-
shop run by C. Fairburn. To familiarize them with CBT-E interventions and ensuring 
adherence, all therapists attended weekly, 2-hour peer intervision, taking place in 
three parallel groups of around 12 colleagues each, supervised by senior therapists, 
throughout the experimental period. Making sure all patients are discussed, case 
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load records were used and all patient evaluations monitored. Irregularly, to monitor 
adherence, audiotaped sessions were reviewed.
Statistical analysis
Statistical analyses were performed with SPSS version 25 and R statistical 
programming environment. Differences between groups were expressed as differ-
ence in proportion for categorical data and as mean difference for continuous 
data. Chi-squared (χ²) or Fisher’s exact tests (as appropriate) were used to compare 
categorical measures between two groups, and t-tests or Mann-Whitney U tests (as 
appropriate for the distribution of data) to compare continuous data. Paired t tests 
for continuous data were used to compare differences within groups. Linear mixed 
model analyses, for the analysis of the repeated continuous outcomes, were conduct-
ed according to a two-level structure (patient and repeated measures). To control for 
possible confounding, we added the baseline score of the dependent outcome varia-
ble plus the variables from the baseline analysis with a p <.05. Effect sizes were calcu-
lated using Cohen’s d. Treatment outcome analyses were performed on the respond-
ers (complete measures available at baseline and EOT) and on an imputed dataset. 
Multiple imputation (with 50 imputations for each missing observation) was used 
for missing outcome data, under a missing-at-random (MAR) assumption; compar-
ing both patient groups with and without EOT EDE-Q global score, analyses showed 
that with regard to gender, age, eating disorder diagnosis, DASS global score, EDE-Q 
global score and baseline BMI, no significant differences were found. Analyses were 
performed using SPSS, first on the imputed datasets separately. Next, the outcomes 
of the 50 imputations were combined using Rubin’s rules (Rubin, 1987).With regard 
to cost-effectiveness calculations, all analyses were performed on intention-to-treat 
basis (ITT), using the imputed dataset. Unless indicated otherwise, the cost-effective-
ness results are based on the multiple imputed data. 
Cost-effectiveness calculations
Treatment costs in euros were established for each patient by multiplying stand-
ard Dutch cost prices, index year 2016 (Zorginstituut Nederland, 2016), with the 
number of outpatient contacts, number of days in day care and/or inpatient stay; 
both contacts with patients as well as contacts concerning patients are included. As 
the time horizon, mean time frame between start and EOT, was little under a year, no 
discounting for future costs/effects was applied.
Differences in costs and effects between 2012-2014 and 2015-2017 samples were 
calculated as the difference in cumulative direct costs. A total of 2,500 nonparametric 
bootstrapped samples was extracted from the 50 imputed data sets, with a number 
of patients per sample equal to the number of patients in the original dataset. For 
each bootstrapped sample, incremental costs, incremental effects, and incremental 
cost-effectiveness ratio (ICER) were calculated as: ICER = (CostsCBT-E – CostsTAU)/
(EffectsCBT-E – EffectsTAU), where effect was remission rate based on EDE-Q global 
score < 2.77. These ICERs were plotted on cost-effectiveness planes and used for 
further calculations. The reference intervention (TAU) is positioned in the origin 
of the cost-effectiveness plane where the horizontal axis differences in health gains 
between CBT-E and TAU indicates, and the vertical axis differences in costs. Along 
the horizontal and vertical axis, Figure 2 is divided into four quadrants. ICERs in the 
upper right (“North East”) quadrant indicate that CBT-E generates better health at 
additional costs, and, in the lower left (“South West”) indicate less health gains from 
CBT-E at lower costs, compared to TAU. While TAU dominates CBT-E In the upper left 
(“North West”) quadrant, CBT-E dominates TAU with better health outcomes at lower 
costs in the lower right (“South East”) quadrant. The scatter plot of ICERs falling 
within more than one of the quadrants, indicates uncertainty whether the new inter-
vention is cost effective compared to TAU. Cost-effectiveness acceptability curves 
(CEACs) (Van Hout, Al, Gordon, & Rutten, 1994) have been drawn (Figure 2). Based 
on the distribution of the ICERs, CEACs show the probability that CBT-E is more cost 
effective than TAU as a function of the willingness to pay (WTP) for one additional 
recovered eating disorder patient. Costs for one additional recovered eating disorder 
patient in the Netherlands are, to our knowledge, as yet not established. Crow et 
al. established a cost-effectiveness ratio for bulimia nervosa patients of 20.317 US 
dollars (Crow et al., 2013).
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Results	
Characteristics of the two complete cohorts are shown in Table 1.
TABLE 1
Characteristics of the two cohorts at baseline. Data are shown as mean (SD) unless otherwise indicated.
TABLE 2
Baseline characteristics of samples used in final analyses. Data shown as mean (SD) unless otherwise indicated
Both cohorts primarily consisted of female patients in their late twenties, 
with a mean eating disorder duration of slightly over nine years. At baseline, key 
characteristics as illness duration, baseline BMI and male to female ratio did not 
differ between both cohorts. A few significant, but not clinically relevant, differences 
were found. Patients in 2015-2017 were older (F = 5.93, p = .015) and the distribution of 
the eating disorder diagnoses differed (χ² = 52.95, p <.001), with more anorexia 
nervosa, bulimia nervosa and binge eating disorder patients and fewer EDNOS / 
OSFED patients in 2015-2017. Table 2. shows the characteristics of both samples used 
in the final analyses. 
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Comparing both samples used in the final analyses, ‘eligible for treatment’, BMI 
> 17.5 and being treated within the timeframe of this study (N = 239 2012-2014, 
N = 320 2015-2017), the same significant difference with regard to the diagnosis distri-
bution was found in the 2015-2017 sample (χ² = 22.51, p <.001), except for the diagno-
sis anorexia nervosa, which was equally distributed over both samples. In addition, 
the percentage of laxatives misuse is significantly higher in the 2012-2014 sample 
(Fisher’s exact test, p = .013)
In 2012-2014, mean time frame between start and EOT measurements was 268 days 
(SD = 138); in 2015-2017 mean timeframe was 195 days (SD = 83), a significant difference 
(MW-U=5106; p < .001). Mean treatment episode in 2012-2014 was 300 days (SD = 162), 
in 2015-2017 240 days (SD = 90), a significant difference (MW-U = 30559, p < .001). 
Treatment outcomes for eating disorder and general psychopathology
Table 3 presents outcomes of the 2012-2014 and 2015-2017 samples from baseline 
to EOT. Eating disorder pathology and general psychopathology declined significantly 
in both samples (2012-2014, t = 9.24, p <.001; 2015-2017, t = 21.70, p <.001). Eating 
disorder behaviours also declined significantly (all p <.001). Linear mixed model anal-
yses, adjusted for differences in diagnosis distribution and baseline EDE-Q scores, 
showed no significant differences between both samples with regard to the decrease 
of eating disorder pathology (EMD = -.05, p = .736) or general psychopathology 
(EMD = -1.86, p = .539). In 2012-2014 however, significantly fewer patients reported 
remaining binges after treatment (36.4% vs 56.2%; χ² = 8.27, p = .002). Effect sizes for 
both samples were large (2012-2014, d = 1.19; 2015-2017, d = 1.41). Linear mixed model 
analyses on an imputed ITT dataset did not show a significant difference between 
both samples with regard to the decrease of eating disorder pathology either (EMD 
= -.12, p = .440).
 
Remission rates
With regard to remission rates, UK and Dutch norms were used for the purpose 
of comparison. Remission rate for responders was defined as having an EDE-Q glob-
al score under one SD above community mean, i.e. below 2.77 (UK norms) or 1.79 
(Dutch norms). In 2012-2014, 60.2% (UK norms) and 40.9% (Dutch norms) achieved 
remission. In 2015-2017, remission rate was 62.1% (UK norms) respectively 40.6% 
(Dutch norms); not a significant difference (UK norms, p = .760; Dutch norms, p = 
.965). Imputed ITT analyses did not show a significant difference either; 59.0% 2012-
2014 versus 60.9% in 2015-2017 (F(1, 1063.07) = .45, p =.504).
TABLE 3
Change in eating disorder pathology (EDE-Q scores) and general psychopathology (DASS scores) 
in 2012-2014 and 2015-2017 samples
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A reliable change index (RCI) was established (Jacobson & Truax, 1991) for the 
responders as 0.67 change on the EDE-Q global score. RCI for the 2012-2014 sample 
was 65.3% and 81.6% for the 2015-2017 sample, a significant difference (Fisher’s 
exact test, p = .006). ITT analyses showed RCI of 71.1% for 2012-2014 and 78.8% for 
2015-2017 sample, not a significant difference (F(1, 243.74) = 2.38, p = .124). Clini-
cally significant change (CSC), defined as a RCI plus EDE-Q global score < 2.77, was 
achieved by 46.7% in 2012-2014 and 58.7% in 2015-2017, not a significant difference 
(Fisher’s exact test, p = .078); ITT analyses on CSC showed no significant difference 
either (50.6% in 2012-2014; 56.6% in 2015-2017; F(1, 314.06) = 1.17, p = .279).
When applying a more robust definition of remission (EDE-Q global score < 2.77, 
no eating disorder behaviors and BMI > 18.5), 38.4% of the 2012-2014 responders and 
26.1% of the 2015-2017 responders achieved remission, a significant difference (Fish-
er’s exact test, p = .046). Applying this definition to the imputed data did not show a 
significant difference (23.8% in 2012-2014, 31.9% in 2015-2017; F(1, 185.37) = 2.12, 
p = .147).
For outpatients, attending under 10 treatment sessions was regarded as dropout. 
In 2012-2014, 16.7 % of the outpatients dropped out, in 2015-2017, it was 11.9 %, not a 
significant difference (Fisher’s exact test, p = .110). 
Care consumption
Inpatient admission rate dropped from 15.5% (37/239) in 2012-2014 to 10.9% 
(35/320) in 2015-2017 (χ² = 2.52, p = .113), not a significant difference. Inpatient stay 
shortened significantly; in 2012-2014 mean duration was 14.1 weeks (SD = 7.5), in 
2015-2017, it was 8 weeks (SD = 3.5) (MW-U = 348, p <.001). In addition, the number 
of day care contacts reduced significantly; in 2012-2014 23.4% of patients was offered 
day care (M= 42 days, SD = 29), in 2015-2017 4% of the inpatients received day care 
(M = 12, SD = 13), before being discharged (MW-U = 127.5, p <.001). On the over-
all number of treatment sessions, no significant difference was found between 
2012-2014 (M = 32.3, SD = 25.1) and 2015-2017 (M = 31.1, SD = 16.5) (MW-U = 41385, 
p = .096). For outpatients, underweight as well, in 2015-2017, mean number of 
sessions was 23.8 (SD = 11.4; range = 4-80); 38.4% (109/284) had 22-28 sessions, assess-
ment sessions included. 
Treatment costs
Table 4 shows that mean service costs dropped considerably between 2012-2014 
and 2015-2017.
Cost-effectiveness
Figure 2 shows the cost-effectiveness plane and the CEAC. After calculating the 
distribution of  ICERs over four quadrants, there is a 71% likelihood that CBT-E domi-
nates TAU and leads to more remissions at lower eating disorder treatment costs per 
patient. The likelihood that CBT-E leads to less remissions at lower costs is 29%. The 
likelihood that TAU leads to lower  treatment costs is 0%. Based on the CEAC, assum-
ing a WTP no extra direct treatment costs for extra remissions, there is probably a 
preference in terms of cost-effectiveness for CBT-E.
TABLE 4
Eating disorder treatment costs per cost category and differences in costs between 2012-2014 and 2015-2017 samples
FIGURE 2
Cost effectiveness plane and cost effectiveness acceptability curve of the base case scenario with eating disorder 
remission as effect parameter (with inpatient and day care setting)
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Discussion
The study aim was to examine effectiveness and cost-effectiveness following 
implementation of an EST in a routine treatment center. Two sizeable cohorts of 
patients were therefore compared, one receiving TAU between 2012-2014, the other 
receiving CBT-E between 2015-2017. There are two main findings. First, with regard 
to effectiveness, no significant differences were found between the two cohorts; in 
both cohorts, eating disorder and general psychopathology, measured with self- 
reports, decreased significantly. With regard to responders’ remission rates, findings 
are mixed: with regard to RCI, a significant difference was found in favor of CBT-E. 
When applying a robust definition of remission, a significant difference was found 
in favor of the 2012-2014 cohort. Imputed ITT analyses, however, did not show any 
significant differences between both samples. Comparing completers remission rates 
(global EDE-Q score < one SD above community mean) of the Byrne and the Knott 
studies (Byrne et al, 2011; Knott et al, 2015) to the 2015-2017 responders, outcomes 
are in line, although the Knott rate stands out (66.7% Byrne study; 78.3% Knott study; 
62.1% 2015-2017 sample UK norms). When comparing the 2015-2017 robust defined 
remission rate to the Turner rate (Turner et al., 2015), outcomes appear in line (31% 
Turner study; 26.1% in 2015-2017), although the Turner study included patients with 
lower BMIs. Comparing ITT robust remission rates, the 2015-2017 rate seems some-
what better (19% Turner study; 31.9% in 2015-2017).
Compared to the 2012-2014 sample, treatment duration and the duration of the 
inpatient stay reduced in 2015-2017. In addition, by stopping offering outpatient 
daycare, those contacts reduced significantly as well.
Second, CBT-E is potentially cost effective when limiting the cost analysis to 
eating disorder treatment costs. Based on the distribution of the cost-effectiveness 
plane, there is a 71% likelihood that CBT-E is more cost effective and a 29% likelihood 
that CBT-E leads to less remissions at lower costs. The likelihood that TAU leads to 
lower costs is 0%. 
The finding that, on clinical outcome, no significant differences were found 
between a specialized psychological treatment, like CBT-E, and TAU is in line with the 
literature (Hay, Claudino, Touyz, & Abd Elbaky, 2015; Van den Berg et al., 2019), both 
anorexia reviews stated that difficulties in establishing differences may be due to the 
nature of an optimized TAU consisting of recommended, multimodal interventions, 
such as engaging the patient, nutritional & physical rehabilitation and establishing 
a regular eating pattern. As effectiveness was examined shortly after CBT-E being 
implemented, as staff gets more experienced, outcomes may enhance over time. The 
finding that CBT-E for adult patients with all types of eating disorders and a BMI > 
17.5 is superior to TAU from a cost-effectiveness perspective is, to our knowledge, 
new. It is in contrast with the outpatient anorexia nervosa study of Egger, Wild and 
Zipfel (2016) which found the probability of CBT-E being cost-effective compared to 
TAU was < 90% for all WTPs. 
Strengths
The main strength of this study is that the examined treatments were not offered 
within the limiting context of a selective clinical trial, so findings are likely to gener-
alize to other routine centers. Besides, for the cost-effectiveness analyses, instead 
of model costs, actual costs were used. As ample effort was undertaken to imple-
ment CBT-E model truly, throughout all multidisciplinary teams and parallel to 
implementing new interventions, terminating all CBT-E incompatible interventions, 
outpatients who needed hospitalization were offered continuous and similar inter-
ventions despite the different treatment setting.
With regard to clinical outcome, beside remission rates, results on reliable and 
clinical significant change were reported. This study also contributes to enhancing 
transparency by making clinical outcome gathered over several years and numerous 
patients, public. Studying and learning from the variation in service outcomes can 
help develop more effective health care (Clark et al., 2018).
Limitations
While, as is common in routine settings, a considerable amount of data are missing, 
analyses showed that patients with and without complete data did not differ and 
missing data were handled adequately. As there are no follow up data, longer term 
effects could not be taken into account. 
Due to the design of comparing two consecutive cohorts over a 5-year period, 
potential confounding variables might have occurred, due to the lapse of time. 
Although a considerable time frame, it is in line with other effectiveness studies; 
Byrne study captured a 4-year period (Byrne et al., 2011) and the Turner study 3 
years (Turner et al., 2015). As baseline analyses showed that key characteristics did 
not differ between both cohorts, the patient population can be assumed not to have 
changed over time. The difference with regard to the eating disorder diagnoses distri-
bution is linked to slightly changed DSM-5 criteria. Program leadership, senior staff 
and the financing system did not change during the time frame of this study. In 2015-
2017, however, staff grew, while other than during TAU, treatment was delivered not 
only by academic staff but also by psychiatric nurses and dieticians. One of the prin-
ciples underlying CBT-E is that treatment can be delivered by therapists irrespective 
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of their prior education, so long as they are well-trained in CBT-E and have a keen 
interest in treating eating disorders. This principle seems to be effective, as outcome 
did not change after CBT-E implementation. 
During the CBT-E period, therapist fidelity was not assessed systematically. 
Therefore, to monitor and enhance CBT-E adherence, during intervision, audiotaped 
sessions were reviewed. In the study design, a 6-month ‘transition period’ was put in 
between the lead time of both cohorts to prevent contamination of the TAU period 
with newly-learned CBT-E interventions and at the same time, allowing staff to be 
familiarized with CBT-E. However, contamination cannot be completely ruled out. 
With regard to costs, additional societal and potential concurrent health costs were 
not measured and valuated. Besides, the used standardized costs may differ from 
actual costs accrued or paid by third-party payers.
Implications 
The finding that, when limiting cost analysis to direct treatment costs, an EST, 
including intensive intervision, is more cost effective than TAU may be important 
for decision makers and may help speed up implementation of ESTs. CBT-E is a time 
limited, outpatient treatment; therefore, implementing CBT-E will lead to a shorter 
inpatient stay and treatment duration, which is beneficial for patients and leads to 
better value health care (Porter, 2010). 
An altered treatment staff is likely to enhance cost-effectiveness, although not 
analysed in this study. Implementing CBT-E and as consequence, terminating 
all incompatible interventions has impact on staff, especially when they are less 
CBT-orientated and no longer able to use interventions they used before.
Conclusions
The findings suggest that CBT-Enhanced is potentially cost-effective compared to 
TAU, when the cost analysis is limited to direct treatment costs. Based on the dataset 
used, it cannot be claimed that on clinical outcomes, CBT-E is more effective. This 
study shows that implementing an EST throughout outpatient as well as inpatient 
settings, is feasible, leads to lower treatment costs with similar treatment effect and 
has the advantage of shorter treatment duration and a shorter inpatient stay. 
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Abstract
Objective: For anorexia nervosa, firm evidence of the superiority of specialized 
psychological treatments is limited and economic evaluations of such treatments in 
real world settings are scarce. This study examined differential (cost-) effectiveness 
for inpatient and outpatient anorexia nervosa patients before and after implement-
ing cognitive behavioral therapy-enhanced (CBT-E) throughout a Dutch treatment 
center. 
Methods: Differences in treatment costs, weight regain and improvement of 
eating disorder pathology were examined between two consecutive cohorts of 
adult patients, with one cohort (N = 75, between 2012-2014) receiving regular treat-
ment-as-usual (TAU), and the other (N = 88 between 2015-2017) receiving CBT-E. 
Results: In both cohorts, eating disorder attitudes improved. On clinical outcome 
no differences between the two cohorts were found, except on weight gain which was 
better in the CBT-E cohort (estimated mean difference = 1.39 kg/m2, SD = .28; 95% CI 
0.82 - 1.9; p < .001). Limiting the cost-analysis to direct treatment costs, the cost-ef-
fectiveness plane of the base case scenario for all patients indicates a 97% likelihood 
of CBT-E being superior to TAU at higher costs. The cost-effectiveness acceptability 
curve indicates that, assuming a willingness-to-pay of € 9713,- or more for an extra 
remission, CBT-E is more likely to be cost-effective, compared to treatment-as-usual. 
Discussion: Findings suggest that in this real-world study, CBT-E is both effective 
and cost-effective on weight regain in adult anorexia nervosa patients, compared to 
treatment-as-usual, a regular, multimethod treatment. These findings may contrib-
ute to implementation of specialized psychological treatments for anorexia nervosa 
in real world settings. 
Introduction
Anorexia nervosa is a psychiatric disorder associated with a poor prognosis. For 
adults with anorexia nervosa, evidence is lacking for prioritizing one specialized 
treatment over the other, or even for prioritizing specialized over non-specialized 
treatments (Zeeck et al., 2018; Van den Berg et al., 2019). Furthermore, with regard 
to regaining weight or with regard to reducing anorexia nervosa psychopathology, 
no conclusive recommendations can be made on an optimum treatment setting 
(Madden, Hay & Touyz, 2015; Hay et al., 2019), even though guidelines agree on hospi-
tal admission in case of high medical or psychiatric risk (Hay et al., 2019). Individ-
ual eating-disorder-focused cognitive behavioural therapy is one of the specialized 
psychological treatments for adults recommended by NICE (NICE, 2017). For under-
weight patients, Fairburn et al. (Fairburn, 2008) developed an enhanced eating-disor-
der-focused individual cognitive behavior therapy (CBT-E Underweight), an adaption 
of CBT-E for normal weight eating disorder patients. Effectiveness studies showed 
that CBT-E Underweight can be delivered in both routine outpatient practice (Byrne et 
al., 2011; Fairburn et al., 2013; Turner et al, 2015; Signorini et al., 2017; Frostad et al., 
2018) and inpatient practice (Dalle Grave et al., 2013). Despite these findings, imple-
mentation of recommended specialized treatments in routine practice lag, especial-
ly in inpatient settings (Thompson-Brenner et al., 2018).
Published CBT-E Underweight effectiveness studies involved a limited number of 
therapists and, in most outpatient studies, patients with severe underweight were 
excluded (Byrne et al., 2011; Signorini et al., 2017; Frostad et al., 2018). Besides, as the 
involved outpatient services were unable to offer inpatient care, in case of hospitali-
zation, CBT-E interventions were discontinued. 
Examining cost-effectiveness of recommended treatments next to effectiveness, 
is valuable and may contribute to decision making on what treatment best to offer in 
clinical practice, but for anorexia nervosa, they are rarely done (Crow et al., 2013). An 
economic evaluation on adolescents with anorexia nervosa suggests that specialist 
outpatient services have a higher probability of being cost-effective than both general 
services and inpatient services (Byford et al., 2007). Until now, there has been only 
one economic evaluation of CBT-E Underweight; Egger et al., examined the cost- 
effectiveness of focal psychodynamic psychotherapy, treatment-as-usual (TAU) and 
CBT-E for outpatients. They found that, employing weight gain as effect measure, 
CBT-E Underweight was dominant compared with TAU, although differences in weight 
regain between the conditions were negligible (Egger et al., 2016).
The aims of the present study were to examine (1) effectiveness and (2) cost- 
effectiveness of CBT-E Underweight, offered to all referred adult anorexia nervosa 
inpatients and outpatients (N = 88) receiving treatment between 2015 and 2017, 
compared with treatment-as-usual offered to all referred patients (N = 75) between 
2012-2014. We hypothesized that, compared to treatment-as-usual, implementing 
CBT-E Underweight would lead to an improvement in effectiveness and in cost- 
effectiveness. 
This is the first CBT-E (cost)-effectiveness study including all referred inpatients 




In this nonequivalent control group pretest-posttest study, differential (cost-) 
effectiveness was examined between two cohorts of adult, eating disorder outpatients 
and inpatients, with a body mass index (BMI: kg /m2) between 12.5 and 17.5. The first 
cohort received treatment-as-usual (TAU) between July 1, 2012 and December 31, 
2014 (N = 75), the second received CBT-E between July 1, 2015 and December 31, 2017 
(N = 88), after implementing CBT-E throughout all treatment settings. 
Setting and participants
Both cohorts consisted of consecutive referrals by general practitioners or general 
hospitals to a Dutch routine eating disorder center, which treats patients over 18 on 
a voluntary basis. All included patients met DSM-IV (American Psychiatric Asso- 
ciation, 1994) or DSM-5 (American Psychiatric Association, 2013) criteria for anorex-
ia nervosa or other specified eating disorder similar to anorexia. Exclusion criteria 
were immediate medical risk requiring hospitalization in a general hospital, BMI 
under 12.5, the presence of an interfering psychotic disorder or cognitive impair-
ment. In addition, since the intake procedure involves up to three contacts, patients 
with under four contacts were excluded. 
The authors assert that all procedures contributing to this work comply with the 
ethical standards of the relevant national and institutional committees on human 
experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All 
procedures involving patients were approved by The Dutch Central Committee on 
Human Research; informed consent, as part of routine service evaluation, was 
obtained from all patients.
 
Assessment
Assessment points were at start and end of treatment. Digital scales were used to 
measure weight and a wall-mounted stadiometer for height. Eating disorder attitudes 
and behaviors were measured with the Dutch self-report Eating Disorder Examination- 
Questionnaire (EDE-Q 6.0; Fairburn & Beglin, 2008), which has good psychometric 
properties (Aardoom et al., 2012). General psychopathology was measured with the 
Dutch self-report Depression Anxiety Stress Scale, which has good psychometric 
properties (DASS-21; Lovibond & Lovibond, 1994; De Beurs et al., 2001). Due to missing 
data, common in routine settings (Turner et al., 2015), sample sizes vary across some 
analyses.
Two effect measures for cost-effectiveness analyses were used: (a) the propor-
tion of patients reaching BMI ≥18.5, the World Health Organization cut-off point 
for healthy weight, as weight regain is key in supporting psychological and physical 
changes needed for recovery (NICE, 2017) and (b) the proportion of patients achieving 
an EDE-Q global score under one SD above community mean, i.e. under 2.77 (UK 
norms, used for comparison; Mond, Hay, Rodgers & Owen, 2006). 
Interventions
Treatment-as-usual during July 1, 2012 - December 31, 2014
Treatment during the TAU period consisted of regular medical care, weight resto-
ration, psychoeducation, psychomotor inventions and an eclectic psychological 
approach of cognitive, behavioral, schema focused and psychodynamic interven-
tions. TAU was delivered in outpatient, day-care and / or inpatient units. Outpatient 
treatment was preferably group based; day-care was offered to patients with a BMI 
between around 16.5 and 17.5; inpatient treatment was offered to patients with a BMI 
under 16.5, and usually lasted until healthy weight was reached. During TAU, struc-
tured supervision was not offered.
CBT-E during July 1, 2015 - December 31, 2017
Outpatients were offered CBT-E Underweight, an individual, outpatient treatment, 
originally designed for adult patients with a minimum BMI of 15, but now offered 
to all underweight outpatients. Treatment takes up to about 40 sessions; in accord-
ance with CBT-E guidelines (Fairburn, 2008), the number of sessions depends on the 
degree of underweight. CBT-E Underweight consists of three phases, the first phase 
aims at preparing for change, the second at regaining weight and tackling eating 
disorder pathology, the last phase at developing personalized relapse prevention 
skills. 
CBT-E states that restoring underweight, at least from BMI 15 upwards, can take 
place within an outpatient setting, so hospitalization is indicated only when patients 
are psychiatrically and/or somatically unstable (Dalle Grave et al., 2008), and only 
for so long as they are unstable. Inpatient care does not aim at regaining a healthy 
weight. In the inpatient unit, the assistance around mealtimes and the ‘therapeutic 
climate’ are built on CBT-E strategies and comprises individual sessions, psycho- 
educational group meetings, a physical exercise group and a weekly review meeting 




In early 2015, after training all staff of all disciplines, the treatment center trans-
formed the inpatient and the outpatient units into CBT-E based programs. Over a six 
months period, outpatient therapy groups and day-care programs were phased out. In 
the outpatient unit, the only psychological treatment offered was CBT-E Underweight, 
focused version. The complete implementation plan, including a description of the 
CBT-E based inpatient care, has been published previously (Van den Berg et al., 2017).
Therapist Training
 
During TAU, 24 psychologists, psychotherapists, psychiatrists and nurse practi-
tioners delivered psychological treatments. Other staff members, 16 in total, consist-
ing of psychiatric nurses, dieticians and a psychomotor therapist, delivered partial 
treatment interventions within the intensive settings. 
Before implementing CBT-E, all staff completed the web based CBT-E training 
and exam offered by Centre for Research on Eating Disorders at Oxford and worked 
through the guide (Fairburn, 2008). In addition, the staff attended two workshops run 
by C. Fairburn. Since CBT-E Underweight is difficult to master, only after completing 
around 15 CBT-E normal weight, staff members were allowed to offer CBT-E Under-
weight for outpatients after working through the additional digital CBT-E Underweight 
modules. During CBT-E, outpatient treatments were delivered by 13 therapists, in 
the inpatient unit 11 staff members delivered partial interventions; these 24 staff 
members also delivered treatment during TAU. Throughout 2015-2017, to maximize 
adherence, all therapists attended a weekly, two hour peer intervision, supervised by 
senior therapists. Case load records were used to ensure all patients were discussed 
regularly. To monitor adherence, audiotaped sessions were randomly reviewed.
Statistical analysis
Statistical analyses were performed with SPSS version 25 and the R statistical 
computing environment. Group differences for continuous data were expressed as 
mean difference, categorical data as difference in proportion. Categorical measures 
between two groups were compared using chi-square or Fisher’s exact tests (as 
appropriate); to compare continuous data, t-tests or Mann-Whitney U tests were 
used. Differences within groups were compared using paired t-tests for continuous 
data. Statistical significance was defined as α=.05, two-sided, with 95% confidence 
intervals (CI) to express data uncertainty. To analyze repeated continuous outcomes, 
linear mixed model analyses were conducted according to a two-level structure 
(patient and repeated measures). To control for possible confounding, the baseline 
score of the dependent outcome variable plus the variables from the baseline analysis 
were added with a p < .05. Cohen’s d were used to examine effect sizes. 
Clinical outcome analyses were performed on a completers dataset (complete 
measures available at baseline and end-of-treatment) and on a pooled imputed data-
set. For missing data, multiple imputation, with 50 imputations for each missing obser-
vation, was used under a missing-at-random assumption; no differences were found 
between patient groups with and without complete EDE-Q global scores. Analyses 
were performed first on the imputed datasets separately, and then the outcomes of 
the 50 imputations were combined using Rubin’s rules (Rubin, 1987), using SPSS.
All cost-effectiveness analyses were run on intention-to-treat basis, using a pooled 
multiple imputed dataset. Unless otherwise indicated, cost-effectiveness findings are 
based on these imputed data.
Cost-effectiveness calculations
The cost-effectiveness analyses were performed from the direct treatment costs, 
health care provider perspective. For each patient, treatment costs (in euros) were 
established by multiplying standard Dutch cost prices, index year 2014 (Zorginstituut 
Nederland, 2016) by the amount of time spent on outpatient contacts (both contacts 
directly with patients and contacts concerning patients), by the number of days in 
day-care and / or number of hospitalization days. The time horizon of this study 
is from start to end-of-treatment; since this horizon was little over a year for both 
cohorts, no discounting for future costs / effects was applied. Differences in costs 
and effects between both cohorts were calculated as difference in cumulative direct 
costs. A total of 2,500 nonparametric bootstrapped samples was extracted from the 
50 imputed data sets, with the number of patients per sample equal to the patient 
numbers in the original dataset. 
Two different incremental cost-effectiveness ratios (ICERs) were calculated for 
each bootstrapped sample as ICER = (CostsCBT-E – CostsTAU) / (EffectsCBT-E – EffectsTAU) 
where effect was either EDE-Q global score < 2.77 or BMI ≥ 18.5. ICERs were calcu-
lated separately for all patients and for the subgroup of outpatients only, to explore 
the influence of hospitalization costs. The ICERs were plotted on cost-effectiveness 
planes and used for further calculations. TAU as comparator intervention is posi-
tioned in the origin of the cost-effectiveness plane with the horizontal axis indicating 
differences in effect and the vertical axis differences in costs. Figures 2 is divided into 
four specific quadrants along the horizontal and vertical axis with ICERs in the upper 
right quadrant indicating CBT-E generating better health gain at additional costs, 
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ICERs in the lower left indicating less health gain from CBT-E at lower costs. While 
TAU dominates CBT-E in the upper left quadrant, CBT-E dominates TAU with better 
effects at lower costs in the lower right quadrant. The scatter plot of ICERs in more 
than one quadrant indicates uncertainty about whether the examined intervention 
is comparatively cost-effective. Figure 2 provides the cost-effectiveness acceptability 
curves (CEACs) (Van Hout, Al, Gordon, & Rutten, 1994). Based on the distribution 
of the ICERs, CEACs indicate the probability of CBT-E being more cost-effective 
than TAU as a function of the willingness-to-pay (WTP) for one additional recovered 
patient. The WTP for one additional recovered Dutch anorexia nervosa patient are, 
to our knowledge, yet to be established.
The Journal Article Reporting Standards (Applebaum et al., 2018), the Strength-
ening the Reporting of Observational Studies in Epidemiology statement (Vanden-
broucke et al., 2007) and the Consolidated Health Economic Evaluation Reporting 




The flowchart of participants for both cohorts is shown in Figure 1.
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FIGURE 1
Flowcharts TAU cohort and CBT-E cohort
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Characteristics TAU and CBT-E cohort
Baseline characteristics of both cohorts are shown in Table 1, no differences 
were present on clinical characteristics. In the TAU cohort, 42.4% of patients had an 
illness duration ≥ 7 years (range 0.5-51 years), in the CBT-E cohort 39.3% (range 0.3-40 
years). With regard to BMI under 15, 24.0% in the TAU cohort (lowest BMI 12.5) and 
23.9% in the CBT-E cohort (lowest BMI 12.8) were severely underweight.
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TABLE 1
Baseline characteristics of TAU cohort and CBT-E cohort. 
Data shown as mean (SD) unless otherwise indicated
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Comparing patients with complete measures at baseline and end-of-treatment 
(completers) with patients without complete measures (non-completers) in the 
TAU cohort, no differences were found with regard to demographics and psycho-
pathology, although completers received more treatment sessions (p =.022). In the 
CBT-E cohort, completers had higher EDE-Q global, restraint and shape concern scores 
(respectively p = .021, p = .025 and p = .029) and a longer inpatient stay (p = .001). 
Comparing completers between both cohorts did not show any statistically signifi-
cant differences.
Treatment outcomes for completers 
Treatment outcomes for completers on eating disorder and general psychopa-
thology are shown in Table 2. In both cohorts, eating disorder attitudes and general 
psychopathology improved over time, except for the EDE-Q subscale shape concern, 
which did not improve in the TAU cohort. In both cohorts, eating disorder behaviors 
did not improve significantly, although in the CBT-E cohort, a trend on the decrease 
of vomiting was found (p = .066). 
Mean BMI increase in the TAU cohort was 1.3 (SD = 1.6; 95% CI 0.62, 2.01), in CBT-E 
2.7 (SD = 1.9; 95% CI 2.2, 3.2); linear mixed model analyses showed that BMI increase 
in the CBT-E cohort was higher (EMD = 1.39, SD = .28; 95% CI 0.82, 1.9, p < .001). 
The DASS subscale depression decreased more in the TAU cohort (EMD  =  4.22, p  = .047). 
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TABLE 2
Changes in eating disorder pathology (EDE-Q† scores) and general psychopathology (DASS‡ scores) 
in TAU cohort and CBT-E
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Remission rates completers
Remission, defined as EDE-Q global score < 2.77 (UK norms) or < 1.79 (Dutch 
norms), was achieved by 53.8% (UK norms) respectively 50.0% (Dutch norms) of 
patients during TAU; during CBT-E 59.0% (UK norms) respectively 37.7% (Dutch 
norms) remitted, with no statistical difference between CBT-E and TAU remission 
(UK norms p = .655; Dutch norms p =.286). Reliable Change Index (RCI) was estab-
lished (Jacobson & Truax, 1991) as 0.81 change on the EDE-Q global score. No statis-
tical difference was present between RCI in TAU (62.5%) and CBT-E (65.0%) (p = 
.829). On Clinically Significant Change (CSC), defined as RCI plus EDE-Q global score 
< 2.77, no statistical difference was present between TAU (41.7%) and CBT-E (51.7%) 
(p = 407). Applying a robust definition of remission (EDE-Q global score < 2.77, no 
eating disorder behaviors and BMI ≥ 18.5), again no difference was found between 
TAU (23.1% remitted) and CBT-E (19.7% remitted) (p = .720). On reaching BMI ≥ 18.5, 
a difference was found with 17.6% of patients in the TAU cohort reaching healthy 
weight versus 47.1% in the CBT-E cohort (p < .001).
Treatment outcomes on multiple imputed data 
Pooled paired sample tests on an imputed dataset showed that eating disorder 
attitudes as well as general psychopathology improved in both cohorts (all p <.001). 
On the decrease of eating disorder behaviors, no differences were found between 
both cohorts. Imputed linear mixed model analyses showed a difference with regard 
to BMI change in favor of CBT-E (EMD = 1.33, SD = .29, 95% CI .76 -1.90, p < .001).
Remission rates on multiple imputed data
Pooled multiple imputed analyses did not show differences on remission rates 
between both cohorts, both on UK (64.0% TAU, 61.4% CBT-E, p = .729) and Dutch 
norms (26.7% TAU, 30.7% CBT-E, p = .573). Imputed analyses showed no differences 
on either RCI (61.3% TAU; 56.8% CBT-E, p = .559) or on CSC (48.0% TAU; 45.5% CBT-E; 
p = .745). Applying the robust defined remission rate also did not show a difference 
(9.3% TAU; 14.6 % CBT-E, p = .304). Examining reaching BMI ≥ 18.5 however, pooled 
imputed data showed a difference with 17.3% in TAU versus 46.6% in CBT-E reaching 
health weight (p < .001). 
Attrition rate for outpatients
Outpatient dropout rate was defined as having attended fewer than ten treatment 
sessions, as in the CBT-E Underweight this is when the first evaluation takes place. 
During TAU, attrition rate was 46.1% (18/39) versus 11.5% during CBT-E (3/26), signif-
icantly lower (p = .003).
Care consumption & Admission rate
On care consumption, several differences were found. During TAU, the number 
of outpatient sessions was lower (M =14.5, SD = 12.09; range 4-62, median = 11) than 
during CBT-E (M = 31.4, SD = 15.6; range 4-57, median = 31; p < .001). During TAU 
period, fewer patients were admitted (33.3%) compared to CBT-E (65.9%) (p <.001). 
During TAU however, inpatient stay lasted longer with 64.4 nights (SD = 5.58) versus 
44.3 nights (SD = 24.0) during CBT-E (p = .002).
Treatment costs
Table 3 shows mean treatment costs for both cohorts. Except for day-care, treat-
ment costs were higher in the CBT-E cohort.
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TABLE 3
Eating disorder treatment cost categories and differences in costs between CBT-E and TAU cohort
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Cost effectiveness
The cost-effectiveness plane and the CEAC for all patients, with eating disorder 
remission (EDE-Q global score < 2.77) as effect measure indicates a 41% likelihood 
of CBT-E being more effective at higher treatment costs and a 56% likelihood of less 
effects at more costs. The probability of being cost-effective based on the CEAC is < 25% 
for all WTPs (figures not shown). 
Employing healthy weight (BMI ≥18.5) as effect measure, ICERs distribution was 
radically different and indicates a 97% likelihood of CBT-E being superior to TAU, albe-
it at higher treatment costs, see Figure 2. The CEAC indicates a probable preference 
for CBT-E (>50% probability of cost-effectiveness), assuming a WTP of € 9713,- or 
more for an extra remission. Examining outpatients only, the superiority of CBT-E 




Cost-effectiveness plane and cost-acceptability curve of the base case scenario with reaching healthy weight (BMI 
≥18.5) as effect parameter (all patients)
Discussion
This study examined effectiveness and cost-effectiveness for anorexia nervosa 
patients after implementing cognitive behavior therapy-enhanced (CBT-E), a recom-
mended specialized treatment, throughout a routine inpatient and outpatient setting. 
For this purpose, two cohorts were compared, one receiving regular treatment- 
as-usual (TAU) between 2012-2014, the next receiving CBT-E between 2015-2017. Both 
cohorts were seriously affected, with around 24% of patients having a BMI under 15, 
and around 40% of patients having an illness duration of seven years or longer.
There are two main findings. The first finding is that weight regain was better 
in the CBT-E cohort. Other than on weight regain, no relevant differences in clin-
ical outcomes were found. In both cohorts, anorexia nervosa attitudes improved 
significantly, which is important because weight regain is usually accompanied by 
an increase in eating, shape and weight concerns, so challenging maintaining the 
weight regained. In both cohorts, no significant decrease on bingeing, vomiting and 
laxatives misuse was found. With regard to those behaviors it is worth noting that the 
use of the self-report EDE-Q may have overestimated the reporting of binges in this 
study (Fairburn & Beglin, 1994). 
The second main finding was that when limiting the cost-analysis to direct treat-
ment costs, employing healthy weight as effect measure, the ICER distribution for 
all patients indicates a 97% likelihood of CBT-E leading to better effects than TAU, at 
higher costs. The CEAC indicates a probability of CBT-E being cost-effective assum-
ing a WTP of € 9713,- or more for each additional remission. This WTP of € 9713,- is 
lower than some reported costs-of-illness for anorexia nervosa (Stuhldreher et al. 
2015). Differences between TAU and CBT-E were minimal, when eating disorder 
remission was employed as effect measure. Examining outpatients only, the supe-
riority of CBT-E over TAU is even stronger, on reaching healthy weight, but also on 
eating disorder remission. 
The hypothesis of CBT-E being more effective was confirmed with regard to 
weight gain and economic evaluation showed that CBT-E was superior to TAU on 
weight gain, although at higher costs. 
The present finding suggesting that, within a routine setting, CBT-E for adult 
patients with anorexia nervosa leads to better weight regain compared to TAU is, to 
our knowledge, new. 
Several factors may have contributed to the better weight gain during CBT-E; as 
weight regain is usually better within an inpatient setting compared to an outpatient 
setting (Waller, 2016), the higher admission rate, although shorter, during CBT-E may 
have contributed. In addition, literature suggests that studies with reported training 
have a larger effect on weight regain compared to studies without reported training 
(Van den Berg et al., 2019), so perhaps the structured training during CBT-E may have 
contributed as well, next to the probable potency of CBT-E. 
Comparing our findings in the CBT-E cohort with other CBT-E anorexia effective- 
ness studies is somewhat limited because some studies excluded patients with 
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BMI <15 or did not offer inpatient care. When comparing the BMI increase of 
2.75 (SD = 1.9) during CBT-E with 2.77 (SD = 1.81) of the Fairburn anorexia nervosa 
outpatient study, which included patients with a slightly higher BMI, findings appear 
similar (Fairburn et al., 2013). The present CBT-E finding of 47.1% of patients reach-
ing healthy weight, also corresponds with 38.8% found in the considerable more 
intensive inpatient study of Dalle Grave (Dalle Grave et al., 2013). In the Fairburn 
study (Fairburn et al., 2013), 61% of treatment completers reached BMI ≥ 18.5, within 
an outpatient setting; at the same time, attrition rate in the Fairburn study was high-
er, probably because patients dropped out when they needed hospitalization. The 
19.7% robust remission rate in the CBT-E period appears to be in line with the 17% 
and 8.8% respectively in the Turner and Byrne studies (Turner et al., 2015; Byrne et 
al., 2011), although slightly different definitions were used across the studies.
There are two possible explanations for the higher treatment costs in the CBT-E 
cohort compared with TAU: first, the higher outpatient costs appear to be related to 
the lower attrition rate, with more outpatients completing the recommended number 
of sessions. Secondly, the higher admission rate led to higher inpatient costs. At the 
same time, total costs of CBT-E treatment still contrast well with internationally 
reported average treatment costs (Stuhldreher et al. 2015). The found lower attrition 
rate is of note because anorexia nervosa treatments are known for their high drop-
out rates and thus the lower attrition rate could be related to high acceptability of 
CBT-E. The CBT-E focus on engaging may pay off here, because therapists are able 
to commit more outpatients to complete their treatment. The comparatively higher 
admission rate in the CBT-E cohort may be related to staff members still mastering 
CBT-E Underweight in order to treat severely underweight patients on an outpatient 
basis, combined with available inpatient facilities at hand. 
Limitations
Due to absence of follow up data, longer term effect were not examined. The five 
year time frame of this study, although in line with similar studies (Turner et al., 2015; 
Byrne et al., 2011), may be a confounding variable. The analyses however suggested 
that there was no change in both the key patient characteristics and program leader-
ship and / or financing system. Additional societal and potential concurrent health 
costs were not measured and valued; as little knowledge is available on direct treat-
ment costs of anorexia nervosa, the purpose in this study was establishing direct 
costs. Finally, therapist fidelity was not systematically assessed during the CBT-E 
period, rather, to monitor and enhance CBT-E adherence, audiotaped sessions were 
reviewed during intervision.
Strengths
As this study did not take place within the limiting context of a selective clinical 
trial, with a select group of therapists, findings may be generalizable to other real-
world inpatient and outpatient settings. By making clinical outcome and actual 
treatment costs, instead of model costs, public, this study contributes to enhancing 
transparency, allowing learning from variations found between services, so helping 
development of more effective health care (Clark et al., 2018). 
This study may contribute to the evidence of the effectiveness of specialized, 
recommended psychological treatments for anorexia nervosa. In particular, it 
contributes to the evidence base on effectiveness of CBT-E, in inpatient settings with 
multidisciplinary staff, as well as in outpatient settings. A growing evidence base may 
lessen clinical uncertainty and subsequently reduce eclectic treatment approaches 
(Wonderlich et al., 2020). 
The findings of this study may contribute to decision making in clinical practice, 
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Introduction
In this brief report we provide an overview of an outpatient multidisciplinary 
group based treatment, offered in collaboration with a general hospital between 2004 
and 2009, to morbidly obese patients awaiting bariatric surgery. 
Obesity is defined as abnormal or excessive fat accumulation that may impair 
health (World health Organization, 2020). Worldwide, the prevalence of morbid 
obesity (having a body mass index over 40 kg/m2) is estimated at 0.64% in men and 
1.6% in women (NCD Risk Factor Collaboration, 2016). In 2014, 18.4% of the world’s 
obese adults lived in high-income English-speaking countries, these countries 
contained an even larger share of the world’s severely obese people (27.1%), followed 
by 13.9% in the Middle East and north Africa (NCD Risk Factor Collaboration, 2016). 
In the Netherlands, in 2018, one percent of the population aged 20 years or older, was 
morbidly obese (Centraal Bureau voor de Statistiek, 2018). 
Obesity affects mental wellbeing as well; obesity is firmly associated with an 
increased risk of depression (Luppino et al., 2010) and it is suggested that 30% of 
individuals seeking weight control treatment might be diagnosed with a binge eating 
disorder (De Zwaan, 2001). In individuals opting for bariatric surgery, findings 
suggest a preoperative prevalence of psychiatric disorders between 20-60%, mainly 
consisting of affective, anxiety and / or eating disorders (Wimmelmann et al., 2014).
For morbid obesity, as non-surgical interventions are usually ineffective in the 
long run, bariatric surgery is an increasing popular treatment option, already in 
2004. Bariatric surgery is a treatment option for people with a body mass index over 
40 kg/m2, or over 35 kg/m2 with other significant comorbid disease that could be 
improved if they lost weight, e.g. type 2 diabetes or high blood pressure. Bariatric 
surgery is the option of choice for adults with a body mass index over 50 kg/m2 when 
other interventions have not been effective (National Institute for Health and Care 
Excellence, 2014). Since early 2000, the number of bariatric procedures for morbidly 
obese individuals has been steadily increasing. In the Netherlands, the number of 
surgical procedures increased from around 800 in 2003 (Buchwald & Williams, 2004) 
to 6807 in 2013 (Agrisani et al., 2015) and has currently stabilized at 12.000 proce-
dures a year. Earlier on, surgical weight loss procedures mainly concerned gastric 
banding, later, partly due to limited effectiveness, non-adjustable procedures like 
gastric bypass surgery became procedures of first choice. 
It is estimated that successful long-term weight loss after gastric banding surgery 
was achieved by approximately 48% of patients (Tice, Walsh, Petersen & Feldman, 
2008); for non-adjustable procedures, successful weight loss is estimated at 70-80% 
(Livhits et al., 2012).
 
Due to mixed findings on surgery effects and due to high comorbidity of complex 
psychopathology in their bariatric population, in 2004 collaboration was sought by 
the departments of bariatric surgery and medical psychology of an Amsterdam based 
general hospital, with Novarum, a specialized eating disorder center. This collabora-
tion consisted of offering the bariatric patients of this hospital specialized psycho-
logical help aimed at disturbed eating behavior, prior to surgery. Around that time, 
Novarum was already treating morbidly obese patients with an eating disorder, and 
amongst patients seeking treatment, there were already patients who had undergone 
bariatric surgery and were struggling with the (re)appearance of disturbed eating 
disorder behavior. 
By offering all their bariatric patients pre-operative behavioral and weight 
management interventions aimed at establishing a regular eating pattern, regardless 
of whether they were diagnosed with an eating disorder or not, it was assumed that 
the effect of bariatric surgery would be enhanced (Garcia-van den Berg, Van Es & De 
Vries, 2005). If patients were not willing to enter psychological treatment, they were 
obliged to lose a fixed amount of weight, as determined by the operating surgeon, 
prior to surgery. Thus, the bariatric patients of this hospital were accepted for bari-
atric surgery after either completing psychological treatment and acquiring skills to 
control over-eating, or after having lost the required amount of weight. 
Method
Participants
Between 2004 and 2009, around three hundred bariatric patients, all over 18 years 
of age, were seen at Novarum to assess whether patients were (1) motivated and 
(2) eligible for psychological group therapy treatment. The main exclusion criteri-
um was language difficulties. A considerable percentage of assessed patients met 
the exclusion criterium of poor literacy: in a pilot study, 68.4% (39/57) of referred 
patients were excluded (Van den Berg, Peen, Van Empelen, & Dekker, 2014). After the 
start of the first therapy groups, a known history of antisocial behavior became an 
additional exclusion criterium. Motivated patients who were regarded non-eligible 




The 24-week group based treatment consisted of around eight male and female 
patients. Within the treatment groups, patients awaiting bariatric surgery were 
mixed with morbidly obese patients seeking psychological help for their disturbed 
eating behavior, but who did not opt for bariatric surgery; it was assumed that clinical 
 outcome of a homogenous bariatric patient group may be negatively affected by a shared 
ambivalence towards non-surgical, behavioral interventions. So mixing bariatric 
patients with non-bariatric, morbidly obese patients was thought to be favorable for 
bariatric patients.
The intensive outpatient program consisted of a guided meal and three therapy 
modules; (1) a weight management module, aimed at establishing a long-lasting, regular 
 eating pattern, improving the quality of daily diet and reducing overall energy intake, 
(2) a cognitive behavioral therapy module, aimed at acquiring skills for uncontrolled 
overeating and improving poor body image (Fairburn, 1995; Werkboek Eetbui- 
stoornis, 2002), and (3) an exercise module, aimed at increasing physical activity. 
During the guided meals, exposure interventions with regard to dietary rules and rate 
of eating were offered. After completing treatment, bariatric patients were offered an 
additional psychoeducation group focusing on the upcoming operation. 
Remarks	on	clinical	outcome	
Two brief accounts of findings on clinical outcome were presented in earlier 
Dutch language articles (Olthof et al., 2010; Van den Berg et al., 2014). In these two 
pilot studies, clinical outcome of several treatment groups taking place between 2006 
and 2009, was examined. At baseline, no differences were found between bariatric 
and non-bariatric patients with regard to the degree of morbid obesity, with regard to 
reported depressive symptoms on the Beck Depression Inventory (Van der Does, 2002), 
with regard to reported psychological problems & somatization (Symptom Checklist, 
Arrindell & Ettema, 1986) or with regard to the level of reported avoidance behaviors 
due to a poor body image (Body Image Avoidance Questionnaire; Rosen, Srebnik, 
Saltzberg & Wendt, 1991).
Although in both pilot studies, bariatric and non-bariatric patients did lose weight, 
in both studies, opting for bariatric surgery was associated with less weight loss. With 
regard to reported body image, findings suggested that bariatric patients reported 
a smaller decrease of avoidance behaviors compared to non-bariatric patients 
at end-of-treatment. Over the years, the dropout rate was high: of the examined 
 therapy groups, 50% of patients dropped out before the end of treatment. 
Discussion
When examining preliminary outcome of the bariatric psychological treatment 
offered, one of the main findings is that, compared to non-bariatric patients, bariatric 
 patients lost less weight and profited less from the interventions aimed at improving 
poor body image. It may be that bariatric patients were less motivated to participate 
in preoperative treatment aimed at behavioral change as they, rightfully, expect the 
surgical procedure itself to be helpful in gaining control over eating. In addition, 
bariatric patients may expect that once they have lost a significant amount of excess 
weight, their body image will improve and a significant maintaining factor related to 
over-eating, i.e. a poor body image, will have disappeared. So in their view, acquiring 
skills aimed at uncontrolled overeating, may be, obsolete. 
The offered interventions within the group therapy were not aimed at specific 
eating disorder pathology, but were aimed at establishing a regular eating pattern. 
We presumed that individuals with morbid obesity struggle with irregularities in their 
daily menu, as disturbed eating behavior is regularly reported by individuals who 
are severely obese (De Zwaan 2001; Wilson & Fairburn, 2007). It was assumed that 
offering interventions aimed at establishing a regular eating pattern and acquiring 
skills for (uncontrolled) overeating, would enhance effectiveness of bariatric 
surgery. We did not examine whether the ability to establish a regular eating pattern 
and /or the acquired self-control on overeating, did actually improve adherence to 
the post-operative required lifestyle and dietary recommendations, compared with 
patients who did not participate in pre-operative treatment. 
At hindsight, several limitations with regard to the treatment offered, come to 
mind. First, the considerable number of patients who were regarded non-eligible 
for participation due to poor literacy was worrying. Literature suggests that in the 
Netherlands, the prevalence of obesity has increased in the period 1987-1991 parti- 
cularly in those with a relatively low educational level (Seidell, Verschuren, & Kromhout, 
1995). Nowadays, it is known that low socio-economic status, likely to be associated 
with the prevalence of poor literacy, is negatively associated with suboptimal weight 
loss after surgery (Wimmelmann et al., 2014). So presumably, an important part of 
the bariatric sample was not reached. The found high dropout rate in the two pilot 
studies may be indicative of a (partial) mismatch with the treatment demands or 
expectations of the participants. 
Around 2009, partly due to the high dropout rate, the intensive cooperation with the 
hospital gradually came to an end. Up till now, the extent to which the presence of pre- 
operative eating disorder pathology should be considered an impediment to bariatric 
surgery is still controversial (Wimmelmann et al., 2014). Some Dutch hospitals 
exclude patients who are pre-operatively diagnosed with a binge eating disorder 
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from bariatric surgery, while other hospitals do not regard the presence of a binge 
eating disorder to be an exclusion criterium. Nowadays, literature suggests that it is 
more beneficial to offer behavioral interventions after surgery, rather than preoper-
atively, so the focus of attention has shifted to postoperative screening and treatment 
(Sheets et al., 2015). Post operatively, it is possible to identify patients who are expe-
riencing suboptimal weight loss and/or are struggling with the (re) occurrence of 
disturbed eating behavior and offer more personalized interventions. In addition, as 
presurgical eating disorder pathology can resolve as consequence of surgery, offer-
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Abstract
Purpose: Bariatric surgery is the most effective long-term treatment for sustained 
weight loss in obesity. Studies have shown that not all patients lose the expected 
amount of weight. The aim of this study was to develop a better understanding of 
which behavioral and psychological factors are associated with suboptimal weight 
loss.
Methods: The present paper describes a cross-sectional study that included 
140 participants. The mean follow-up period after bariatric surgery was 3.16 years. 
Eating disorder pathology (Eating Disorder Examination-Questionnaire), impulsivity 
(Barratt Impulsiveness Scale-II) and depressive symptoms (Beck Depression Inven-
tory) were compared with successful and suboptimal participants. A weight loss of 
more than or equal to 50% of excess weight, was considered to be successful.
Results: More than 81% of the participants met the criterion for successful weight 
loss. The suboptimal weight loss group reported more symptoms of eating disorder 
pathology (p = .001), more loss of control over eating (p = .001), and more avoidant 
behavior due to poor body image (p < .001). The suboptimal weight loss group scored 
higher on impulsivity (p = .007) and on depression (p < .001). More early weight loss 
was associated with better weight outcome later on (r = .491). Reporting more eating 
disorder pathology, a longer follow-up period and pre-operative super-obesity (body 
mass index ≥ 50 kg/m2) at the time of surgery were associated with poorer weight loss 
(p < .001).
Conclusion: Eating disorder pathology, loss of control over eating and avoidant 
behavior due to poor body image, as well as depressive symptoms and impulsivity, 
(as reported postoperatively) are associated with suboptimal weight loss.
Introduction
Obesity is a public health concern that has been increasing worldwide and is 
associated with reduced life expectancy, multiple medical conditions and psycho-
pathology[1, 2]. Bariatric surgery (BS) is the most effective long-term way of losing 
weight [3-5]. However, studies have indicated that a that there is suboptimal weight 
loss or gradual weight regain in approximately 20-30% of patients, regardless of the 
malabsorptive or combined restrictive malabsorptive procedure used [6, 7].
Identifying variables associated with successful weight loss is of importance 
because suboptimal weight loss, considered a long- term complication, can lead to 
the re-emergence of obesity related health risks, and impaired quality of life [8]. The 
causes of suboptimal weight loss are thought to be multi-factorial and include -along-
side technical, surgery-related factors- demographic, behavioral and psychological 
factors [9-16]. Being a male, age over 40 and a body mass index (BMI) over 50 kg/m2 
(super obesity) at time of surgery are found to be firmly associated with suboptimal 
weight loss [7, 10, 13, 17].
Previous studies of patient factors have focused on pre-operative factors, and 
little attention has been paid to the impact of psychological and behavioral factors 
during the period after surgery [9]. With regard to those post-operative factors, the 
literature is more inconclusive [18]. Dietary changes that patients must commit to 
after surgery may be associated with post-operative weight loss, but there is insuf-
ficient evidence for firm conclusions, and further research is needed [9]. The litera-
ture suggests that eating disorder pathology after surgery is more closely related to 
weight loss than pre-operative eating disorder pathology [19, 20]. Disordered eating 
behaviors after surgery such as loss of control over eating, grazing and stress eating 
are associated with poorer weight loss [16, 18, 21]. Most empirical support has been 
found for the association between loss of control over eating and poorer weight loss 
[18; 22]. Besides post-operative eating disorder pathology, more weight loss in the 
first six months has been identified as a positive predictor of later weight loss [9]. 
The association between post-operative weight loss and the presence of psycho- 
pathology, like depression, is still unclear [9]. Some studies have found no difference 
in weight loss between patients with and without the existence of post-operative a 
psychiatric disorder, while others have found a correlation between a post-operative 
depressive disorder and suboptimal weight loss [9, 23, 24].
Due to a limited amount of research, the literature is inconclusive about the asso-
ciation between weight loss after BS and a negative body image [25]. The study by 
Grilo and colleagues (2005) found that both checking and avoidance behaviors are 
significantly associated with the over-evaluation of weight and shape, a core feature 
of eating disorder pathology in general and in the bariatric population [26]. According 
to Ortega and colleagues (2012), a main predictor of psychopathology after BS is 
negative body image. A negative body image is associated with poorer mental health 
and higher symptoms of depression [27, 28]. The symptoms of depression may lead 
to disordered eating behaviour (e.g., LOC over eating and grazing), which may lead 
to weight regain
Impulsivity is another psychological factor associated with suboptimal weight 
loss after BS [15]. Impulsivity is a multi-faceted construct, and in our study we 
focused on impulsivity as a personality trait. Impulsivity, measured using self-report 
questionnaires, is considered to be a stable personality trait considers the tendency 
for disinhibited or spontaneous behavior without adequate forethought or conside- 
ration of the consequences [29]. Several facets of impulsivity, such as heightened 
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reward sensitivity and insufficient response inhibition, have been linked to obesity 
[30]. On a behavioral level, people with a higher level of impulsivity tend to eat more 
unhealthy foods [31]. The review by Schag and colleagues (2013) showed that impul-
sivity in obese patients mainly expresses itself in disordered eating behaviors by loss 
of control over eating [32]. It has also been suggested that impulsivity has an indirect 
negative impact on weight loss after BS that is mediated by depression for instance 
when being in a negative mood enhances impulsivity and thus leads to impulsive 
overeating [15]. Obese people showed more disordered eating behaviors especially 
when they experience a negative mood [33]. The study by Schag and colleagues (2016) 
showed that impulsivity and depressive symptoms both are associated with disor-
dered eating behaviors [15].
According to previous research the prevalence of psychopathology in bariatric 
patients is approximately 50% [7, 34-36]. Psychopathology seems to be related with 
post-operative weight loss [37]. Successful or suboptimal post-operative weight loss is 
associated with the degree to which patients benefited from previous psychological 
treatment.
The aim of this study was to develop a better understanding of which post- operative 
behavioral and psychological factors are associated with suboptimal weight loss after 
BS.
In addition, we examined whether better weight loss in the first six months 
was associated with better weight outcome on long-term. We also explored the 
factors; pre-operative super-obesity, age and gender were associated to subopti-
mal weight loss. We hypothesized that post-operative eating disorder pathology, 
depression and impulsivity were associated with suboptimal weight loss after BS. 
Methods
Participants
Participants were recruited through advertising on online Dutch platforms devel-
oped for bariatric peer support. In addition, recruitment by advertising took place 
through Dutch general hospitals where BS is performed. Finally, eligible patients of 
an eating disorder treatment center were invited by health professionals to partic-
ipate. In total, 129 of the 140 (92%) participants were recruited through online 
platforms and general hospitals and 11 of the 140 (8%) participants were recruited 
through an eating disorder treatment center.
Participants were included if the follow-up period after BS was at least nine 
months, if they were older than 18 and if the bariatric surgical procedure was a malab-
sorptive procedure or combined restrictive malabsorptive procedure. A nine-month 
follow-up period was chosen as a cut-off point given that surgical impact usually 
begins to decrease around one year post-operatively, and the influence of psycho-
logical factors may, therefore, become more evident [16]. Since postoperative weight 
loss varies between restrictive procedures (e.g. gastric banding) and malabsorptive 
or combined malabsorptive procedures (e.g. gastric bypass), with greater weight loss 
occurring in patients undergoing malabsorptive or combined malabsorptive proce-
dures, in this study participants who had undergone a restrictive procedure (N = 13) 
were excluded [16]. Self-report questionnaires were used to assess all participants. 
The self-report questionnaires were completed by 153 of the 186 participants. Partic-
ipants who did not completed the self-report questionnaires were excluded from 
the final analysis. This study finally included 140 participants and it was conducted 
between June 2014 and June 2016.
The participants were assigned to a successful or a suboptimal weight loss group. 
The definition used for success was: percentage of excess weight loss (% EWL) of 50% 
or more at the time of completing the questionnaire. Percentage of EWL was calcu-
lated as ((Δ pre-surgery weight and post-operative weight) / (initial weight – ideal 
weight)) X 100% [5, 7]. A body mass index (BMI) of 25 kg/m2 was used as the criterion 
for ideal weight.
To define successful weight loss, some studies recommend using a weight 
outcome measure that reduces the influence of initial BMI when comparing the 
results for patients with a lower and higher BMI; total body weight loss (TBWL) 
outcome measure [9]. Due to the fact that % EWL is the most commonly used metric, 
% EWL definition was used throughout this study [3, 6, 13, 21, 24, 38 ].
Central Committee on Human Research (CCMO) has waived the requirement 
of ethical approval. The CCMO has ruled that Dutch law on research with humans 
does not apply to the collection of anonymized retrospective information for routine 
procedures. All participants gave informed written consent before enrolment. The 
datasets generated and/or analysed during the current study are available from the 




Online self-report questionnaires were used to assess all participants. The 
socio-demographic variables used were gender and age. Other variables used were 
type of surgery, pre-operative weight in kilograms (kg), weight at six months follow-
up after BS (kg), current weight (kg) and date of surgery.
Eating disorder pathology was evaluated using the Dutch version of the Eating 
Disorder Examination Questionnaire (EDE-Q), which is designed to assess eating 
disorder pathology [39, 40]. The EDE-Q consists of 36 items and four subscales (eating 
restraint, eating concerns, weight concerns and shape concerns) and yields a global 
score. Scores per subscale are the average score of all items in the scale. The global 
scale is the mean score of the four subscale means. The frequency of various forms 
of overeating, including binge eating, was also assessed by the EDE-Q. Loss of control 
(LOC) over eating was defined as the presence of any LOC episodes in the previous 
28 days. This method of LOC over eating was previously used in other studies [22, 
41, 42]. Items are rated on a 7-point Liker scale (0 to 6), with higher scores reflecting 
greater severity or frequency. The internal consistency of the EDE-Q is high (Cron-
bach’s α = .95) [43].
Body image was assessed using the Dutch version of the Body Image Avoid-
ance Questionnaire (BIAQ), which consists of 19 items [44, 45; Dutch version not 
published]. This is a self-report questionnaire which measures behavioral avoidance, 
which is related to body image distress or dissatisfaction. The questionnaire has four 
subscales (clothing avoidance, avoiding social activities, eating restraint and groom-
ing & weighing) and yields a global score. The subscale clothing avoidance meas-
ures disgust or covering up the body through clothing choices; the subscale avoiding 
social activities measures avoidance of social situations involving eating or focus on 
appearance; the subscale restraint measures dietary restrictions and the subscale 
grooming/weighing measures checking behavior such as scrutinizing oneself in 
the mirror and weighing. All items are scored on a 6-point scale according to the 
frequency of engagement in the behavior, from never (0) to always (5). The original 
BIAQ has a high internal consistency (Cronbach’ s α = .89) [44].
Impulsivity was measured using the Dutch version of the Barratt Impulsiveness 
Scale-II (BIS-II), which consists of 30 items with a 4-point Likert scale [46, 47; Dutch 
version not published]. The BIS-II consists of three subscales of impulsivity (atten-
tion, motor and non-planning impulsivity) and yields a global score. The attention 
subscale measures poor concentration and thought intrusions; the motor subscale 
measures acting without thinking and the non-planning subscale measures the lack 
of future planning. The global score can range from 30-120, with a higher score indi-
cating more impulsivity. Internal consistency (Cronbach’s α = .83) and test-retest reli-
ability (Spearman’s rho = .83) are high [48].
Depressive symptoms were assessed with the Dutch version of the Beck Depres-
sion Inventory (BDI), a self-report questionnaire consisting of 21 items, with a higher 
score indicating a higher level of depressive symptoms. Internal consistency (Cron-
bach’s α = .88) is high [49- 51].
Data analysis
Statistical analyses were performed using the IBM SPSS statistics program, 
version 19. Analysis of variance (ANOVA) was used for all variables except the nomi-
nal variables, to compare the differences between <50% EWL and ≥50% EWL. For 
analyses comparing two nominal variables, a chi-square test was used (type of 
surgery, loss of control (LOC) over eating, previous psychological treatment, pre-op-
erative super-obesity, gender and age at time of surgery) . There were statistically 
significant differences in the follow-up time after surgery between the groups, and 
the group means were therefore adjusted for confounders by entering follow-up time 
after surgery as a covariate. ANOVA assumptions were tested. In case of non-normal 
distribution, data were transformed through ANCOVA before statistical testing; this 
is indicated in the Results section. A Pearson’s R analysis was conducted to meas-
ure the strength of the association between weight loss in the first six months and 
total weight loss after surgery. Multiple logistic regression analyses were conducted 
to identify variables that predicted less weight loss. The cut-off for significant mean 
differences between the groups was set at p < . 05.
Results
The mean age of all the participants was 47.52 (SD = 9.79) and the mean pre-oper-
ative BMI was 46.76 kg/m2 (SD = 8.00). The average follow-up time post-operative was 
3.16 years (SD = 2.83). Eighty-one percent of the participants (n = 105) met the criteri-
on for successful weight loss; nineteen percent (n = 27) met the criterion for subopti-
mal weight loss. The mean follow-up time after bariatric surgery was significantly 
longer in the suboptimal group (p = .003), with an average of 4.99 years (SD = 4.45; 
range 0.95 - 24.48 years), compared to the successful group, which was 2.72 years 
(SD = 2.09; range 0.76 - 15.54 years). A significant difference in distribution between 
<50% EWL and ≥50% EWL in the participants recruited through the Dutch eating 
disorder treatment center was found χ²(1) = 15.085, p < .001. In the total cohort of 
<50% EWL, 26% (7/27) was recruited through the treatment center.
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Data of the EDE-Q (eating restraint, eating concerns, weight concerns, shape 
concerns and EDE-Q global score), BIAQ (avoiding social activities and eating 
restraint) and the BDI global score were not normally distributed, therefore an 
ANCOVA transformation was performed. By comparison with the successful group, 
participants in the suboptimal group scored higher on eating concerns (p = .003), 
weight concerns (p = .001), shape concerns (p = .001) and EDE-Q global score (p = 
.001). Participants from the suboptimal group scored higher on clothing avoidance (p 
< .001), avoiding social activities (p < .001) and BIAQ global score (p < .001), whereas 
the successful weight loss group scored higher on grooming & weighing (p = .002).
Analysis of variance identified significant differences in the BIS-II subscales for 
attention (p =. 019), non-planning (p = .022) and in the BIS-II global score (p = .007); 
the scores in the suboptimal group were higher than those in the successful group. 
With regard to the BDI global score, the suboptimal group scored significantly higher 
than the successful group (p < .001) (Table 2).
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TABLE 1
Descriptive statistics of the study sample (N = 140)
TABLE 2
Outcome measures of self-report questionnaires among participants with successful and suboptimal weight loss
In total, 83% of the participants had a gastric bypass (N = 117). There was no 
significant difference between type of surgery (gastric bypass and other type of 
surgery or gastric banding) with regard to weight loss χ²(1) = .588, p = .443 (Table 1). 
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A Pearson’s R analysis revealed a moderate positive correlation (r = .491). More 
weight loss in the first six months after BS seems to be associated with more weight 
loss at time of measurement.
Several multiple regression analyses were performed and a significant differ-
ence was found only with backward multiple linear regression, which indicated that 
pre-operative super-obesity, longer follow-up time after surgery and a higher score 
on the EDE-Q global score were related to less weight loss (Table 4).
TABLE 3
Outcome measures of variables among participants with successful and suboptimal weight loss
Overall, there were significant differences between the groups in terms of loss 
of control (LOC) over eating based on the EDE-Q (p = .001), previous psychological 
treatment (p = .014) and pre-operative super-obesity (p = .032). In the suboptimal 
group, 44% had pre-operative super-obesity, while 24% of the successful group had 
pre-operative super-obesity (Table 3).
TABLE 4
Multiple backward regression to predict weight loss
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Discussion
The aim of this study was to identify the behavioral and psychological factors that 
are associated with suboptimal weight loss in post-bariatric surgery patients. This 
study, through bivariate analyses, found an association between suboptimal weight 
loss and the following behavioral factors: disordered eating behaviors, negative 
body-image avoidant behavior and less weight loss in the first six months. Besides, 
this study suggests that suboptimal weight loss is associated with two psychological 
factors, namely impulsivity and depressive symptoms. In addition, with regard to 
behavioral and psychological factors, an association between suboptimal weight 
loss and previous psychological treatment was found. Finally, in our multiple back-
ward regression analysis we found that pre-operative super-obesity, eating disorder 
pathology and a longer follow-up period seems to be associated with suboptimal 
weight loss.
In this study, weight loss was suboptimal in 19% of the participants. This finding 
is consistent with previous research [6, 7, 24]. Our results support findings from previous 
research that post-operative eating disorder pathology (such as concerns about 
weight, body image, eating pattern and loss of control over eating) are associated 
with suboptimal weight loss after bariatric surgery (BS) [15, 18 - 20, 52]. Weight loss 
after BS depends on the adoption of a personalized healthy eating pattern that takes 
into account both individual and psychological factors influencing dietary adherence 
[53]. Most empirical support can be found for the specific association between 
post-operative, self-reported, loss of control (LOC) over eating and suboptimal 
weight loss [22, 54]. The subjective sense of LOC over eating has significant impact on 
weight. The possible explanation can be that global caloric intake is probably higher 
when there is a LOC over eating and less weight loss can therefore be expected 
[22]. Post-operative disordered eating behaviors are also likely to compromise 
the adherence to dietary plans [53, 55].
In the present study we found that successful weight loss in the first six months is 
associated to successful weight loss during the follow-up period; this is in accordance 
with the literature [9]. A possible explanation could be that the ability to adjust to the 
required BS recommendations directly after surgery is linked to the ability to main-
tain the required behavioral adjustments. However, the evidence is insufficient as a 
basis for firm conclusions. We are not aware of any research whether early adherence 
to post-operative conditions predicts later outcome.
We found that body-image avoidant behavior is associated with suboptimal 
weight loss after BS. The core feature of eating disorder pathology in the bariatric 
population, is over-evaluation of weight and shape [26]. The study by Grilo and 
colleagues (2005) found that body image avoidant behavior is significantly associated 
with over-evaluation of weight and shape. The higher presence of avoidant behavior 
in the suboptimal weight loss group compared to the successful group in our study 
could be a result of possible disappointment with the amount of weight lost, lead-
ing to body avoidance. The direction of this relationship remains unclear due to the 
lack of pre-operative data in our study. There is no consensus in the literature about 
what relationships exist between weight loss after BS and body image [25]. In the 
review by Bertoletti and colleagues (2019) concerns about body image were related to 
depressive symptoms, loss of control over eating and experiences of social discrim-
ination and bullying. Further, this review reports that improvement in body image 
was associated with a decrease in compulsive eating symptoms, reduction of BMI 
and increase in percentage excess weight loss in some studies, but that other studies 
did not find an association between body image and weight loss after BS. However, 
the assessment of weight and shape concerns is complicated in post-operative bariat-
ric patients, since shape concerns in the population of bariatric patients are different 
than in other populations [55]. Weight loss is frequently accompanied with loose skin 
which is associated with higher body dissatisfaction and depressive symptoms [56].
Impulsivity is a central factor in disordered eating behaviors and obesity and 
can contribute to the experience of suboptimal outcomes after BS [57]. In our study 
we found that impulsivity (i.e. poorer concentration and thought intrusions) is 
associated with poorer weight loss after BS. The research by Schag and colleagues 
[15] suggests that impulsivity has an indirect impact on weight loss after BS that is 
mediated by depression and transferred through disordered eating behaviors. The 
disinhibition observed in people with obesity and loss of control over eating, and the 
emotional dysregulation associated with mood disorders, all likely share common-
alities that may be associated with suboptimal weight loss after BS. Another possible 
explanation could be that higher levels of impulsivity make it difficult to comply with 
the recommendations after BS. Facets of impulsivity may represent a transdiagnostic 
process that underlies multiple health-related behaviors, including physical activity, 
diet and adherence to treatment regiments [58].
In the review of Herpertz and colleagues (2004) was found that earlier studies 
have generated conflicting results about the post-operative presence of depressive 
symptoms and weight loss [18]. The difference in level of depression in our study 
must be interpreted with caution. The direction of this relationship is unclear due 
to the lack of pre-operative data. A different study design would be needed to clarify 
the direction of the relationship. The finding of mild depressive symptoms in partici-
pants with suboptimal weight loss may be related to disappointment that weight loss 
has been less than expected.
In addition, we found in our study that previous psychological treatment is asso- 
ciated with suboptimal weight loss. A history of psychopathology seems to be associated 
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with weight loss [37]. Positive or negative post-operative weight loss is associated 
with the degree to which patients benefited from psychological treatment in the 
past. Our findings were not supported by previous studies, in which was found that 
patients who had received previous psychological treatment had improved weight 
loss compared with individuals without pervious psychological treatment [37, 59]. 
Due to the lack of additional information with regard to the nature of these psycho-
logical treatments in this study further interpretations cannot be made.
We found an association between higher baseline BMI at time of surgery, particu-
larly pre-operative super-obesity, and suboptimal weight loss. This is in line with the 
literature [13]. The predictor found in other studies for suboptimal weight loss when 
being over 40 years at the time of surgery was not found in this study, probably due to 
the small number of participants below the age of 40.
Our finding that the duration of the follow-up period was associated to subopti-
mal weight loss needs additional research in the form of a longitudinal study. It is 
advisable to have a measurement at a predefined time after BS. A possible explana-
tion could be that a higher impulsivity leads to difficulties maintaining the required 
behavioral adjustments. Bariatric surgery patients in need of support due to subop-
timal weight loss, may feel at loss for help and guidance with regard to the required 
behavioral adjustment [60]. Among BS patients there is a demand for improved infor-
mation preoperatively, to prepare for post-operative issues.
The strength of our study is that we studied the impact of post-operative behavioral 
as well as the psychological factors on suboptimal weight loss. Since there is only a 
limited body of research addressing the impact of post-operative psychological and 
behavioral factors on suboptimal weight loss, this study is an extension of the existing 
body of literature. Identifying variables associated with successful weight loss is of 
importance because suboptimal weight loss, considered a long- term complication, 
can lead to the re-emergence of obesity related comorbidities and an impaired quality 
of life. Another strength of our study is the average duration of the follow-up post-op-
erative, since this is associated with suboptimal weight loss. A long follow-up duration 
is essential to observe the impact of behavioral and psychological factors on weight 
loss post-operative. Our findings that increased impulsivity post-operative and eating 
disorder pathology post-operative are associated with suboptimal weight loss are of 
importance for clinical implications.
This study has some potential limitations that should be taken in considera-
tion when interpreting the findings. There was a recruitment bias: the participants 
recruited through a Dutch treatment facility and the participants recruited through 
Dutch online platforms and Dutch general hospitals were heterogeneous. The study 
by Fitzgibbon and colleagues (1993) indicates that obese individuals seeking treat-
ment reported greater psychopathology and more loss of control over eating than 
those who did not seek treatment [61]. In addition, people who are disappointed 
after BS could be more inclined to participate in an online survey of weight loss after 
BS than participants who lost more weight after surgery. Only post-operative data 
were obtained. Due to the lack of pre-operative data, it remains unclear whether the 
observed differences were already present before surgery or whether they developed 
after surgery. Therefore, a causal relationship cannot be claimed. A limitation of this 
study is the lack of information about the weight trajectory after BS; due to this lack 
of information, it is unknown whether participants in the suboptimal weight group 
initially lost weight and may have regained weight over time. Another limitation to 
consider is that different types of malabsorptive procedures and combined restric-
tive malabsorptive procedures were included. These procedures can differ in efficacy 
[4]. However, the majority of the participants had a gastric bypass. Furthermore, all 
data were collected through self-report measures. Self-report questionnaires can be 
inaccurate because of response distortions and retrospective recall [39]. In particu-
lar self-report on pre-operative weight, 6 months post-operative weight and current 
weight is prone for inaccuracy. In addition, not all the measurements used were 
validated for this specific population. Despite these limitations, the current find-
ings show that psychological and behavioral factors are associated with suboptimal 
weight loss, which is of importance to optimize the effect of BS.
Conclusion
In this study several post-operative psychological and behavioral factors of eating 
disorder pathology, impulsivity and depressive symptoms were associated with 
suboptimal weight loss.
The early identification of postoperative factors, such as loss of control over 
eating or depression, that negatively impact successful weight loss and for which 
there are evidence-based treatments, will probably improve the overall efficacy of 
bariatric surgery [21]. Pre-operative and frequent post-operative monitoring of these 
psychological and behavioral factors are therefore needed.
Because gradual weight regain and suboptimal weight loss are associated with the 
number of years since surgery, it is important to have a long follow-up period during 
which patients are monitored. During follow-up, it can be useful to help patients to 
achieve early weight loss by helping them to adjust to postoperative recommenda-
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This thesis examines the effectiveness of psychological treatments for adults 
with eating disorders, from emaciated, underweight patients struggling with anorex-
ia nervosa in part I, patients with bulimia or a binge eating disorder in Part II, to 
morbidly obese patients struggling with disturbed eating behavior in part III. For 
each different eating disorder classification, treatment effects vary considerably 
(Waller, 2016; De Jong, Schoorl & Hoek, 2018).
In Part	I, we focused on psychological treatments for adults with anorexia nervosa, 
the eating disorder classification with the poorest treatment outcome. For anorexia 
nervosa, there is a lack of evidence for prioritizing one specialized psychological 
treatment over the other (Hay, Claudino, Touyz, & Abd Elbaky, 2015). Evidence is also 
lacking for prioritizing specialized over non-specialized, control treatments (Zeeck 
et al., 2018; Murray, Quintana, Loeb, Griffiths, & Le Grange, 2019). As recently new 
specialized treatments have been developed and their efficacy was being examined 
in high-quality randomized controlled trials, conducting a meta-analysis to examine 
whether the evidence base for specialized psychological treatments can be broad-
ened, made sense. Part I of this thesis presents this meta-analysis.
Part	 II examines whether changing to offering a recommended psychological 
treatment to Novarum patients with the full range of eating disorders, would improve 
recovery rates, compared with care-as-usual. Besides being effective whether a treat-
ment offers optimal health effects at the most reasonable costs is important. Conse-
quently, differential effectiveness and cost-effectiveness of Cognitive behavioral 
therapy-Enhanced (CBT-E; Fairburn 2008) was compared with treatment-as-usual. In 
the first study in Part II differential (cost-) effectiveness was examined for patients 
with bulimia, binge eating disorder or other specified feeding or eating disorder. In 
the second study presented in Part II, the examined samples included patients with 
anorexia nervosa. 
The number of published effectiveness studies examining the feasibility of 
recommended treatments is increasing, especially for patients with bulimia nervo-
sa or binge eating disorder (Thompson-Brenner et al., 2018). With regard to treat-
ments for anorexia nervosa, there is, however, a paucity of effectiveness studies. 
Despite findings that offering of recommended treatments in routine practice is 
feasible, in the field of eating disorders however, it is still uncommon to make actu-
al use of recommended treatments (Thompson-Brenner et al., 2018). Not offering 
recommended treatments on a regular base may contribute to a suboptimal treat-
ment effect, as clinical outcome may be enhanced by replacing the usually eclectic 
approach by so-called evidence-based practice (Waller & Turner, 2016). 
In Part	III, the focus shifted to eating disorder pathology as found in individu-
als with morbid obesity (i.e. having a body mass index over 40 kg/ m2), specifically, 
to the recommended treatment for morbid obesity, weight loss surgery (National 
Institute for Health and Care Excellence, 2014). Obesity is not included in the DSM-5 
eating disorder section as obesity itself is not necessarily caused by a psychologi-
cal dysfunction (Hoek & van Elburg, 2014). Disturbed eating behavior is, however, 
regularly reported by individuals who are severely obese (De Zwaan 2001; Wilson & 
Fairburn, 2007). The prevalence of a binge eating disorder in the population of obese 
individuals seeking weight control treatment is estimated to be 30% (de Zwaan, 2001; 
Meany, Conceição, & Mitchell, 2014). Consequently, developing effective interven-
tions for those reported disturbed eating behaviors, may benefit from knowledge on 
eating disorder pathology. 
As non-surgical interventions aimed at morbid obesity are usually ineffective in 
the long run, weight loss surgery has been suggested to be the most effective meth-
od to lose weight (Wimmelmann, Dela, & Mortensen, 2014). Although the majority 
of patients achieves a successful degree of excess weight loss after surgery, 20-30% 
experience suboptimal weight loss (Livhits et al., 2011). Several psychological and 
behavioral factors are assumed to be associated with this (Hindle, De la Piedad 
Garcia, & Brennan, 2017). In the cross-sectional study presented in Part III, possible 
associations of psychological and behavioral variables and suboptimal weight loss 
were examined in a sample of 140 patients who have had weight loss surgery. Part III 
also includes a brief report about an evaluation of the multidisciplinary group-based 
program which Novarum offered to bariatric patients awaiting surgery, over several 
years. Besides examining clinical outcome of the interventions offered, a discussion 
of the rationale behind the offered pre-surgical program is offered.
The main objective of Part I is to contribute to the body of knowledge on the efficacy 
of psychological treatments for anorexia nervosa. In Chapter 2, by conducting a 
meta-analysis, we systematically assess whether specialized treatments are superior 
to non-specialized, control treatments. In Part II, the main objective is to examine the 
effectiveness and the cost-effectiveness of cognitive behavioral therapy-enhanced, 
an empirically supported treatment, in a real-world setting, offering treatment 
to adult patients with anorexia nervosa, bulimia, binge eating disorder and other 
specified feeding or eating disorders. The main objective in part III is to develop 
a better understanding of the association between psychological and behavioral 
factors and clinical outcome after bariatric surgery.
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The present chapter provides a discussion on the main findings of the studies 
included in the three parts of the thesis, and some concluding remarks. It concludes 
by discussing methodological issues, suggestions for further research, and implica-
tions for clinical practice. 
Part	I		
Treatment	of	anorexia	nervosa
For adults with anorexia nervosa, treatments are limitedly effective. For recom-
mended specialized psychological treatments, the therapy results also seems very 
modest (Waller, 2016). As mentioned earlier, there is a lack of evidence for the supe-
riority of specialized psychological treatments over non-specialized, control treat-
ments (Zeeck et al., 2018; Murray, Quintana, Loeb, Griffiths, & Le Grange, 2019). The 
aim of the study presented in Part I, was therefore to expand the evidence base of 
specialized treatments by conducting a meta-analysis including RCTs on recently 
developed, specialized treatments.
Main findings
In the meta-analysis, 17 studies were included, six of them (35%) were assessed 
as having a low risk of bias and so regarded as high-quality studies. Three of the 17 
studies were solely inpatient studies, though in several included outpatient studies, 
patients were hospitalized during participation in the trial. In six of the included 17 
studies, at least one of the arms consisted of a recommended treatment for adults 
with anorexia nervosa (Royal Australian and New Zealand College of Psychiatrists, 
2014; National Institute for Health and Care Excellence, 2017). The recommended 
eating-disorder-focused CBT (CBT-E, Fairburn 2008) and Maudsley Anorexia Nervo-
sa Treatment for Adults (MANTRA, Schmidt, Wade & Treasure, 2014) were includ-
ed in the psychological treatment condition, the recommended Specialist Support-
ive Clinical Management (SSCM; McIntosh et al., 2006) was included in the control 
condition. Two main end-of-treatments outcomes were assessed, weight gain and 
improvement of eating disorder pathology; improved quality of life was a secondary 
outcome measure.
Findings of meta-analyses indicate no differences between psychological treat-
ments and control conditions on weight gain, on eating disorder pathology or on 
quality of life. 
Studies which included patients over 18 years were more effective on weight gain 
than studies also including younger patients. In high-quality studies and in studies in 
which therapist training was reported, larger effects were found on both weight gain 
and on quality of life, compared to low quality studies and studies without reported 
training. At the same time, in sensitivity analyses including high-quality studies only, 
no differences between psychological and control conditions were found. Subgroup 
analyses on outpatient studies only, did not lead to a different finding either. 
A meta-regression analysis on year of publication did also not show any differences 
between psychological and control conditions.
Our hypothesis that the meta-analysis would indicate that specialised psycholog-
ical treatments would be superior to control conditions was not met.
The finding of not being able to establish a superiority of psychological treatments 
over control treatments, is in line with the literature (Hay et al., 2015; Zeeck et al., 
2018). Including RCTs on the recently developed psychological treatments MANTRA 
and CBT-E Underweight, did not lead to different findings. Subgroup analyses 
on treatment arms including the optimized control condition SSCM versus other 
control conditions, did not show a difference in pooled effect size either, nor on 
weight gain, on eating disorder pathology or on quality of life.
Understanding the lack of difference on clinical outcome between specialized
treatments and treatment-as-usual 
Our findings may suggest that even recently developed, well thought through, 
manual-based psychological treatments lack sufficient strength for added value to 
be detected compared with control conditions, despite the fact that they are recom-
mended treatments in both national and international guidelines (Zorgstandaard 
Eetstoornissen, 2017; Royal Australian and New Zealand College of Psychiatrists, 
2014; National Institute for Health and Care Excellence, 2017). However, stating 
that specialized, recommended treatments lack sufficient strength superiority 
over control treatments to be established, may be premature. Due to the paucity 
of high-quality randomized controlled trials, the number of eligible studies which 
could be included in a meta-analysis was limited. Next, the found high heterogeneity 
may have confounded findings; due to this high heterogeneity two, potential power-
ful, outlier studies on recently developed treatments had to be excluded from the 
analyses. In addition, the nature of control conditions gave rise to another difficulty 
with detecting additional benefits of specialized psychological treatments. Since key 
interventions as nutritional & physical rehabilitation and engaging patients in partici-
pating in weight restoration are offered within every treatment (Hay et al., 2015), also 
in control conditions, within a randomized controlled trial, the different research 
conditions inevitably overlap. With inpatient research conditions, establishing 
additional benefits of specialized treatment is even more challenging. In an inpatient 
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unit, a range of multifarious interventions is offered, multiple times per day, for 
multiple days per week (Thompson-Brenner et al, 2018), and this is true for both 
a specialized inpatient condition and for a treatment-as-usual inpatient condition. 
Despite these factors reminding us to be cautious stating that psychological treat-
ments do not seem to be superior to control treatments, added value of those psycho-
logical treatments has not been detected, not even in high-quality, controlled outpa-
tient studies on recently developed therapies. Thus, it may be fair to say that the 
psychological treatments MANTRA and CBT-E, and the optimized control condition 
SSCM which all three are recommended in clinical guidelines, may lack evidence 
to support their recommendation (Royal Australian and New Zealand College of 
Psychiatrists, 2014; National Institute for Health and Care Excellence, 2017; Zorg-
standaard Eetstoornissen, 2017). The Dutch guideline on eating disorders however, 
recommends MANTRA, CBT-E and SSCM partly because they are manual-based, as 
opposed to more eclectic, non-manual based approaches. 
Limitations
A general limitation of the meta-analysis presented in Part I, arises from the 
paucity of therapy research on anorexia nervosa, as a consequence, only a small 
number of eligible studies could be included, and even smaller number of those 
studies could be assessed as a high-quality study. 
A second limitation arises from the nature of anorexia nervosa treatments whereby, 
in a randomized controlled trial, both control conditions and specialized treatments 
partially overlap, potentially  limiting the extent to which eventual additional benefits 
of psychological interventions can be detected, as is discussed in the previous 
paragraph.
In none of the three included inpatient controlled trials, the treatment method 
offered within the inpatient unit was included as a variable of interest. In those three 
inpatient studies, patients were allocated to specific short-term modules superim-
posed on general medical and psychotherapeutic inpatient care (Pillay & Crisp, 
1981; Geist, Heinmaa, Stephens, Davis, & Katzman, 2000; Wade, Frayne, Edwards, 
Robertson, & Gilchrist, 2009). In the one controlled study in which inpatient care was 
compared with outpatient care, inpatient care was offered by different services and 
was labeled “multidisciplinary psychiatric inpatient treatment approach”, suggesting 
that eclectic care was offered (Gowers et al., 2007). 
In the outpatient trials included in the meta-analysis, randomized patients were 
either withdrawn from the study, or their participation was temporally interrupted 
when they had to be admitted. Consequently, an important element of treatment, 
which for severely underweight patients inevitably still includes a period of hospita- 
lization, was not included and clinical findings of the inpatient stay were excluded 
from outcome analyses. Possible additional clinical benefits of an inpatient stay 
designed according to a specialized treatment method could also not be examined.
Suggestions for further research
For anorexia nervosa, replicating randomized clinical trials including conditions 
on MANTRA, SSCM and on CBT-E, may be valuable for further research. Ideally, 
to lower heterogeneity, those replicating RCTs should be on homogenous patient 
groups, using standardized outcome measures. To avoid possible researcher alle-
giance, those controlled trials should preferably not be conducted by the original 
team developing one of the specialized treatments. 
It would also be of particular interest to conduct inpatient RCTs on specialized 
psychological treatments. Being hospitalized is a regular element of recommend-
ed treatment for severely underweight patients, and to examine the efficacy of an 
anorexia treatment, clinical outcome of all parts of care should considered; inpatient 
care as well as the offered outpatient care. For an inpatient condition to be included 
in a RCT, it is essential that the interventions of the inpatient program are recogniz-
able as specialized treatment and are, if possible, distinguishable from treatment-as- 
usual interventions. The inpatient program should therefore be designed according 
to key principles of the specialized psychological treatment, and all multidiscipli-
nary staff should be properly trained in order for all to work in univocally. To our 
knowledge, up till now, few of the recommended specialized treatments have been 
tested in RCTs as the basis of residential or day-hospital programs (Thompson-Brenner 
et al., 2018).
When designing a randomized controlled trial including severely underweight 
patients, due to the high medical risks associated with underweight, medical ethical 
committees will not approve a waiting list condition in the trial, patients who are 
severely underweight cannot be allocated to a waiting list condition. Consequently, 
as severe patients will always be offered some kind of support aimed at nutritional 
and physical stabilization as discussed earlier, some overlap between an active and a 
comparative condition is inevitable. 
Finally, exploring moderating is a direction for further research, enabling the 
field of eating disorder to move to a precision medicine approach in which therapists 





When developing psychological treatments, it is important to establish their effi-
cacy in a controlled setting. Of equal importance are effectiveness studies in which the 
benefits and applicability of treatments are examined in a non-controlled, real-world 
setting, where the vast majority of patients receives treatment and where treatment 
 interventions are offered by a wide range of staff members. Besides clinical outcome, 
in effectiveness studies, it is important to examine the feasibility of the developed 
treatment, focusing on recruitment, acceptability, attrition, accessibility and on 
treatment costs (Wade, 2020). 
In Part II, we examine whether changing from offering eclectic treatment-as-usual 
to offering CBT-E, an individually based cognitive behavior therapy for eating disorders 
as recommended for bulimia nervosa, binge eating disorder and for anorexia 
nervosa (National Institute for Health and Care Excellence, 2017) improves clinical 
outcome and enhance cost-effectiveness, as it is assumed that outcome may be 
enhanced by replacing an eclectic approach with an empirically supported treatment 
(Thompson-Brenner et al., 2018; Kazdin, Fitzsimmons-Craft, & Wifley, 2017; Waller 
& Turner, 2016). In two consecutive cohort studies, we examined possible benefits 
of offering CBT-E to eating disorder patients with a body mass index over 17.5 kg/m2 
(i.e. patients with bulimia nervosa, a binge eating disorder or other specified feeding 
or eating disorder) and separately for patients with anorexia nervosa. 
Main findings
For patients with bulimia, binge eating disorder or other specified feeding or 
eating disorder and a body mass index over 17.5, no significant differences on clin-
ical outcome were found between treatment-as-usual and CBT-E. In both cohorts, 
eating disorder pathology decreased significantly. With regard to cost-effectiveness, 
findings indicated a 71% likelihood of CBT-E dominating treatment-as-usual, and 
leading to more remissions at lower treatment costs. There is a 29% likelihood of 
CBT-E leading to fewer remissions at lower costs. The likelihood of treatment-as- 
usual leading to lower treatment costs is 0%. This comparative superiority of CBT-E 
from a cost-effectiveness perspective, was found for both outpatients and for inpa-
tients. The improved cost-effectiveness is understandable in the light of a shorter 
treatment duration and a shorter inpatient stay during the CBT-E period. 
The hypothesis of CBT-E being more effective than treatment-as-usual was 
not met for patients with an eating disorder and a body mass index over 17.5, but 
the hypothesis of CBT-E being more cost-effective was.
For anorexia nervosa patients, findings suggested that weight regain was sig- 
nificantly better in the CBT-E cohort. With that exception on weight gain, no other 
differences in clinical outcome between both cohorts were found, anorexia nervosa 
attitudes improved in both cohorts. When limiting the cost-analysis to direct 
 treatment costs, and employing healthy weight as effect measure, the ICER distribu-
tion for all patients indicates a 97% likelihood of CBT-E leading to better effects than 
TAU, at higher costs. The CEAC indicates a probability of CBT-E being cost-effective 
assuming a WTP of € 9713,- or more for each additional remission. When employ-
ing eating disorder remission as effect measure, differences between both cohorts 
were minimal. Examining outpatients only, the superiority of CBT-E over TAU is even 
stronger, on reaching healthy weight, and also on eating disorder remission. 
For patients with anorexia nervosa, the hypothesis of CBT-E being more effective 
was met on weight gain. Economic evaluation showed that CBT-E was superior 
to treatment-as-usual on weight gain, although at higher costs. Two factors can 
probably be linked to the found higher treatment costs during the CBT-E period; 
(1) compared to treatment-as-usual, more patients were admitted to the inpatient 
unit, although for a shorter period of time, and (2) fewer patients stopped treatment 
prematurely. Consequently, more patients received the recommended number of 
outpatient sessions. 
Comparing clinical outcomes for normal weight patients in our (cost-)effective-
ness study, with original Oxford studies by Fairburn and his team, the proportion of 
patients achieving remission seems in line (Fairburn et al., 2009; Fairburn et al., 2015). 
Comparing our findings of the anorexia nervosa (cost-) effectiveness study to both an 
Oxford-Italy outpatient anorexia nervosa study (Fairburn et al., 2013) and an inpa-
tient Italian-Oxford study (Dalle Grave et al., 2013), findings also seem in line, on both 
the outcomes measures ‘weight regain’ and on ‘the proportion of patients achieving 
healthy weight’. As the clinical outcome of our presented studies is generally in line 
with outcome found in studies undertaken by the treatment developing team, both 
for anorexia nervosa patients and for bulimia or binge eating disorder patients, 
CBT-E might be assumed to be applicable in a real-world setting, where treatment 
is offered by multidisciplinary staff members. The comparative low dropout rate 
found in both (cost-) effectiveness studies contributes to the feasibility of CBT-E. 
 
For bulimia and binge eating disorder, implementing CBT-E led to improved 
cost-effectiveness 
The main benefit of implementing CBT-E for bulimia and binge eating disorder, 
is an improved cost-effectiveness. This superior cost-effectiveness is important 
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for decision makers in the field of mental health, as it may speed up implement-
ing empirically supported treatments like CBT-E. For patients, a shorter duration of 
treatment is beneficial and adds to better value based health care (Porter, 2010). 
For anorexia nervosa, implementing CBT-E led to better weight gain at higher costs
Replacing offering treatment-as-usual by offering CBT-E for patients with anorexia 
nervosa seems to enhance weight gain, which is a main benefit of a psychological 
treatment. This found superiority on weight regain of CBT-E appears to be in contrast 
with the literature and also seemingly with the reported findings of the meta-analysis 
presented in Part I of this thesis. However, in none of the included inpatient condi-
tions in the meta-analysis, were the inpatient units designed based on key principles 
of specialized psychological treatment (i.e. CBT-E), as was done in the inpatient unit 
of Novarum. It is possible, therefore, that the power of a specialized treatment may 
be strengthened when a similar treatment method is offered both during the inpa-
tient stay and during the outpatient part of treatment. 
With regard to the find higher costs in the anorexia nervosa sample, it is worth 
noting that the found direct treatment costs are still modest compared to interna-
tionally reported treatment costs, for example the reported mean costs of € 13625,- 
for hospitalized patients in a German study (Stuhldereher et al., 2015). One of the 
drivers of the higher costs in the CBT-E cohort was the higher admission rat and, as 
staff grow more experienced in treating low weight anorexia nervosa patients on an 
outpatient base, the admission rate may eventually lower over time. 
With the exception of weight gain, no differences in clinical outcome between CBT-E 
and treatment-as-usual were found
Changing Novarum, the treatment center in which the effectiveness studies took 
place, into a solely CBT-E based center was a huge effort; the intensive outpatient 
units were halted, as were all outpatient group-based therapy groups, two inpatient 
unites were merged into one, and an inpatient program had to be designed. All staff 
members had to be trained and a lot of effort continues to be spent on monitoring 
adherence to the method. From that perspective, the findings that, with the excep-
tion of improved weight gain in the CBT-E period, no differences on clinical outcome 
were found, is probably humbling. On the other hand, as the treatment-as-usual 
previously offered in Novarum included various elements of cognitive behavioral 
therapy, establishing differences would have been challenging due to possible simi-
larities in interventions offered during both periods. 
Limitations
With regard to the (cost-) effectiveness studies presented Part II, the limitation of 
not being able to have included longer term effects of both underweight cohorts, has 
already been mentioned. Since, even after successful treatment, there is a high risk 
of relapse (National Institute for Health and Care Excellence, 2017), particularly with 
regard to the weight regain of underweight patients, examining follow-up data will 
be a valuable addition. 
In 2015, when Novarum changed to CBT-E treatment, no published randomized 
controlled trial in which the efficacy of CBT-E Underweight was firmly established for 
anorexia nervosa patients was available. Redesigning the inpatient units according 
to CBT-E Underweight principles and changing all offered psychological interven-
tions into CBT-E interventions could therefore be argued to be somewhat early. At 
the same time, waiting would take an excessive period, as definitively establishing 
the superiority of a psychological treatment for anorexia nervosa, is probably still 
some distance away. 
Suggestions for further research
As mentioned in Part I, for nearly all severely underweight patients, a (short) 
period of hospitalization aimed at physical rehabilitation is an essential part of 
treatment, usually offered prior to further outpatient treatment. There are consid-
erable differences in the nature of these hospitalizations with regard to offered 
treatment methods. How those differences relate to clinical outcome is rarely 
examined. Consequently, possible additional clinical benefits of an inpatient stay 
designed according to a specialized treatment method are yet to be examined. Since 
few of the recommended specialized treatments have been tested as the basis of a 
 residential program, within a randomized controlled trial (Thompson-Brenner et al., 
2018), research on randomized controlled trials examining differences in inpatient, 
 residential treatments, followed by a subsequent outpatient treatment using a similar 
treatment method, would be valuable. Clinical outcomes including both the 
inpatient stay and the subsequent outpatient treatment need to be examined. It would 
be of particular interest to test inpatient CBT-E within a randomized controlled trial, to 
examine whether the comparative improved weight gain of CBT-E found in Chapter 4, 
can also be established in a controlled study. First, specialized inpatient treatment 
programs could be compared with eclectic, general inpatient programs; next, 




Suggestions for further research on bulimia and on binge eating disorder differ 
from anorexia nervosa. In contrast to anorexia nervosa, the efficacy and effectiveness 
of CBT-E for bulimia and binge eating disorder are well established and, as the 
cost-effectiveness study in Part II suggests, cost-effectiveness also appears promising. 
For bulimia, in order to enhance treatment effects, research is needed on identify-
ing possible moderating and mediating factors of treatment effect. For binge eating 
disorder research could focus on lowering the dose in which treatment can be offered 
while maintaining the same outcome; literature suggests the regularly used 20 face-to-
face sessions therapy may be reduced in number of sessions offered and/or through 
the way it is delivered (National Institute for Health and Care Excellence, 2017; 
Waller, 2016). Examining clinical outcome and cost-effectiveness of a less intensive 
treatment, whether or not partly digital, may also be interesting. The findings in Part 
III indicate that the treatment of binge eating disorder pathology in patients who are 
severely obese, appears to be more challenging compared to normal weight eating 
disorder patients. 
Recommendations for clinical practice
As both included effectiveness studies did not take place within the limiting 
context of a selective clinical trial, with a select group of therapists, but involved 
all staff members, findings may be generalizable to other real-world inpatient 
and outpatient settings. Findings of the anorexia nervosa study and of the normal 
weight eating disorder study may both boost implementing specialized treatments. 
For normal weight eating disorder patients, cost-effectiveness, an important factor, 
favors CBT-E compared to treatment-as-usual. With regard to the anorexia nervosa 
study, improved weight gain and a comparative lower dropout rate during the CBT-E 
period, are important benefits; the higher costs found are reasonable and justify 
broader use of CBT-E. 
Part	III	
Eating	disorders	and	obesity	
In Part III, the focus shifts to the presence of eating disorder pathology in patients 
who are morbidly obese. In particular, the focus of this part of the thesis is the occur-
rence of eating disorder pathology in patients opting for bariatric surgery. 
The finding that, for the treatment of morbid obesity, non-surgical interventions 
are usually ineffective (Wimmelmann, Dela, & Mortensen, 2014), has far-reach-
ing implications. First, bariatric surgery, an invasive surgical procedure requiring 
lifelong adherence to lifestyle and dietary recommendations, is suggested as most 
effective weight loss method. Furthermore, it means that, for morbidly obese patients, 
a successful treatment on eating disorder pathology will not lead to sustained weight 
loss. These two aspects affect eating disorder treatment for morbidly obese patients, 
first, accepting the excess weight, at least to an important extent, needs to be a treat-
ment goal. Second, as morbidly obese patients increasingly opt for bariatric surgery, 
to offer appropriate interventions, the eating disorder therapists need to under-
stand how weight loss surgery can affect eating behavior. The brief report in Part III 
concerns an evaluation of the multidisciplinary group-based program which Novar-
um offered to bariatric patient awaiting surgery, over several years. 
When confronted with a demand for specialized psychological help related to 
suboptimal outcome after bariatric surgery, examining suboptimal post-operative 
weight loss in more detail is essential. What percentage of patients do actually 
experience suboptimal weight loss? And, within a bariatric population, can we identify 
possible psychological variables associated with suboptimal weight loss? Previous 
research on psychological and behavioral factors associated with surgical outcome 
focused mainly on pre-operative characteristics, and less is known of factors (re)
occurring after surgery (Hindle, De la Piedad Garcia, & Brennan, 2017). Literature 
suggests that with regard to disturbed eating behavior, post-operative occurrence of 
pathology has a stronger association with the degree of post-operative weight loss 
than the presence of pre-operative eating disorder pathology, although findings are 
still inconclusive (Meany, Conceição, & Mitchell, 2014). The aim of the cross-sectional 
study presented in Part III is to develop a better understanding of the association 




One of the main findings in the brief report is that bariatric participants appeared 
to benefit less from the multidisciplinary group-based program compared to 
non-bariatric participants. Although the findings of two pilot studies discussed in 
the brief report need validation, they suggest that patients opting for surgery did lose 
less weight and their poor body image improved less, compared to patients who did 
not opt for surgery. Second, when entering treatment, no differences were found 
between patients who did and those who did not opt for surgery, neither with regard 
to the degree of obesity, nor with regard to reported negative body image or reported 
psychological and / or somatic distress. 
The brief report described how, in the early days of bariatric surgery, the main 
strategy of Novarum was to offer all bariatric patients pre-operative treatment inter-
ventions, originally developed for binge eating disorders, regardless of whether 
or not patients were actually diagnosed with a binge eating disorder. Based on the 
frequently reported disturbed eating behavior by severely obese patients (De Zwaan 
2001; Wilson & Fairburn, 2007), our clinical impression was that offering strategies 
aimed at establishing regular eating and aimed at gaining control over over-eating, 
made sense. We assumed that acquiring those skills would help patients to adjust to 
the required dietary restrictions after surgery, and would therefore enhance surgical 
outcome. Our findings that bariatric patients appeared to benefit less from treatment 
compared to non-bariatric patients may, however, be seen in line with recent litera-
ture stating that behavioral interventions are best offered after surgery. On the other 
hand, whether bariatric patients who have been offered pre-operative behavioral 
interventions had a better surgical outcome, compared to bariatric patients who did 
not receive such pre-operative treatment was not examined. 
 
In Chapter 6, it was found that in a Dutch sample of 140 obese men and women 
who had undergone bariatric surgery (malabsorptive procedures or combined 
restrictive malabsorptive procedures), 19% of patients reported suboptimal weight 
loss. This percentage is in line with the literature (Livhits et al., 2011). These findings 
suggest that patients experiencing suboptimal weight loss reported more post-oper-
ative symptoms of eating disorder pathology, more loss of control over eating and 
reported more avoidant behavior due to poor body image, compared to patients who 
experienced successful weight loss. Furthermore, in comparison, patients who expe-
rienced suboptimal weight loss, reported higher scores on an impulsivity self-report 
and reported more depressive symptoms. With regard to non-psychological factors, 
having a body mass index > 50 kg/m2 at time of surgery, and a longer follow-up peri-
od after surgery were associated with poorer weight loss. On the other hand, being 
able to lose more weight loss in the early period after surgery was associated with 
better weight outcome later on. 
Lack of understanding the pathogenesis of obesity hinders the development of persona-
lized and effective behavioral interventions for bariatric patients
Unlike with people with eating disorders, sustained behavior change in individu-
als with obesity is remarkably difficult to achieve (Cooper et al., 2010), and is one of 
main reasons for non-surgical interventions usually being ineffective in the long run 
(Wimmelmann, Dela, & Mortensen, 2014). The finding that behavior change is very 
difficult to achieve has far-reaching implications, especially when behavioral factors 
do seem to be associated with suboptimal surgical outcome. One of these implica-
tions touches on the rationale of offering bariatric patients peri-surgical behavioral 
interventions in order to enhance surgical outcome, while the understanding is that 
behavioral change is particularly difficult to achieve. Pessimistically, a rather poor 
treatment response could be argued to be incorporated from the start, however, on 
the other hand, around 80% of bariatric patients does benefit from bariatric surgery. 
Several factors, particularly associated with the bariatric population, further chal-
lenge the already modest effects of behavioral interventions:
(a) Of the bariatric patients referred for psychological treatment in our pilot studies, 
  a considerable number was regarded as ‘not eligible for psychological treatment’ 
 due to poor literacy and / or language difficulties. An association between 
 socioeconomic status and literacy can be assumed, so probably a considerable  
 number of bariatric patients may have a lower socioeconomic status. Literature   
 suggests an association between lower socioeconomic status and suboptimal   
 weight loss (Livhits et al., 2011). In addition, as findings in the field of anxiety   
 and depression disorders suggest, lower socioeconomic status appears to be 
 also associated with poorer treatment response to psychological treatments   
 (Finegan, Firth, Wojnarowski, & Delgadillo, 2018). 
(b) Bariatric patients, regularly do not enter pre-operative psychological treatment   
 out of free choice. A considerable number of participants follow treatment   
 because operating hospitals require participation in order to proceed with   
 surgery. Being doubtful beforehand whether treatment is necessary and   
 suitable, might be negatively associated with treatment outcome. Literature   
 suggests a negative association between a low motivation to change and
  treatment response (Dray & Wade, 2012). 
(c) When bariatric patients, rightfully, expect the surgical procedure itself to be   
 helpful in gaining control over eating, they may be less motivated to participate   
 in pre-operative treatment aimed at behavioral change.
(d) In addition, when one has decided that a somatic intervention best suits the   
 problem of one’s excess weight, rather than behavioural interventions, possible   




(e) Finally, bariatric patients may expect that once they have lost a significant   
 amount of excess weight, their body dissatisfaction will improve, meaning
 that one important maintaining factor related to over-eating, i.e. body
  dissatisfaction, will disappear. Consequently, acquiring skills aimed at 
 uncontrolled over-eating prior to surgery, may be, in their opinion, irrelevant. 
The body of knowledge on the pathogenesis of (morbid) obesity is still incom-
plete. For instance why obesity seems resistant to psychological methods of treat-
ment (Cooper et al., 2010) is still not understood. Across the different disciplines 
involved in obesity research (e.g. medicine, psychology, sociology), there are still 
gaps in understanding why some individuals are vulnerable for developing (morbid) 
obesity and others are not. In addition, with regard to bariatric surgery, why some 
individuals experience disturbed eating behaviour (re)emerging after surgery, while 
others do not (Meany, Conceição, & Mitchell, 2014) it is not yet understood. This 
current lack of understanding might be a barrier in understanding factors moder-
ating treatment outcome of an intervention like bariatric surgery. More generally 
speaking, understanding pathogenesis of morbid obesity may be a precondition for 
developing effective strategies aimed at the psychological and behavioral aspects 
associated with severe obesity. 
Limitations
The exact temporal sequence in which post-operative factors associated with 
suboptimal weight loss occur is not known and is rather difficult to establish. This 
could be viewed as a limitation as it makes understanding possible causal pathways 
more difficult (Hindle, De la Piedad Garcia, & Brennan, 2017). For example, the 
direction of the found association of reported depressive symptoms and suboptimal 
weight loss is unclear; did the mood drop in response to poorer weight loss or has 
there been a depressed mood prior to the suboptimal weight loss? To be able to offer 
appropriate interventions, understanding causal pathways is relevant. Another limi-
tation relates to the difficulty of assessing eating disorder pathology, especially loss 
of control over eating, in individuals who are (morbidly) obese (Meany, Conceição, & 
Mitchell, 2014; van Riel et al., 2020). In a population of patients who have undergone 
bariatric surgery, a procedure which limits food intake, proper assessment of pres-
ence and severity of eating disorder pathology is even more complicated (Meany, 
Conceição, & Mitchell, 2014).
Chapter	7 Chapter	7
Suggestions for further research
To broaden the evidence base on pre-operative and post-operative factors associ-
ated with clinical outcome after surgery, and in order to understand possible causal 
pathways, patients should be assessed prior to surgery and should be assessed 
frequently, during a long follow up period, after surgery. With a better understanding 
of those factors and of possible causal pathways, further research can focus on 
developing effective, targeted interventions for potentially changeable factors like 
disturbed eating behavior, increased avoidance behavior due to a poor body image 
and for depressive symptoms.
Recommendations for clinical practice
Understanding in which phase of the bariatric surgical process, psychological 
interventions aimed at disturbed eating behavior, are best offered is relevant. As 
findings indicate that pre-operative disturbed eating behaviors can remit after 
surgery, and other findings indicate that maladaptive eating patterns can emerge 
after surgery while not being present pre-operatively (Meany, Conceição, & Mitchell, 
2014), the effectiveness of offering pre-operative eating disorder interventions can be 
questioned, particularly as literature suggests that pre-operative treatment aimed at 
behavioral change has limited effect. Therefore, it might be recommended to offer 
treatment aimed at eating disorder pathology only post-operatively.
The finding that post-operative disturbed eating disorder behavior is associated 
with suboptimal weight loss opposed to the presence of pre-operative eating pathology 
 (Livhits et al., 2011) has increased the awareness that post-operative close monitoring, 
during a considerable length of time, of possible (re)occurrence of a maladaptive 
eating pattern and of psychopathology like depressive symptoms or alcoholism is 
highly relevant. 
In the recent European guideline on bariatric surgery, a multidisciplinary 
post-operative follow up is recommended, although a minimal duration of this 
follow up period is not mentioned (Di Lorenzo et al., 2020). With regard to regular 
monitoring in order to detect disturbed eating behavior or psychological problems 
after surgery, no recommendations are made. The guideline only includes the rather 
general recommendation of “post-operative nutritional and behavioral advice to be 
provided” (Di Lorenzo et al., 2020).
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This thesis considers the effectiveness of psychological treatments for adults with 
anorexia nervosa, bulimia nervosa and binge eating disorder, and, as it is can occur 
in individuals who are morbidly obese, the effectiveness of psychological interven-
tions for eating disorder pathology. 
Obesity, defined as an abnormal or excessive fat accumulation, is not included 
as a psychiatric disorder in the DSM-5 eating disorder section, as obesity itself is not 
necessarily caused by a psychological dysfunction (Hoek & van Elburg, 2014). 
Eating disorders affect both mental and physical well-being of patients (Royal 
Australian and New Zealand College of Psychiatrists, 2014), this also applies to being 
(morbidly) obese (Luppino et al., 2010). Obesity is firmly associated with an increased 
risk of depression, obese women are, in particular, more likely to experience a mood 
disorder (Luppino et al., 2010). With regard to eating pathology, literature suggests 
that 30% of obese individuals seeking weight control treatment might be diagnosed 
with a binge eating disorder (de Zwaan, 2001; Meany, Conceição, & Mitchell, 2014). 
In obese individuals opting for bariatric surgery, findings indicate a pre-operative 
prevalence of axis I disorders between 27% and 42%, mainly consisting of affective 
disorders, anxiety disorders and eating disorders (Herpertz et al., 2004).
Although anorexia nervosa is a relatively rare disorder in many non-western 
countries, bulimia nervosa and binge eating disorder are common disorders around 
the world (Hoek, 2016). Worldwide, the prevalence of obesity (having a body mass 
index over 30 kg/m2) has nearly tripled since 1975, the proportion of individuals with 
morbid obesity (having a body mass index over 40 kg/m2) is a small fraction of all 
individuals with obesity (NCD Risk Factor Collaboration, 2016).
Treatment outcome is poor for eating disorders, around 30% of patients with 
anorexia nervosa are estimated recover in the first decade of the disorder (Wonder-
lich, Bulik, Schmidt, Steiger, & Hoek, 2020). For bulimia nervosa and for binge eating 
disorder, remission rates range from 22% to 68% (De Jong, Schoorl, & Hoek, 2018). 
For morbid obesity, non-surgical interventions have proven to be ineffective in the 
long run, so weight loss surgery has been suggested as the most effective weight 
loss method. Although the majority of patients achieves successful weight loss after 
surgery, 20-30% experience suboptimal weight loss (Livhits et al., 2011). Literature 
suggests an association between this suboptimal weight loss and psychological and 
behavioral factors (Wimmelmann, Dela, & Mortensen, 2014).
This thesis consists of three parts. Part I examines the efficacy of psychologi-
cal treatments for anorexia nervosa. Part II examines the differential effectiveness 
and the cost-effectiveness of Cognitive behavioral therapy-Enhanced, a specialized 
psychological treatment compared with treatment-as-usual, for patients with bulimia 
and a binge eating disorder and separately for patients with anorexia nervosa and 
Part III examines psychological and behavioral factors associated with clinical 
outcome of weight loss surgery. 
Part	I	
Treatment	of	anorexia	nervosa
The efficacy of specialized psychological treatments for anorexia nervosa
For anorexia nervosa, the eating disorder most difficult to treat, only a limited 
number of specialized psychological treatments are available, and findings with regard 
to their efficacy are inconclusive. Evidence is lacking for prioritizing one specialized 
psychological treatment over the other (Hay, Claudino, Touyz, & Abd Elbaky, 
2015). Furthermore, evidence for prioritizing specialized over non-specialized, 
control treatments, regularly offered in routine practice (Zeeck et al., 2018; Murray, 
Quintana, Loeb, Griffiths, & Le Grange, 2019), is lacking. 
As there has recently been an increase of high-quality randomized controlled 
trials, run with newly developed psychological treatments, conducting a meta-analysis 
to examine whether the evidence base for specialized psychological treatments can 
be broadened was relevant. In Chapter	2, by conducting a meta-analysis, we syste- 
matically assess whether specialized treatments for anorexia nervosa are superior to 
non-specialized, control treatments. 
We hypothesized that differences in treatment effect would be found in favor of 
specialized psychological treatments, on either the outcome measure ‘weight regain’ 
and/or on the outcome measure ‘improvement of eating disorder psychopathology’, 
or on the outcome measure ‘improvement of quality of life’.
 
Main findings
The meta-analyses indicated that no differences between psychological treat-
ments and control conditions could be established on weight gain, on eating disorder 
pathology or on quality of life. Our findings may also suggest that recently developed, 
recommended psychological treatments for anorexia nervosa lack sufficient strength 
for added value to be detected compared with control conditions. Our findings 
suggest that studies including patients over 18 years were more effective on weight 
gain than studies including younger patients. In high-quality studies and in studies in 
which therapist training was reported, larger effects were found on both weight gain 
and on quality of life, compared to low quality studies and studies without reported 
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training. At the same time, in sensitivity analyses including high-quality studies only, 
no differences between psychological and control conditions were found.
Our hypothesis that specialised psychological treatments would be superior to 
control conditions was not met. It may, however, be premature to state that special-
ized, recommended treatments lack sufficient strength compared with control treat-
ments. Due to the lack of high-quality randomized controlled trials, the number of 
eligible studies which can be included in a meta-analysis is limited. In addition, the 
found high heterogeneity may have confounded findings; due to this high hetero- 
geneity two, potential powerful, outlier studies on recently developed treatments 
had to be excluded from the analyses. Furthermore, one reason hindering detecting 
additional benefits of psychological treatments has to do with the nature of control 
conditions. Key interventions as nutritional & physical rehabilitation and engaging 
patients in participating in weight restoration, are offered within every treatment 
(Hay et al., 2015), including in control conditions. Consequently, comparative 
research treatment conditions inevitably overlap.
Further methodologically sound, clinical research is needed to be able to substan-
tially broaden the evidence base of psychological treatments for anorexia nervosa. 
Part	II			
Status	Cognitive	behavioral	therapy-Enhanced
Examining effectiveness and cost-effectiveness of offering CBT-E compared 
to treatment-as-usual
The second part of this thesis examines the effectiveness and the cost-effective-
ness of Cognitive behavior therapy-Enhanced (CBT-E), an evidence-based psycho-
logical treatment developed by C. Fairburn et al. from Oxford University (Fairburn, 
2008). Novarum replaced their previously offered eclectic treatment-as-usual with 
CBT-E, in their outpatient and their inpatient units. Chapter	3 presents a consecutive 
cohort study in which differential (cost-)effectiveness of treatment-as-usual and 
CBT-E for patients with bulimia, binge eating disorder or other specified feeding or 
eating disorder and a body mass index over 17.5 kg/m2 was examined. Chapter	4 
presents findings on examining differential (cost-)effectiveness of CBT-E compared 
to treatment-as-usual, for patients with anorexia nervosa.
We hypothesized that both effectiveness and cost-effectiveness would be superior 
in the CBT-E cohort, both for underweight patients and for normal weight patients. 
We assumed that, in line with the literature, offering a specialized psychological treat-
ment would enhance clinical outcome compared with offering an eclectic treatment 
(Thompson-Brenner et al., 2018; Kazdin, Fitzsimmons-Craft, & Wifley, 2017; Waller 
& Turner, 2016). As outpatient CBT-E treatment has a fixed, relatively short duration, 
and as the duration of the CBT-E based inpatient stay is limited by nature, we 
assumed a reduction in direct treatment costs in both the CBT-E normal weight and 
the underweight cohorts, so assumed CBT-E to be superior from cost-effectiveness 
perspective. 
Main findings 
For patients with bulimia, binge eating disorder or other specified feeding or 
eating disorder, and a body mass index over 17.5, no significant differences on clinical 
outcome were found between treatment-as-usual and CBT-E. 
In both cohorts, eating disorder pathology decreased significantly. With regard 
to cost-effectiveness, findings indicated a 71% likelihood of CBT-E dominating treat-
ment-as-usual and leading to more remissions at lower treatment costs. This compar-
ative superiority of CBT-E from a cost-effectiveness perspective, was found for both 
outpatients and for inpatients. The improved cost-effectiveness is understandable in 
the light of the found shorter treatment duration and a shorter inpatient stay in the 
CBT-E cohort. For patients with an eating disorder and a body mass index over 17.5, 
the hypothesis of CBT-E being more effective than treatment-as-usual was not met, 
while the hypothesis that CBT-E is more cost-effective was met.
For anorexia nervosa patients, the findings suggested that weight regain was 
significantly better in the CBT-E cohort. With that exception on weight gain, no other 
differences in clinical outcome between both cohorts were found; in both cohorts, 
anorexia nervosa attitudes improved. When limiting the cost-analysis to direct treat-
ment costs, and employing ‘achieving healthy weight’ as effect measure, the ICER 
distribution for all patients indicates a 97% likelihood of CBT-E leading to better 
effects than TAU, at higher costs. The CEAC indicates a probability of CBT-E being 
cost-effective assuming a WTP of €9713 or more for each additional remission. When 
employing ‘eating disorder remission’ as effect measure, differences between both 
cohorts were minimal. 
For patients with anorexia nervosa, the hypothesis of CBT-E being more effective 
was met on weight gain. Economic evaluation showed that CBT-E was superior to 
treatment-as-usual on weight gain, although at higher costs. Two factors probably 
relate to these found higher treatment costs; (1) compared to treatment-as-usual, 
more patients were admitted to the inpatient unit, although for a shorter period of 
time, and (2) fewer patients stopped treatment prematurely, consequently, more 
patients received the recommended number of outpatient sessions. 
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Findings of both presented studies may both boost implementing specialized 
treatments; for normal weight eating disorder patients, cost-effectiveness favors 
CBT-E compared to treatment-as-usual; for anorexia nervosa patients, the improved 
weight gain and a comparative lower dropout rate during the CBT-E period, are 




Psychological factors associated with clinical outcome of weight loss surgery
In Part III, the focus shifts to the occurrence of eating disorder pathology in 
morbidly obese patients opting for bariatric surgery. As non-surgical interven-
tions aimed at morbid obesity are usually ineffective in the long run, weight loss 
surgery, an invasive surgical procedure requiring lifelong adherence to lifestyle and 
dietary recommendations, has been suggested as the most effective method to lose 
weight (Wimmelmann, Dela, & Mortensen, 2014). Although the majority of patients 
achieves a successful degree of excess weight loss after surgery, literature suggests 
that 20-30% of patients experience suboptimal weight loss (Livhits et al., 2011). 
Several demographic factors are associated with this poorer weight loss; being male, 
having a lower socioeconomic status, having super obesity (body mass index ≥ 50 kg 
/m2) at time of surgery, and a relatively older age (Livhits et al., 2011; Wimmelmann et 
al., 2014). With regard to psychological factors, the following associations are found; 
(1) post-operatively reported disturbed eating behaviors, (2) poor adherence to post- 
operative treatment plan and (3) poor psychological functioning (Hindle, De la 
Piedad Garcia & Brennan, 2017). 
Chapter	 5 examines clinical outcome and possible benefits of a multimodal 
group-based therapy offered at Novarum to bariatric patients prior to surgery. Based 
on the frequently reported disturbed eating behavior by severely obese patients (De 
Zwaan 2001; Wilson & Fairburn, 2007), our clinical impression was that offering strat-
egies aimed at establishing regular eating and gaining control over over-eating made 
sense. We assumed that acquiring those skills, would help patients to adjust to the 
required dietary restrictions after surgery, and would therefore enhance surgical 
outcome. 
Chapter	6 presents a cross-sectional study examining the association between 
post-operative behavioral and psychological factors and suboptimal weight loss in a 
sample of 140 participants who have had bariatric surgery (malabsorptive procedures 
or combined restrictive malabsorptive procedures). We hypothesized that reported 
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post-operative eating disorder pathology was associated with suboptimal weight loss, 
as the presence of eating disorder pathology may interfere with the ability to adhere 
to the recommended postsurgical eating pattern.
Main findings
In Chapter 5, one of the main findings is that patients opting for surgery appeared 
to benefit less from the treatment offered. Preliminary findings indicate that they 
did lose less weight and their poor body image improved less, compared to morbid-
ly obese group participants who did not opt for surgery. When entering treatment, 
no differences were found between referred patients who did and those who did 
not want to undergo bariatric surgery, neither with regard to the degree of obesity, 
nor with regard to reported negative body image or reported psychological and / or 
somatic distress. 
Chapter 6 reported that, in the examined sample, 19% of patients reported 
suboptimal weight loss. The findings suggest that patients experiencing suboptimal 
weight loss reported more symptoms of eating disorder psychopathology, reported 
 more loss of control over eating and more avoidant behavior due to a poor body 
image, compared to patients who experienced successful weight loss. Furthermore, 
in comparison, patients who experienced suboptimal weight loss, reported higher 
scores on an impulsivity self-report and reported more depressive symptoms. With 
regard to non-psychological factors, having a body mass index  over 50 kg/m2 at time 
of surgery, and a longer follow-up period after surgery were associated with poorer 
weight loss. On the other hand, being able to lose more weight loss in the early period 
after surgery, was associated with better weight outcome later on. Our hypothesis 
that reported post-operative eating disorder pathology appears to be associated with 
suboptimal weight loss, was confirmed. 
Our findings that bariatric patients appear to profit less from treatment compared to 
non-bariatric patients may be seen in line with recent literature stating that behavioral 
interventions are best offered after surgery (Meany, Conceição, & Mitchell, 2014). As 
literature suggests that both pre-operative disturbed eating behaviors can remit due 
to surgery, and that maladaptive eating patterns can emerge after surgery while not 
being present pre-operatively (Meany, Conceição, & Mitchell, 2014), it may be recom-
mended offering treatment aimed at eating disorder pathology only post operatively. 
 
Post-operative close monitoring of possible (re)occurrence of a maladaptive 
eating pattern and or psychopathology like depressive symptoms during a consider-





Dit proefschrift gaat over de effectiviteit van psychologische behandelingen voor 
volwassen cliënten met anorexia, bulimia of een eetbuistoornis en dit proefschrift 
gaat over de effectiviteit van behandelinterventies voor eetgestoord gedrag zoals dit 
kan voorkomen bij cliënten met morbide obesitas. 
Obesitas, een abnormale of een zodanig overmatige vetstapeling in het lichaam dat 
dit aanleiding geeft tot gezondheidsrisico’s, is niet als een psychiatrische eetstoornis 
geïncludeerd in de eetstoornissen sectie van het psychiatrisch classificatiesysteem 
DSM-5 (American Psychiatric Association, 2013) omdat obesitas niet noodzake- 
lijkerwijs wordt veroorzaakt door psychologisch disfunctioneren (Hoek & van 
Elburg, 2014). 
Het hebben van een eetstoornis heeft een aanzienlijke impact op zowel psycho-
logisch als lichamelijk functioneren, dit geldt evenzeer voor (morbide) obesitas 
(Luppino et al., 2010). Zo hangt het hebben van obesitas onder meer samen met 
een verhoogde kans op het ontwikkelen van een depressieve stoornis, dit geldt in 
het bijzonder voor vrouwen die kampen met ernstig overgewicht (Luppino, 2010). 
Er wordt geschat dat rond de 30% van personen die behandeling zoekt voor hun 
overgewicht gediagnosticeerd kan worden met een eetbuistoornis (de Zwaan, 2001; 
Meany, Conceição, & Mitchell, 2014). Bij obesitas cliënten die zich aanmelden voor 
bariatrische chirurgie wordt geschat dat tussen de 27% en 42% bekend is met een 
as I stoornis, voornamelijk met een affectieve stoornis, een angststoornis en / of 
een eetstoornis (Herpertz et al., 2004). 
Hoewel anorexia in niet-westerse landen weinig voorkomt, zijn bulimia en 
eetbuistoornissen wereldwijd veelvoorkomend (Hoek, 2016). De prevalentie van 
obesitas (er is sprake van een body mass index boven 30 kg/m2) is wereldwijd sinds 
1975 verdrievoudigd. Een beperkt deel van de mensen met obesitas heeft morbide 
obesitas (er is sprake van een body mass index boven 40 kg/m2) (NCD Risk Factor 
Collaboration, 2016).
Behandelresultaten van eetstoornis behandelingen zijn tamelijk beperkt. Zo 
schat men dat van de patiënten met anorexia ongeveer 30% herstelt gedurende het 
eerste decennium van hun ziekte (Wonderlich, Bulik, Schmidt, Steiger, & Hoek, 
2020). Voor bulimia en voor eetbuistoornissen variëren herstelpercentages tussen de 
22% en de 68% (De Jong, Schoorl, & Hoek, 2018). Omdat gebleken is dat voor morbide 
obesitas niet-chirurgische behandelingen geen duurzaam effect sorteren, is baria- 
trische chirurgie behandeling eerste keus. Hoewel bariatrische chirurgie bij veel 
patiënten tot significant gewichtsverlies leidt, lijkt er bij 20% tot 30% van geopereerde 
patiënten sprake van suboptimaal gewichtsverlies; òf patiënten vallen na operatie 
onvoldoende af, òf na aanvankelijke gewichtsreductie komt men weer aan in gewicht 
(Livhits et al., 2011). Literatuur geeft aan dat psychologische factoren en gedrags-
factoren met suboptimale gewichtsverlies samenhangen (Wimmelmann, Dela, & 
Mortensen, 2014).
Dit proefschrift bestaat uit drie delen. Deel I gaat over de werkzaamheid van 
psychologische behandelingen voor patiënten met anorexia nervosa. In deel II 
beschrijven wij twee studies waarin de effectiviteit en de kosteneffectiviteit van 
Cognitive behavior therapy-Enhanced, een aanbevolen gespecialiseerde psycholo- 
gische behandelmethodiek, vergeleken is met treatment-as-usual. In deel III is geke-
ken naar postoperatieve psychologische factoren en gedragsfactoren die mogelijk 
samenhangen met suboptimaal gewichtsverlies na een maagverkleiningsoperatie. 
Deel	I		De	behandeling	van	anorexia
De effectiviteit van gespecialiseerde psychologische anorexia behandelingen 
Voor de behandeling van anorexia, de eetstoornis met het minst gunstige behandel-
resultaat, zijn slechts een beperkt aantal gespecialiseerde psychologische behandel- 
methodieken beschikbaar. Resultaten met betrekking tot de effectiviteit van deze 
behandelingen spreken elkaar tegen; zo bestaat er onvoldoende evidentie voor 
de superioriteit van de ene gespecialiseerdere behandeling boven de ander (Hay, 
Claudino, Touyz, & Abd Elbaky, 2015). Sterker nog, er bestaat geen evidentie voor 
de superioriteit van gespecialiseerdere behandelingen boven niet-gespecialiseerde, 
controle behandelingen, zoals deze in de reguliere praktijk doorgaans worden aange-
boden (Zeeck et al., 2018; Murray, Quintana, Loeb, Griffiths, & Le Grange, 2019). Nu 
er in de afgelopen jaren een aantal high-quality gerandomiseerde klinische trials zijn 
gepubliceerd waarin recent ontwikkelde psychologische anorexia behandelingen 
zijn onderzocht, was het zinnig een meta-analyse uit te voeren om zo te onderzoeken 
of de bewijslast voor psychologische anorexia behandelingen verbreed zou kunnen 
worden. In hoofdstuk	2 beschrijven wij een meta-analyse waarin onderzocht is of 
gespecialiseerde psychologische behandelingen beter behandeleffect sorteren dan 
niet-gespecialiseerde, controle behandelingen. De hypothese was dat gespeciali- 
seerde behandelingen superieur zijn aan controle behandelingen, zowel op 
de uitkomstmaat ‘gewichtsherstel’, op de uitkomstmaat ‘afname van eetstoornis 
pathologie’ als op de uitkomstmaat ‘verbetering van kwaliteit van leven’. 
Bevindingen
De bevindingen van de meta-analyse gaven aan dat er geen verschillen gevonden 
werden tussen gespecialiseerde behandelingen en controle behandelingen, niet ten 
aanzien van ‘gewichtsherstel’ niet ten aanzien van ‘afname van eetstoornis pathologie’ 
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en niet ten aanzien van ‘verbetering van kwaliteit van leven’. Deze bevindingen 
duiden erop dat aanbevolen psychologische behandelingen geen meerwaarde 
hebben boven controle behandelingen. Er werd gevonden dat studies waarin pati-
enten ouder dan 18 jaar waren geïncludeerd meer effectief waren op gewichtsherstel 
dan studies waarin ook patiënten onder de 18 jaar waren geïncludeerd. In high-quality 
studies en in studies waarin training voor therapeuten gerapporteerd was, werden 
grotere effecten gevonden op zowel ‘gewichtsherstel’ als op ‘verbetering van kwaliteit 
van leven’ in vergelijking met low quality studies en in vergelijking met studies waarin 
therapeuten training niet vermeld was. Sensitivity analyses waarin alleen high-quality 
studies werden geïncludeerd lieten echter ook geen verschil zien tussen gespeciali-
seerde behandelingen en controle behandelingen. 
De hypothese dat gespecialiseerde behandelingen superieur zijn aan controle 
behandelingen werd niet bevestigd. Voordat met zekerheid gesteld kan worden dat 
aanbevolen psychologische behandelingen geen meerwaarde hebben boven controle 
behandelingen, moet er enig voorbehoud worden gemaakt. Gezien het beperkt aantal 
gepubliceerde gerandomiseerde klinische anorexia trials, kon slechts een beperkt 
aantal studies in de meta-analyse worden geïncludeerd. Ook was er sprake van een 
hoge heterogeniteit waardoor een aantal potentieel krachtige, outlier studies, moest 
worden geëxcludeerd. Verder maakt dat de aard van anorexia behandelingen, ook 
van een controle behandelconditie, dat er altijd interventies zullen moeten worden 
aangeboden gericht op herstel van ondergewicht. Vanwege deze overlap tussen 
behandelcondities en controle condities is eventuele superioriteit van een gespecia-
liseerde behandeling boven een controle conditie lastig vast te stellen is. 
Deel	II			
Cognitive	Behavioral	therapy-Enhanced	
Effectiviteit en kosteneffectiviteit van CBT-E vergeleken met treatment-as-usual
In het tweede deel van dit proefschrift is onderzocht wat de effecten zijn op 
behandeleffectiviteit en op kosteneffectiviteit van het vervangen van het eclectisch 
treatment-as-usual Novarum behandelaanbod door een evidence-based behande-
ling, Cognitive Behavior Therapy- Enhanced (CBT-E, Fairburn 2008). In hoofdstuk	3	
is de (kosten)effectiviteit onderzocht voor klinische en poliklinische cliënten met 
bulimia en een eetbuistoornis en een body mass index groter dan 17.5 kg/m2. In 
hoofdstuk	 4 hebben we (kosten-)effectiviteit onderzocht voor klinische en poli- 
klinische cliënten met anorexia. 
Onze hypothese was dat zowel de effectiviteit alsook de kosteneffectiviteit 
superieur zouden zijn in beide CBT-E cohorten, zowel voor cliënten met normaal 
gewicht als voor cliënten met ondergewicht. Aangenomen werd dat, in lijn met de 
literatuur, behandeluitkomsten verbeteren wanneer je een gespecialiseerde behan-
deling aanbiedt, vergeleken met een eclectische behandeling (Thompson-Brenner 
et al., 2018; Kazdin, Fitzsimmons-Craft, & Wifley, 2017; Waller & Turner, 2016). Aan- 
gezien de ambulante CBT-E methodiek een vaste, relatief korte behandelduur heeft 
en het klinisch CBT-E programma van nature beperkt van duur is, veronderstelden 
wij in beide CBT-E cohorten een verlaging van de directe behandelkosten en een 
superieure kosteneffectiviteit. 
Bevindingen
Voor cliënten met bulimia, een eetbuistoornis of een andere gespecificeerde 
 voedings- of eetstoornis met een body mass index groter dan 17.5 kg/m2 werden er 
tussen treatment-as-usual en CBT-E geen verschillen gevonden op afname van 
eetstoornispathologie; in beide cliëntgroepen verminderde eetstoornispathologie. 
Kosteneffectiviteitsanalyses lieten zien dat met 71% waarschijnlijkheid CBT-E 
dominant is aan treatment-as-usual en leidt tot meer remissies tegen lagere 
behandelkosten. Deze superioriteit werd gevonden voor zowel klinische als poli- 
klinische clientgroepen en hangt samen met de gevonden kortere behandelduur en 
de kortere opnameduur binnen het CBT-E cohort. 
Voor eetstoornis cliënten en een body mass index groter dan 17.5 kg/m2 werd de 
hypothesis dat CBT-E meer effectief is dan treatment-as-usual niet bevestigd. De hypo-
these dat CBT-E meer kosteneffectief is werd bevestigd. 
Bevindingen voor cliënten met anorexia lieten zien dat gewichtsherstel in het 
CBT-E cohort groter is dan in het treatment-as-usual cohort. Los van het betere 
gewichtsherstel werden er tussen de beide cohorten geen andere verschillen gevonden 
in behandeluitkomst; anorexia attitudes verbeterden in beide groepen.
 
Uitgaand van directe zorgkosten en gebruik makend van de uitkomstmaat ‘bereiken 
van gezond gewicht’, liet de ICER verdeling een 97% waarschijnlijkheid zien dat 
CBT-E leidt tot beter effect, tegen hogere kosten. De CEAC curven gaven een waar-
schijnlijkheid aan van een beter behandeleffect van CBT-E boven treatment-as-usual, 
als je een willingness-to-pay van €9713 voor een extra remissie veronderstelt. Als de 
uitkomstmaat ‘remissie eetstoornispathologie’ werd gebruikt in de kosteneffectivi-
teitsanalyses, werd er tussen beide cohorten slechts minimale verschillen gevonden.
Voor cliënten met anorexia werd de hypothese dat CBT-E meer effectief zou zijn 
bevestigd ten aanzien van gewichtsherstel. Kosteneffectiviteitsanalyses gaven aan 
dat CBT-E superieur was aan treatment-as-usual op gewichtsherstel, tegen hogere 
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kosten. Deze hogere kosten kunnen samenhangen met het groter aantal cliënten 
dat binnen het CBT-E cohort werd opgenomen en kunnen ook samenhangen met de 
lagere drop out binnen het CBT-E cohort, waardoor meer cliënten het beoogd aantal 
behandelzittingen aangeboden heeft gekregen.
 
Bevindingen van beide besproken studies kunnen helpend zijn bij het implemen-
teren van een gespecialiseerde psychologische behandeling zoals CBT-E in de dage-
lijkse GGZ praktijk. Immers, voor eetstoornis cliënten met een normaal gewicht lijkt 
de kosteneffectiviteit van CBT-E superieur aan treatment-as-usual; voor cliënten met 
anorexia zijn het betere gewichtsherstel en de lagere drop-out belangrijke benefits. 
De gevonden hogere behandelkosten lijken redelijk en rechtvaardigen een brede 




Psychologische factoren die samenhangen met suboptimaal gewichtsverlies 
na bariatrische chirurgie
In deel III wordt ingegaan op eetstoornis pathologie zoals deze kan voorkomen 
bij morbide obese patiënten die opteren voor een maagverkleiningsoperatie, 
richtlijnbehandeling voor morbide obesitas. Hoewel bariatrische chirurgie bij veel 
patiënten lijdt tot significant gewichtsverlies, lijkt er bij 20 tot 30% van geopereerde 
patiënten sprake van suboptimaal gewichtsverlies (Livhits et al., 2011). Verschillende 
demografische factoren worden verondersteld samen te hangen met dit suboptimale 
gewichtsverlies; van het mannelijk geslacht zijn, een lagere sociaal economische 
status hebben, ten tijde van de operatie lijden aan super obesitas (een body mass index 
boven 50 kg/m2) en een relatief hogere leeftijd hebben (Livhits et al., 2011; Wimmel-
mann et al., 2014). Ten aanzien van psychologische factoren lijken postoperatief 
eetgestoord gedrag, het onvoldoende naleven van postoperatieve behandeladviezen 
en een gebrekkig psychologisch functioneren samen te hangen met suboptimaal 
gewichtsverlies (Hindle, De la Piedad Garcia & Brennan, 2017).
In hoofdstuk	 5 wordt de opzet beschreven van een multimodale groeps- 
behandeling die Novarum aanbood aan patiënten in aanloop naar een maag- 
verkleiningsoperatie en worden pilot bevindingen met betrekking tot behandel- 
effect beschreven. Uitgaande van het frequent gerapporteerde eetgestoord gedrag 
door mensen met ernstig obesitas (De Zwaan 2001; Wilson & Fairburn, 2007), was de 
aanname dat het aanleren van vaardigheden gericht op normaliseren van het 
eetpatroon en gericht op het vergroten van zelfcontrole over eetdrang, zinnig was. 
Aangenomen werd dat deze vaardigheden helpend zouden zijn om de aanbevolen 
postoperatieve voedingsadviezen te kunnen opvolgen, en zo operatie effect zou 
kunnen verbeteren.
In hoofdstuk	6 wordt een cross sectionele studie beschreven waarin de associatie 
werd onderzocht tussen postoperatief aanwezige psychologische en gedragsvaria- 
belen en suboptimaal gewichtsverlies in een groep van 140 patiënten die baria- 
trische chirurgie (malabsorptieve ingrepen en een combinatie van restrictieve en 
malabsorptieve ingrepen) hebben ondergaan. De hypothese was dat postoperatief 
gerapporteerde eetstoornispathologie geassocieerd is met suboptimaal gewichts- 
verlies, aangezien optreden van eetstoornispathologie maakt dat aanbevolen richt- 
lijnen voor eetgedrag na operatie niet opgevolgd kunnen worden en het gewichts- 
verlies daarom beperkter zou zijn. 
Bevindingen
De belangrijkste bevinding in hoofdstuk 5 was dat patiënten die opteerden voor 
bariatrische chirurgie minder lijken te profiteren van behandeling dan deelnemers 
die niet in een maagverkleinings traject zaten. In vergelijking verliezen bariatrische 
patiënten minder gewicht en ook sociaalvermijdingsgedrag vanuit een negatieve 
lichaamsbeeld verbetert in deze groep minder. Bij aanvang van de behandeling 
werden er tussen patiënten die wel en patiënten die niet opteerden voor bariatrische 
chirurgie geen verschillen gevonden in de mate van overgewicht, in de ernst van 
negatieve lichaamsbeleving of in de mate waarin men comorbide psychische klach-
ten rapporteert. In hoofdstuk 6 werd gevonden dat in de onderzochte patiëntengroep 
19% van de patiënten suboptimaal gewichtsverlies rapporteert. Patiënten die sub- 
optimaal gewichtsverlies rapporteerden, rapporteerden meer eetstoornis patho-
logie symptomen, rapporteerden meer controle verlies over eten en meer sociaal 
vermijdingsgedrag vanwege een negatief lichaamsbeeld vergeleken met patiënten 
die succesvol gewichtsverlies rapporteerden. Ook rapporteerden patiënten met sub- 
optimaal gewichtsverlies verhoudingsgewijs meer impulsiviteitsklachten en meer 
somberheidsklachten. Voor wat betreft niet-psychologische factoren werd gevonden 
dat een body mass index groter dan 50 ten tijde van operatie en een langere follow 
up periode na operatie beiden geassocieerd waren met suboptimaal gewichtsver-
lies. Aan de andere kant, meer gewichtsverlies in de periode vlak na operatie was 
geassocieerd met beter gewichtsverlies later. De hypothese dat gerapporteerde 




Onze bevinding dat bariatrische patiënten minder lijken te profiteren van de 
aangeboden gedragsveranderende interventies dan deelnemers die niet in een 
maagverkleiningstraject zijn, sluit aan bij de literatuur waarin gesteld wordt dat 
gedragsinterventies het best na operatie aangeboden kunnen worden (Meany, 
Conceição, & Mitchell, 2014). Aangezien in de literatuur gevonden wordt dat pre- 
operatief bestaand eetgestoord gedrag in remissie kan raken na operatie, maar 
ook dat eetgestoord gedrag na operatie kan ontstaan terwijl dit voor operatie niet 
voorkwam, is het aan te raden eetstoornisinterventies alleen na operatie aan te 
bieden (Meany, Conceição, & Mitchell, 2014). Het is aan te bevelen om patiënten 
gedurende geruime tijd na operatie te blijven vervolgen, onder meer om het ontstaan 
van eetgestoord gedrag of het optreden van psychologische problemen zoals 
depressieve klachten tijdig te kunnen signaleren. 
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